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1 Introduction 
1.1 Asymmetric Transfer Hydrogenation Reaction to Carbonylbonds  
1.1.1 Transfer Hydrogenation versus Hydrogenation  
 
 The asymmetric reduction of prochiral ketones to their corresponding optical 
active alcohols is one of the most important molecular transformations in modern 
synthetic chemistry[1,2]. The products are common intermediates for pharmaceuticals, 
biologically active compounds and fine chemicals. For example, they are used in the 
synthesis of Aprepitant (1, a NK-1 receptor antagonist)[3] and herbicide 2[4] (figure 1). 
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Figure 1 The importance of chiral secondary alcohols in chemical synthesis 
 
The racemic reversible reduction of carbonyls to carbinols with 
superstoichiometric amounts of aluminium alkoxides in alcohols was found 
independently by Meerwein, Ponndorf and Verley in 1925[5,6,7]. Scheme 1 shows the 
accepted mechanism of the Meerwein-Ponndorf-Verley reaction (MPV) involving a 
six-membered transition state[8].   
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Scheme 1 MPV: reversible reaction and mechanism 
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Only in the early 1990’s, first successful versions of catalytic asymmetric MPV 
reactions have been reported using C2 symmetric chiral ligands. Pioneering efforts 
were made by the group of Pfaltz using Ir(I) dihydrooxazole complexes 3[9] and the 
group of Genêt with chiral diphosphine Ru(II) catalysts 4[10]. Evans showed that 
lanthanide complexes of tridentate ligand 5[11] reduce aromatic ketones with 
enantioselectivities up to 97% (figure 2).  
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Figure 2 Primary chiral ligands in the asymmetric catalytic version of MPV 
  
In 1996, Noyori and co-workers found that Ru(II) complexe (S,S)-6 modified 
with a 6η- arene and a chiral N-monotosylated 1,2-diamine serve as excellent 
catalysts. It was a breakthrough for catalytic asymmetric transfer hydrogenation 
(ATH) reactions to ketones in terms of enantioselectivities, catalyst loading and 
substrate scope[12]. For example, acetophenone can be reduced quantitatively to its 
corresponding (S)-alcohol with up to 98% ee (scheme 2).  
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Scheme 2 Noyori’s Ru(II) based ATH system using chiral monotosylated 1,2-
diamines as chiral ligands 
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This ATH system is strongly chemoselective. Olefinic bonds, halogen atoms, 
nitro groups and ester functionalities are not affected under such conditions. Several 
efforts have been made in the last decade to improve the catalytic properties by 
designing and employing new chiral ligands. Nevertheless, the system described by 
Noyori remains the method of choice for many substrates up to date due to excellent 
reactivity, selectivity, low costs and readily availability of chiral ligands. Chiral amino 
alcohols like indanol 7[13] and 2-azanorbornyl alcohol 8[14] are also known to act as 
ligands in ATH. The stereoselectivities are comparable with the monotosylated 
diamine analogue but the reactivities are slightly lower. Another interesting difference 
between 1,2-amino alcohols and 1,2-monotosylated diamines is the function of the 
two stereogenic centres R1 and R2 (figure 3). Amino alcohols (X = O) show high 
enantioselectivities for both cis and anti configured ligands, whereas monotosylated 
diamines (X = NTs) require anti configuration for high optical purity of the products. 
Furthermore it could be demonstrated that the stereogenic centre R2 is more 
important for the stereo outcome of the reaction than R1 with amino alcohol ligands. 
For 1,2-monotosylated diamines it’s directly the opposite[15].  
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Figure 3 left: Amino alcohols as ligands in Ru(II) catalyzed ATH reactions; 
 right: monotosylated diamine vs. amino alcohol 
 
Wills[16] showed that a tethered Ru(II) complex containing an arene ligand 
which is covalently bound to the amine functionality in 9 shows higher reactivity than 
non tethered complex 6 (figure 4). This contribution illustrates a rare example in 
which the original Noyori system could be improved in terms of catalyst loading (0.01 
mol%) and reactivity. Interestingly, ligand 10 which is connected via the tosyl motif, is 
less reactive than 6 and 9. The role of the tether is not fully understood at the 
moment. However, it is speculated that the chiral elements of the catalyst are locked 
due to the decreased flexibility of the system.  
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Figure 4 Tethered ligands can improve the reactivity and lower the catalyst loading 
 
Arenes are known to coordinate to many transition metals in hexahapto 
fashion[17]. Several features make them popular ligands in asymmetric catalysis: (1) 
they occupy three out of six coordination sites of Ru in its octahedral environment, 
leaving two sites for a chiral bidentate ligand and one site for the halide/hydride; (2) 
they are easily modified; (3) the dimeric dihalide precursors are readily available.  
Their role in the catalytic process was investigated by Mortreux et al[18]. Model 
substrate 11 was reduced with a variety of substituted arenes 12 a-e using i-PrOH as 
hydrogen source and chiral amino alcohol 13 as ligand (scheme 3). There is no direct 
correlation between steric bulkiness of the arene and the optical purity of β-hydroxy 
ester 14. Anyway, bulky arene 12 c and the arene containing a strong electron 
withdrawing group 12 e lower the reactivity dramatically. 
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Scheme 3 Influence of substitution pattern of arenes in ATH 
 
Isopropanol was chosen as a hydrogen source in initial studies[19]. An 
additional base (alkoxides) was required to obtain reactivity but the conversions 
remained moderate due to reversibility of the reaction. A simple solution to solve this 
problem is the use of an azeotropic mixture of formic acid and triethylamine. The 
evolution of carbon dioxide makes the process irreversible and increases the yields 
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to a satisfying level[12]. Isopropanol and formic acid avoid the use of hazardous 
molecular hydrogen and the special technical equipment. The low costs and 
operational simplicity are two other advantages of organic hydrogen sources, which 
are applied to all ligands mentioned so far.  
Nevertheless, asymmetric hydrogenation (AH) using molecular hydrogen 
exists and is illustrated in scheme 4. It was again Noyori who developed ruthenium 
based catalyst (S,S,S)-15 bearing a chiral diphosphine and a chiral diamine[20]. This 
system is able to reduce a wide range of aromatic ketones with outstanding 
stereocontrol (up to 99% ee) in the presence of a base.   
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Scheme 4 Asymmetric hydrogenation using molecular hydrogen  
 
Huge endeavours have been made to employ new chiral ligands in AH as well. 
Only few of them could improve the catalytic activity (figure 5). Combinations of 
diphosphines such as 16 xyl-BINAP[21], 17 P-Phos[22] and 18 PhanePhos[23] with 1,2- 
or 1,4-diamines such as 19 DAIPEN[21] and 20 IPHAN[24] lead to excellent reduction 
results for numerous aromatic ketones. However, the proper catalyst has to be found 
for each substrate since no universal catalyst is known up to date. 
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Figure 5 Advanced ligands for asymmetric hydrogenation 
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Table 1 compares the two different methodologies (ATH vs. AH). 
Hydrogenations are still favoured in industrial applications due to lower catalyst 
loading, higher substrate concentration and slightly shorter reaction times.  
 
 Transfer Hydrogenation Hydrogenation 
Stereoselectivity  aromatic: 95-98% aromatic: > 98% 
Substrate concentration up to 1M up to 10M 
Reactivity slower than AH faster than ATH 
Solvent organics; H2O is possible limited to organic solvents 
Large scale synthesis small-medium scale large scale 
Turn over Number (TON) up to 104 up to 106 
Catalyst loading 10-2 mol% 10-4 mol% 
Hydrogen source i-PrOH or formic acid molecular H2 
External base i-PrOH: 10-1 eq. of i-PrOK 10-3 eq. of i-PrOK 
 
Table 1 Transfer Hydrogenation versus Hydrogenation 
Asymmetric transfer hydrogenation and asymmetric hydrogenation are 
powerful methods for the enantioselective reduction of prochiral ketones. They will 
probably replace aluminium hydride and boron hydride systems using stoichiometric 
amounts of reductant like BINAL-H[25] or CBS[26] in the future. Nevertheless, there is 
still room for improvement. Aliphatic substrates are only reduced in poor to moderate 
enantioselectivities. Water as solvent can’t compete with organic solvents yet. The 
attention will be turned to these two special features after discussion of the 
mechanism of AH and ATH. 
1.1.2 Mechanistic Aspects  
 
 Experimental and theoretical studies revealed that ATH occurs via newly 
discovered metal-ligand bifunctional catalysis[27], which is in contrast to accepted 
classical pathways involving metal coordinated alkoxides[28]. The mechanism is 
based on a concerted transfer of both a hydride and a proton from the catalyst to the 
carbonyl bond over a pericyclic transition state 21 (scheme 5).   
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Scheme 5 Metal-ligand bifunctional mechanism in ATH 
 
 An external base is necessary to transform 18-electron precatalyst 22 into 
complex 23 under elimination of HCl whereas no further base is needed in all 
remaining catalytic steps. Coordinatively unsaturated complex 23 reacts with 
isopropanol to Ru(II) hydride species 24, which then reduces the substrate to the 
corresponding alcohol. Simultaneous transfer of the hydride and one proton of the 
amino group to the substrate occurs via transition state 21 and regenerates 23. 
Ruthenium complexes 22-24 could be isolated and characterised by x-ray 
analysis[29]. 22 possesses a distorted octahedral structure containing an 
intramolecular hydrogen bond between the chloride and the axial proton of the amino 
functionality. Square planar 16-electron intermediate 23 contains a short ruthenium-
nitrogen bond (1.897 Å) indicating a double bond character between the metal centre 
and the amino nitrogen. Octahedral 18-electron complex 24 is structurally very 
similar to 22. 1H-NMR-spectroscopy studies in deuterated toluene showed a 
resonance at -5.47 ppm corresponding to the metal hydride and moreover 
demonstrated that the diastereomeric purities of 22 and 24 are higher than 98% with 
chiral ligand (S,S)-6.  
The presence of a NH or NH2 in the chelating ligand is crucial for catalytic 
activity. Corresponding dialkylated analogues are totally inactive[27]. The NH moiety 
forms a hydrogen bond with the oxygen of the carbonyl compound to facilitate the 
nucleophilic hydride transfer to the carbon atom in 21. Experimental data disclose 
that 1,2-amino alcohols and 1,2-monotosylated diamines serve as exquisite ligands, 
while 1,2-diols or 1,2-diamines do not show any catalytic activity at all in ATH. Kinetic 
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isotope effect investigations pointed out that the formation of hydride species 24 is 
the rate limiting step in the catalytic cycle[29]. Furthermore, it could be demonstrated 
that the reduction is concerted and doesn’t proceed stepwise[30]. 
The chirality of the ligand determines the enantioselection of this asymmetric 
process. But this differentiation caused by steric interactions between the chiral 
ligand and the ketone is not the only source of enantioselectivity[31]. An attractive 
CH/π interaction[32] between the arene ligand and the aromatic ring of the carbonyl 
substrate seems to play an important role in the enantioselection. This fact is 
supported by the certainty that alcoholic products lacking an aromatic moiety show 
only very poor ee’s[31].  
An alternative mechanism involving a direct hydride transfer from an alcohol 
can be ruled out by computational studies and the fact that the stereochemical 
outcome of the reduction is independent from the chirality of the hydrogen donor[33]. 
Another proposed pathway is the migratory insertion mechanism[33] which can be 
excluded because coordinatively saturated hydride species like 24 don’t bind an 
additional required alkoxide ligand.    
Asymmetric hydrogenation is proposed to proceed in a similar way to the one 
described above for the ATH[34]. Octahedral complex 25 is formed from dihalide 
precursor 26 by successive loss of chloride, coordination of hydrogen and heterolytic 
cleavage under basic conditions (scheme 6). Trans Ru(II) dihydride species 25 could 
be characterised by x-ray and NMR analysis[35]. 
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Scheme 6 Proposed mechanism in asymmetric hydrogenation 
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In contrast to classical diamine free BINAP hydrogenation[28] neither the ketone 
nor the alcohol interacts with the metal centre throughout the process. This metal- 
ligand bifunctional mechanism involves simultaneous transfer of hydridic Ru-H and 
protic N-H from 25 via a six-membered transition state. Complex 27 stabilized by a 
Ru-N double bond reacts with molecular hydrogen and regenerates 25[36].   
One aspect remained a mystery for many years. Although the two 
methodologies are linked mechanistically, transfer hydrogenation catalysts showed 
no reactivity with H2 as hydrogen source. Similar observations have been made for 
the opposite case. This result is surprising because the precursor and metal hydride 
of both processes are viewed to be essentially the same[37]. However generating a 
cationic Ru species by switching the reaction conditions from basic to acidic seems 
to overwhelm the problem using molecular hydrogen in combination with transfer 
hydrogenation catalysts[38] (scheme 7). 
O
OH
Ru
OTfNH2
TsN
28
Ru
solventNH2
TsN
Ru
TsN NH
TfO-
29
Ru
NH2
TsN
TfO-
H
H
Ru
HNH2
TsN
31
30
32
+ H2
- H2
- H+
+ H+
+ H+
- H+
*
 
 
Scheme 7 Use of a transfer hydrogenation catalyst with H2 by changing the catalytic 
conditions from basic to acidic  
 
The catalytic cycle starts with ionisation of 28 in methanol to give ion pair 
complex 29. Ruthenium reversibly coordinates an H2 molecule to form 2η-complex 
30. Deprotonation by the solvent leads to Ru hydride complex 31, which reduces 
enantioselectively aromatic ketones to give the corresponding alcohols and 32. 
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Finally, 29 is regenerated by protonation of 32 with TfOH. This finding opens the way 
to hydrogenate base sensitive substrates as well[39]. In addition to this, it suggests 
that a second catalytic cycle exists in hydrogenation under acidic conditions. Future 
studies will teach us more about this system and show if determined combination of 
AH conditions and ATH catalysts (and the other way round) lead to more 
sophisticated methods. 
 
1.1.3 ATH performed in Water 
 
The considerable interest in the development of water soluble catalysts has 
two main reasons. Firstly, the separation and recovery of the catalyst is much easier. 
The product is extracted with organic solvents while the catalyst remains in the 
aqueous phase. Secondly, water which replaces organic solvents fulfils the criteria of 
environmentally friendly chemistry. Catalysis performed in water includes the use of 
biphasic systems as well as the addition of surfactants[40]. 
Most of reported chiral water soluble ligands have been prepared by 
incorporation of charged groups such as sulfonates[41] 33 a and ammonium ions[42] 
33 b to known ligands (figure 6). The conversions and enantioselectivities are 
generally lower in aqueous phase than in organic solvents. 
33 a
H2N HN S
O
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NH3
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Br
Br
 
 
Figure 6 Chiral water soluble ligands in ATH 
 
  Xiao demonstrated in 2004 that unmodified ligand 6 shows high catalytic 
activity in water using sodium formate instead of formic acid/triethylamine[43]. For 
example acetophenone is reduced to the (S)-alcohol with 76% yield and 95% ee 
within 12 hours. The proposed mechanism is based on Noyori’s findings and involves 
again an 18-electron Ru hydride 34 as key intermediate (scheme 8).  
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Scheme 8 Possible mechanism of ATH in water using sodium formate 
 
1.1.4 Reduction of Aliphatic Substrates 
 
 Reduction of aliphatic ketones remains a major challenge in asymmetric 
hydrogenation. Because the aromatic moiety is missing, totally aliphatic substrates 
are lacking of sp2-orbitals, which can interact with d-orbitals of the metal centre of the 
catalyst. But right these interactions are the origin of enantioselectivity in most 
asymmetric reduction processes. This chapter shows four rare examples of 
asymmetric hydrogenations of alkyl-alkyl ketones with satisfying ee values, including 
a short summary about asymmetric enzymatic reductions.    
In 1987, Corey reported a borane based reduction using chiral 
oxazoborolidines, derived from simple amino acids (scheme 9)[44]. This system is 
able to reduce various aryl ketones with ee’s higher than 95%. In addition to this, 1-
cyclohexylethanone 35 is reduced with 84% ee. The reaction is very fast. All starting 
material is converted to the corresponding alcohol within 10 minutes. 
Oxazoborolidine structure 36 offers both, lewis acidity and lewis basicity in one single 
molecule. The boron of the ring fixes the oxygen of the carbonyl bond. The nitrogen 
next to the boron of the ring binds the boronhydride and thus brings the hydride close 
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to the carbonyl bond. The hydride transfer occurs preferentially from one face 
because the methyl group at the heterocyclic boron atom directs the small alkyl 
group of the ketone upwards. The larger alkyl rest of the ketone is pointed 
downwards due to unfavourable steric interactions with the B-CH3 group. 
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Scheme 9 A first example of a reduction of an aliphatic ketone and the face specific 
hydride transfer model from Corey 
 
 Almost 20 years later, Noyori observed that a system comprising the 
combination of BINAP and α-picolyl amine in 37 reduces tert.-alkyl ketones with very 
high ee’s[45]. But the substrate scope of this AH catalyst is very narrow. Only tert.-
alkyl ketones can be reduced in a satisfying manner. Other aliphatic and even 
aromatic ketones show very poor enantioselection (scheme 10).    
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Scheme 10 Asymmetric reduction of tert.-alkyl ketones 
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 In 2006, Reetz dramatically increased the substrate scope of aliphatics using 
Ru(II)-diphosphonite catalyst 38[46]. Challenging substrates like 1-cyclohexylethanone 
35 and 3-methylbutan-2-one 39 are reduced with essentially complete 
enantioselectivity under AH conditions. Whereas linear aliphatic substrates like 2-
hexanone 40 and 4-methyl-pentan-2-one 41 can still not be reduced with ee’s higher 
than 82% nowadays. The BINOL-derived diphosphonite ligand is shown in scheme 
11. The active ruthenium species and the mechanism are not clear yet up to date.  
O
P PO
O O
O
38
O O
O O
35, 99% ee 39, 99% ee
40, 82% ee 41, 79% ee  
 
Scheme 11 Diphosphonite ligand 38 in AH to aliphatic ketones 
 
The catalysts for the asymmetric reduction of ketones can be classified into 
two categories: chemical catalysts and biological catalysts[47]. Before an impressive 
example of a biocatalytic reduction of aliphatic ketones is presented, the two different 
methodologies are compared in table 2.  
 
 Chemical catalyst Bio catalyst 
Stereoselectivity & 
Substrate scope 
aromatics: excellent ee’s, 
aliphatics: moderate ee’s 
aromatics and aliphatics  up 
to 99% ee 
Substrate concentration in the M range in the mM range 
Reaction times faster than bio cat. slower than chem. cat. 
Solvent several organic solvents often water 
Large scale synthesis well established problematic 
Hydrogen source H2, alcohols, formate alcohols, glucose, formic acid 
Modification methods by chemical design and 
synthesis   
by mutagenesis  
Availability many catalysts available 
for a broad reaction scope 
still difficult to get enough 
coenzyme (NADH)  
Green chemistry produces a lot of metal 
waste; organic solvents 
are not optimal 
no metal waste; very 
environmentally friendly when 
run in water 
Price cheap-moderate moderate-expensive 
 
Table 2 Advantages and disadvantages of chemical catalysts 
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One of the major disadvantages using bio catalysts is the difficult application 
to large scale synthesis, which is caused by solubility problems of the substrates in 
water and the long reaction times. In addition to this, it’s troublesome to isolate the 
product from the reaction mixture. Nevertheless, the advantages are obvious: 
excellent stereoselectivities for a broad substrate scope including challenging 
aliphatics and environmentally friendly and safe procedures (no molecular hydrogen 
in use).  
Dehydrogenases are enzymes that catalyse the reversible reduction of 
carbonyl bonds. Natural substrates of the enzymes are alcohols like ethanol, lactate 
and glycerol and their corresponding carbonyl compounds. It’s noteworthy that the 
substrate scope is not limited to natural products. To exhibit catalytic activities, 
enzymes require a coenzyme such as NADH 42 (nicotinamide adenine dinucleotide) 
which transfers a hydride to the carbonyl bond (scheme 12). NAD+ 43 is reduced by 
FAD (formate dehydrogenase), which oxidizes formic acid 44 to carbon dioxide 45. 
Depending on the enzyme, either the pro-H-(S)-hydride or pro-H-(R)-hydride is 
transferred from the re- or si-face. These four possibilities allow nature to 
biosynthesise (S)-alcohols and (R)-alcohols in high enantiomeric purity.    
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Scheme 12 Reversible NAD+/NADH redox process in dehydrogenase 
 
 Harada demonstrates that excellent stereoselectivities can be obtained using 
biocatalysts[48,49]. Reduction of several aliphatic alcohols with a powder of geotrichum 
candidum APG4 leads to ee’s of 99% (scheme 13). He used NAD+ as cofactor and 
isopropanol as hydrogen source. The reductions are performed at 30°C in a buffer at 
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pH 7 for 20 hours. The yields are only moderate but such high stereoselectivities 
have no precedent in metal catalyzed systems up to date. For example 2-octanone 
46 is reduced to (S)-2-octanol 47 in 99% ee. Four more aliphatic alcohols 48-51 are 
obtained with complete enantioselectivity.  
 
O geotrichum candidum APG4
NAD+, i-PrOH, pH 7, 30°C, 20h
OH
ee: 99%, S
yield: 62%
48, ee: 99%, S
yield: 77%
OH
49, ee: 99%, S
yield: 49%
OH
50, ee: 99%, S
yield: 61%
OH OH
51, ee: 99%, S
yield: 76%
46 47
 
 
Scheme 13 The reduction of aliphatic ketones with geotrichum candidum APG4. 
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1.2 Cyclodextrins 
1.2.1 Chemical Structure, Production and Properties 
Cyclodextrins (CD’s) are cyclic oligosaccharides comprised of α-1,4-linked 
glucopyranose units (figure 7). The major industrially produced CD is β-CD 52 
consisting of seven glucose units. Two other CD’s are also produced in reasonable 
quantities:  α-CD (six glucose units) and  γ-CD (eight glucose units) [50,51,52]. 
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Figure 7 Left: structure of β-CD; right top: 4C1-conformation of glucose unit in β-CD; 
right bottom: numbering of carbon atoms in glucose 
 
As a consequence of the 4C1-conformation of the glucopyranose units, all 
primary hydroxy groups are situated on one of the two edges of the ring, whereas all 
secondary hydroxy groups are located on the other edge[50].  
 
7.8 Å
15.3 Å
secondary face
secondary alcohols
at C-2 and C-3
primary face
primary alcohols
at C-6 hydrophobic cavity
7.8 Å
 
Figure 8 Doughnut shape icon of CD illustrating the size and dimensions of β-CD 52 
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The resulting doughnut shaped form offers a polar surface because all 
(primary and secondary) hydroxy groups are pointed outside (figure 8). This makes 
CD’s water soluble. The cavity is hydrophobic, because only the axial hydrogen 
atoms H3 and H5 are pointed inside. The diameter of  β-CD’s hydrophobic cavity is 
7.8 Å and allows inclusion complex formation with various guest molecules. Table 3 
shows that aromatic (53, 54, 55, 57) and aliphatic 56 compounds form inclusion 
complexes with binding constants[53] up to 103 M-1. Structures containing a tert.-butyl 
or adamantly rest show especially good binding affinities. The complexes are formed 
by non covalent interactions such as hydrogen bonds, dipole-dipole interactions and 
hydrophobic interactions. This feature makes CD’s attractive for supramolecular 
chemistry, which was defined by J. M. Lehn[54] as: chemistry beyond the molecule, 
the designed chemistry of the intermolecular bond. It’s noteworthy that intermolecular 
interactions (~0.5-5 kcal/mol) are about an order of magnitude weaker than covalent 
chemical bonds (~40-250 kcal/mol). This affords the involvement of multiple types of 
interactions in one binding mode. 
  
Compound α-CD β-CD γ-CD 
benzoic acid, 53 16 M-1 23 M-1 3 M-1 
4-methylbenzoic acid, 54 36 M-1 66 M-1 8 M-1 
4-tert-butylbenzoic acid, 55 51 M-1 457 M-1 59 M-1 
1-adamantanecarboxylic acid, 56 114 M-1 501 M-1 42 M-1 
Ibuprofen, 57 55 M-1 2600 M-1 59 M-1 
 
Table 3 Inclusion complex formation constants of CD’s with various guest molecules 
 
The structures of unmodified CD’s are fairly rigid, due to intramolecular 
hydrogen bonds between C-2-OH and C-3-OH of adjacent glucose units[55].  
CD’s are industrially produced from starch and the enzyme cyclodextrin 
glucosyl transferase (CTG), which can be isolated from several bacteria like Bacillus 
macerans, Klebsiella oxytoca or Bacillus circulans[53]. This enzymatic reaction results 
in a complicated mixture of several cyclic and linear oligosaccharides. Isolation and 
purification of CD’s is performed with the addition of an appropriate complex forming 
agent (e.g. toluene for the isolation of  β-CD), filtration and crystallization. Several 
1000 tons of CD’s are produced per year. They are widely used as additives in 
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pharmaceuticals, food and cosmetics, as well as in analytical chemistry (e.g. 
separation of enantiomers by chiral HPLC)[53].     
1.2.2 Use of Cyclodextrins in Organic Reactions 
 
The properties discussed above make CD’s attractive components in organic 
chemistry and supramolecular catalysis/enzyme mimics in particular[56]. A short 
summary follows here: 
 
1) CD’s are water soluble  
2) their hydrophobic cavity can host a variety of guest molecules 
3) their structure is well defined due to intramolecular H bonds 
4) the hydroxyl groups allow functionalisation 
5) CD’s are chiral and therefore applicable to enantioselective reactions 
 
Since β-CD is employed in this thesis, the following chapters are only dealing 
with β-CD-examples. α-CD’s and γ-CD’s are not mentioned because they are much 
more expensive than β-CD. In addition to this, α-CD offers a smaller binding cavity, 
which limits the potential substrate scope. 
 
1.2.2.1 CD’s in Enzyme Mimic Reactions 
 
Breslow[57] started his pioneering work mimicking enzymatic reactions using 
the appropriate features of β-CD in the late 1970s. He showed that unmodified β-CD 
accelerates the hydrolysis of various esters at pH 10. The p-nitrophenyl ester of (E)-
3-(carboxymethylene)-1,2-ferroceneocyclopentene 58 hydrolyzes 1.5 x 108 faster in 
the presence of β-CD (scheme 14). Interestingly one of the two enantiomers reacts 
62-fold faster than the other one. This stereoselection is explained by the fact that β-
CD forms a stronger inclusion complex with one of the two enantiomers. β-CD-
oxyanion 59 attacks the carbonyl group of the ester producing acylated β-CD 60 and 
p-nitrophenol 61. It’s important to note that this reaction is not catalytic, nevertheless 
it can be regarded as a first imitation of an enzymatic reaction (esterase) using the 
properties of β- CD.  
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Scheme 14 Hydrolysis of esters with CD-oxyanion 59 
  
A development of so called naked CD models is the attachment of functional 
groups, which are able to catalyse a reaction. This leads to more sophisticated 
enzyme models. The functional group can either be linked to the primary or to the 
secondary face of CD. Scheme 15 shows the enzyme mimic of transaminase, which 
converts α-keto acid 62 to α-amino acid 63[58]. The cofactor pyridoxamine has been 
attached covalently to both sides of β-CD. Pyridoxamine derivative 64 is modified on 
the primary face. It was found that both model compounds were effective in the 
transamination process. 
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Scheme 15 Transaminase model with pyridoxamine cofactor covalently attached to 
the primary face of CD 
 
 An excellent example for a peptidase model combining a metal complex as 
cofactor and CD as binding site is shown in scheme 16[59]. Kostic used palladium(II) 
complexes attached to β-CD in 65 for the hydrolytic cleavage of non activated amide 
bonds at neutral pH. The selective cleavage of the 11mer peptide 66 is explained like 
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this: β-CD binds the aromatic side chain of the only phenylalanine (Phe) present in 
the peptide and thus brings the Pd(II) aqua complex near the carbonyl oxygen of 
proline. The Lewis acid Pd(II) ion binds to the carbonyl oxygen of proline and 
activates the carbonyl carbon for nucleophilic attack by a water molecule. The 11mer 
has been successfully cleaved into a pentamer and a hexamer.   
 
β
SSH
Pd
OH2H2O
AcLys-Gly-Gly-Phe-Ser-Pro-Phe-Ala-Ala-Arg-Ala
AcLys-Gly-Gly-Phe-Ser and Pro-Phe-Ala-Ala-Arg-Ala
pH 7, 60°C, 24 h
65
66
11 mer
5mer and 6mer  
 
Scheme 16 A protease model for selective cleaving of a non activated amide bond 
 
1.2.2.2 Asymmetric Reduction of Ketones  
 
Furthermore, CD’s are used as binding sites for dehydrogenase models. In 
1978, Sugimoto compared the reduction of aryl trifluoromethyl ketones with either 
NAH (nicotinamide without the dinucleotide part) or sodium borohydride in the 
presence of  β-CD.  No ee-value higher than 10% could be observed at conversions 
from 20-99%[60].  
Since then, several efforts have been made to reduce ketones to their optically 
active secondary alcohols using  β-CD as the only chiral source[61,62,63]. A rare 
example with enantioselectivities higher than 50% is shown in scheme 17. Rao 
describes the asymmetric reduction of azido arylketones 67 using sodium 
borohydride as the hydrogen source and stoichiometric amounts of β-CD[64]. Only 
three out of 17 substrates show ee’s higher than 60% and no aliphatic substrates are 
reported. Reactive groups which can catalyze the reduction have not been covalently 
attached to β-CD. This is probably the reason why the stereo outcome of this 
reduction system is not satisfying.  
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Scheme 17 Asymmetric reduction of azido arylketones using stoichiometric amounts 
of β-CD and NaBH4 
 
1.2.2.3 CD modified on Secondary Face 
 
The primary face is easier to modify than the secondary one. Substitution 
reaction of commercially available mono-6-tosyl-β-CD 68 with various nucleophiles 
leads to desired product 69 in only one step (scheme 18). That’s why much more 
publications are available dealing with CD’s modified on the primary face.  
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Scheme 18 Modification at position 6 on the primary face of β-CD 
 
Extremely difficult, selective one step functionalizations of unprotected CD 
have been reported (e.g. mono-2-tosyl-β-CD). Nevertheless they are neither 
reproducible nor reliable[65]. An alternative strategy was developed by Bruncel and 
goes via protection of primary alcohols[66]. The modification on the secondary face 
takes at least four steps (scheme 19). 
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Scheme 19 Modification of position 3 on the secondary face of β-CD 
 
The key intermediate for the modification on the secondary face is 2,3-
mannoepoxy-β-CD 70, which is synthesized from β-CD 52 in three steps: protection 
of all seven primary hydroxyl groups with TBDMSCl followed by selective sulfonation 
of more acidic hydroxyl group at position 2 leads to compound 71. Under alkaline 
conditions one observes 70 in an overall yield of 25%. Epoxide opening with a 
nucleophile leads to β-CD modified at position 3, 72. Regioisomer (modified at 
position 2) is only formed in minor amounts with various nitrogen- and sulfur 
nucleophiles[67]. Deprotection on the primary face with fluoride finishes the synthesis 
of CD’s modified at position 3, which undergo an interesting change in their cavity 
form[68]. Epoxide opening with a nucleophile of choice inverts two stereo centres (C-2 
and C-3). This transforms the modified glucose into an altrose unit, which adopts no 
more 4C1-conformation 73 but energetically more stable 1C4-conformation 74. The 
conformational flip occurs because three unfavourable axial substituents (at C1, C2 
and C3) change to preferred equatorial positions (figure 9).   
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Figure 9 Altrose-flip from 4C1-conformation to the more stable 1C4-conformation 
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This flip causes a desymmetrization respectively a distortion of the 
hydrophobic cavity of β-CD. Lichtenthaler recently proved the distorted cavity in solid 
state with a crystal structure of mono[3-(2-imidazolylthio)]-altro-β-CD[69]. The 
conformational change can also be followed by 1H-NMR spectroscopy. The coupling 
constant between H1 and H2 increases significantly from the di-equatorial (3JH1H2 = 
3.2-3.6 Hz) to the di-axial situation (3JH1H2 = 6.4-7.6 Hz). Lichtenthaler suggested that 
distorted mono-altrose-CD’s had interesting molecular recognition properties[69]. They 
are supposed to restrict the orientation of a guest molecule, and altering its own 
conformation to fit better the geometry of the spherical guests.   
Despite of these interesting properties only few model compounds modified on 
the secondary face have been published so far[58,70]. It’s still not clear if modification 
on the secondary face brings advantages compared to the easier accessible primary 
face. Rao et al covalently linked imidazole to both sides of β-CD e.g. in 75 (primary 
face) and in 76 (secondary face) (scheme 20). He observed that the hydrolysis of p-
nitrophenylacetate 77 is 80 times faster when imidazole is bound to the secondary 
face instead to the primary one. Breslow reported similar acceleration rates using 
CD’s modified on the secondary face (in the range of 10-100), but neither of them 
explained their findings.  
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Scheme 20 Comparison of primary and secondary face modified CD in hydrolysis of 
ester 77 
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Three arguments indicating that the synthesis of secondary face modified 
CD’s offer newly attractive properties are listed here: 
 
1) The opening of the cavity on the secondary face is slightly bigger, which 
facilitates the penetration of the guest molecule  
2) The chiral environment of secondary face modified CD’s is closer to the 
guest, because secondary alcohols have one methylene group less 
3) Unique binding properties are proposed due to a conformational flip of the 
modified altrose unit 
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2 Aim of the Work 
 
 A wide range of chiral aromatic secondary alcohols is available through ATH 
and AH nowadays. However these catalytic systems fail in the reduction of totally 
aliphatic ketones, which serve as important intermediates in modern chemistry. The 
goal was to design and synthesize a novel class of catalysts for the reduction of 
aromatic and challenging aliphatic substrates in particular. Within this context β-CD 
was attached covalently to Ru(II) complexes (scheme 21). The special binding and 
solubility properties of CD and the well known reactivity of ruthenium catalysts 
towards carbonyl bonds opens the way for the asymmetric reduction of aliphatic 
ketones in water. 
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N X
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Scheme 21 Design of new class of water soluble ATH catalyst 
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3 Results and Discussion 
3.1 Concept and Design of Catalyst 
 
 The idea behind this new concept is illustrated in scheme 22. Substitution of β-
CD tosylate 68 with aminoethanol 78 leads to modified β-CD 79, which reacts further 
to 80 with ruthenium dimer 81. Ru chloride 80 undergoes hydride exchange upon 
treatment with excess of sodium formate 82. Ruthenium hydride 83 consisting of a β-
CD unit which is covalently linked[71] over aminoethanol 78 to a ruthenium arene 
complex should act as catalyst for the asymmetric reduction of various ketones. It’s 
expected that the aryl- or alkyl rest of the ketone enters the hydrophobic cavity of β-
CD and the reduction occurs according to metal-ligand bifunctional mechanism[27] 
involving a H bond between the carbonyl oxygen of the ketone and the amino proton 
of the ligand and a hydride transfer from the metal to the carbonyl carbon. 83 can be 
regarded as an enzyme model: the metal serves as the active site while β-CD offers 
the binding site. The huge advantage of this novel catalyst is that it provides not only 
the possibility to reduce aromatic but also notorious difficult aliphatic substrates[45,46].  
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Scheme 22 Design of novel catalyst 
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Several β-CD’s modified on the primary and secondary face have been 
synthesised during these studies, including amino alcohols, monosulfonated 
diamines and α-pycolyl amines. Their ruthenium complexes have been tested for 
reactivity in ATH reactions to prochiral carbonyl compounds. 
 
3.2 CD modified on Primary Face 
3.2.1 Amino Alcohols as Side Chains  
 
3.2.1.1 Initial Catalysis Results 
 
Initially it was decided to attach cheap achiral amino ethanol 78 to the primary 
face of β-CD according to a known procedure[71]. Monotosylated β-CD 68 was stirred 
with 80 times excess 78 for 12 hours at 70°C. After precipitation of the reaction 
mixture in acetone and recrystallisation in water one obtained desired product β-CD-
AE 79 in 53% yield as a white solid. 1H-NMR spectroscopy and ESI-MS 
measurements clarified the structure. For catalytic reactions the Ru complexes were 
formed in situ and ketones reduced in the presence of excess of sodium formate as 
hydrogen source at room temperature (scheme 23). The reductions were performed 
with 10 mol% of catalyst in water at pH 8.7. The enantioselectivities of all aromatic 
alcohols were measured by chiral HPLC (A general catalytic procedure is given in 
chapter 5).  
 
NH OH
β
R2
O
R1
R2R1
OH
catalyst:substrate:HCO2Na 
    1      :    10       :   100
81  [RuCl2(C6H6)]2,H2O, 12h, r.t.
*
79, β-CD-AE
O O O O O
Cl
84, 6% ee, R
yield: 61%
85, 12% ee, R
yield: 81%
86, 8% ee, R
yield: 93%
87, 31% ee, R
yield: 67%
88, 47% ee, R
yield: 64%  
 
Scheme 23 ATH with β-CD-EA and Ru(II) arene in water 
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Successful reduction of five aromatic ketones 84-88 proved the concept and 
showed that even with β-CD as the only chiral unit of the Ru complex remarkable ee 
values of alcohols with predominantly (R)-configuration are accomplished. Obviously 
the observed ee values correlate with binding constants of ketones to β-CD[50] 
reflecting preorganization of substrates such that si addition of the hydride to the 
carbonyl group is preferred in the reactive complex. This reaction proceeds in a very 
clean way, no side products were recorded by gas chromatographic analysis 
With these promising results in hand, it was decided to introduce chirality to 
the amino alcohol side chain. It’s known from other groups[15] that the stereo outcome 
of Ru based ATH reactions lacking of β-CD are strongly influenced by the chirality of 
both carbons of the amino alcohol motif. Therefore ligands 89-92 were prepared in 
comparable yields according to β-CD-AE 79 (figure 10).  
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in 59% yield  
 
Figure 10 β-CD bearing chiral amino alcohols 
  
89-92 were tested in the reduction of p-Cl-acetophenone 86 as standard 
substrate. The only difference to the conditions mentioned above is the solvent. A 
mixture of H2O/DMF 3:1 was used due to solubility problems of the ligand in water 
only. Table 4 shows that β-CD-SAP 92 is the best ligand in terms of yield (80%) and 
enantioselectivity (87% ee, S). (R)-alcohols using Ru complexes of ligand 90 and 92 
and (S)-alcohols using ligands 89 and 91 were obtained. These results suggest a 
clear dominance of chirality of the amino alcohol on the outcome of enantioselectivity 
whereas the influence of the chiral centre next to the hydroxyl group of the amino 
alcohol is stronger than the one next to the nitrogen  
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Entry Ligand Solvent Yield [%] ee [%] 
1 β-CD-AS H2O/DMF 3:1 45 72 (R) 
2 β-CD-AR H2O/DMF 3:1 70 62 (S) 
3 β-CD-RAP H2O/DMF 3:1 80 24 (R) 
4 β-CD-SAP H2O/DMF 3:1 80 87 (S) 
 
Table 4 ATH to 86 with four chiral amino alcohols attached to β-CD in H2O/DMF 3:1 
 
3.2.1.2 Optimization of Catalytic Conditions 
 
Several attempts have been made to optimize the catalytic reduction using β-
CD-SAP 92 as ligand and p-Cl-acetophenone 86 as standard substrate by varying 
the following parameters: catalyst loading and solvent (table 5), temperature (table 
6), pH value (table 7), Ru precursor (table 8) and using schlenk conditions (table 9).  
Table 5 shows that 5 mol% of catalyst lead to unsatisfying yields. β-CD-SAP is 
not soluble in reasonable amounts of water. To avoid rather diluted conditions with 
10 mol% the transfer hydrogenation reactions were carried out in a mixture of H2O-
DMF 3:1. 
 
Entry Ligand mol% Solvent  Yield [%] ee [%] 
1 β-CD-SAP 5 H2O (0.25 ml) 45 82 
2 β-CD-SAP 5 H2O/MeOH 3:1 (0.25 ml) 32 81 
3 β-CD-SAP 5 H2O/DMF 3:1 (0.25 ml) 33 83 
4 β-CD-SAP 10 H2O (0.50 ml) 65 82 
5 β-CD-SAP 10 H2O/DMF 3:1 (0.25 ml) 80 87 
 
Table 5 Optimization of catalyst loading and solvent 
 
 An unexpected result was obtained at elevated temperatures (table 6). The 
yield at 50°C is not better compared to the one performed at room temperature. 
However the chiral induction decreases as expected from 87% ee to 75% ee. Indeed 
the ee value at 4°C is 2% higher than at 22°C but the yield is very poor.   
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Entry Ligand mol% Temperature Yield [%] ee [%] 
1 β-CD-SAP 10 4°C 5 89 
2 β-CD-SAP 10 22°C 80 87 
3 β-CD-SAP 10 50°C 76 75 
 
Table 6 Optimization of temperature 
  
In order to optimize the pH value for this specific system several formate 
species were tested in the presence and absence of an alkaline base (table 7). No 
product formation was observed with ammonium formate (pH 6.8, entry 2) or formic 
acid (pH 2.0, entry 3) as hydrogen source. Reductions performed at several pH 
values between 5.7 and 11.8 (entries 4-9) could not increase the yield. So the use of 
100 equivalents of NaOOCH in H2O/DMF 3:1 at pH 8.7 is the optimum (entry 1). 
These results correlate with studies from other groups reporting that the reduction 
using formate in water is pH dependent[72] and high reactivity is only observed at pH 
5-9 while it drops dramatically down at lower pH values. The main problem at low pH 
is that the formate species exists predominantly in the protonated form at pH < 3 due 
to a pKa value of 3.6 for HCOOH in water, which makes the formation of the Ru 
formato complex more difficult. Furthermore the oxygen of the amino alcohol is 
protonated at low pH, which results in decomposition of the Ru complex.  
 
Entry Ligand mol% Formate Additive eq. pH Yield [%] ee [%]
1 β-CD-SAP 10 NaCOOH No 100 8.7 80 87 (S)
2 β-CD-SAP 10 NH4COOH No 100 6.8 0 n.d. 
3 β-CD-SAP 10 HCOOH No 100 2.0 0 n.d. 
4 β-CD-SAP 10 NaCOOH No 10 7.9 57 87 (S)
5 β-CD-SAP 10 NaCOOH 5% HCOOH 100 5.7 73 87 (S)
6 β-CD-SAP 10 NaOOCH 1mM NaOH 100 8.9 63 87 (S)
7 β-CD-SAP 10 NaOOCH 2mM NaOH 100 10.4 73 87 (S)
8 β-CD-SAP 10 NaOOCH 2mM NaOH 10 11.1 68 88 (S)
9 β-CD-SAP 10 NaOOCH 10mM NaOH 10 11.8 56 87 (S)
 
Table 7 Optimization of pH value 
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 Ru cymene reduces model substrate 86 in similar ee’s as Ru arene 81 does 
(table 8). The lower yield can be addressed to the steric hindrance of p-cymene 
which hampers the substrate to enter the cavity and form the inclusion complex. 
Ru(COD) halide precursor shows no activity at all, most likely due to solubility 
problems of the complex in aqueous solution.   
 
Entry Ligand mol% Ru precursor Yield [%] ee [%] 
1 β-CD-SAP 10 Ru[Cl2(arene)]2 80 87 (S) 
2 β-CD-SAP 10 Ru[Cl2(p-cymene)]2 53 82 (S) 
3 β-CD-SAP 10 RuCl2(COD) 0 n.d. 
 
Table 8 Varying the Ru precursor 
 
 The reduction was also tested with so called schlenk technique using 
degassed solvents under an argon atmosphere (table 9). The values under air 
atmosphere are given in parentheses. Actually the yields could be increased about 
20% with a slight loss of enantioselectivity. The Ru complex is probably oxidised in 
the presence of oxygen and loses therefore some catalytic activity. 
 
Entry Substrate Ligand mol% Yield [%] ee [%] 
1 86 β-CD-SAP 10 99 (80) 82 (S), 87 (S) 
2 86 β-CD-SAP 5 42 (33) 76 (S), 83 (S) 
3 88 β-CD-SAP 10 65 (51) 96 (S), 97 (S) 
 
Table 9 Catalysis under schlenk conditions 
 
3.2.1.3 Reduction of Aromatic and Aliphatic Ketones with β-CD-SAP 
 
β-CD-SAP was chosen to testify that this system is not limited for one 
substrate. Several aromatic prochiral ketones were reduced under standard 
conditions: 10 mol% catalyst, H2O/DMF 3:1 as solvent, Ru arene as metal precursor, 
at room temperature under an air atmosphere for 12 hours at pH 8.7.  
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Entry Substrate Yield [%] ee [%] Entry Substrate Yield [%] ee [%]
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Table 10 Catalysis with β-CD-SAP 
 
According to results summarized in table 10 employing β-CD-SAP 
enantiomeric purity of products was achieved as high as 97% and in acceptable 
yield. It is interesting to note that using 92 as a Ru ligand, acetophenone 85 was 
reduced to the (S)-alcohol exhibiting 77% ee, in contrast the Ru complex of (S)-1-
amino-2-propanol lacking the β-CD unit gave the (S)-product in only 35% ee[18].  
Demonstrated that this novel catalytic system is able to reduce prochiral 
aromatic ketones with high enantioselectivities the ultimate goal of this project was 
envisaged: The asymmetric reduction of challenging totally aliphatic carbonyl 
compounds. For initial studies non prochiral aliphatic substrates were used, just to 
check if they show any reactivity under the described conditions. 4-Methyl-
cyclohexanone (100% yield) and cycloheptanone (50% yield) demonstrated that it’s 
possible to reduce aliphatic ketones as well. This positive outcome encouraged to 
test various prochiral aliphatics 93-104. The results using standard conditions are 
summarised in scheme 24.  
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Scheme 24 The reduction of challenging aliphatic ketones 
 
Most substrates could be reduced in good yields. The unsatisfying yields of 
99, 101, 102 and 105 are probably caused by solubility problems of long alkyl chains 
in aqueous solution. But more importantly the enantioselectivities of six alcoholic 
products are higher than 85%. 2-Decanone 95 and geranylacetone 97 showed even 
ee’s of 95%, indicating that the concept works for non aromatics as well. No 
conventional metal catalyst lacking of β-CD achieves such good selectivities for the 
reduction of totally aliphatic ketones up to date[73].  
The olefinic bonds were not reduced in compounds 97, 98 and 99 at all. 
Furthermore styrene was stirred at 50°C in the presence of the catalyst. No alkane 
was detected after 3 days confirming that the reaction occurs strongly 
chemoselective. 
Those enantiomers which could not be separated by chiral gas 
chromatography were converted to mosher esters using enantiomerically pure (R)-α-
methoxy-α-trifluoromethylphenylacetic chloride to determine their ee values (figure 
11)[74]. Mosher explained that the non-equivalence of the α-CF3 resonances in the 
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two resulting diastereomeric esters is based on anisotropic deshielding of the α-CF3 
substituent by the ester carbonyl.  
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O
O
R2
OCH3
H
R1
Ph
CF3
H3CO
O
R1R2
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H3CO
O
R2R1
CF3 is forced out of coplanarity due to 
strong steric interactions of bulky R1
 with bulky phenyl
less deshielded, upfield shifted
CF3 is not forced out of coplanarity
because steric interactions of R1
 and phenyl are weaker
more deshielded, downfield shifted
105 106
R R RS
 
 
Figure 11 Explains the relative up- and downfield shift in mosher esters 
 
The following assumptions are made: 
 
1) R1 is bulkier than R2 
2) The phenyl group is bulkier than the methoxy group 
3) All interactions are of steric nature.  
 
The CF3 group is normally coplanar with the carbonyl of the ester and 
therefore strongly deshielded by the anisotropic field of the polar C=O double bond. 
We now compare the steric interactions of the two diastereomeric esters 105 and 
106. The interactions are stronger in the case of 105, because of bulky phenyl group 
is interacting with bulky R1. On the contrary steric interactions are minimized in ester 
106. As a result of this the CF3 group of ester 105 is much more forced out of 
coplanarity with the carbonyl bond, which explains the relative upfield shift. Treating 
an alcohol with enantiomerically pure mosher chloride allows determination of the ee 
and the absolute configuration of the alcohol in an elegant way. 
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3.2.1.4 Ligand Screening with various chiral Amino Alcohols 
 
Ligand screening with numerous amino alcohols attached to β-CD was 
performed in order to increase the reactivity and selectivity of the catalytic process. 
Some amino alcohols were not commercially available and had to be synthesised by 
epoxide opening with chiral nitrogen nucleophiles[75] (scheme 25). For example trans-
epoxy-butane 107 was opened using stoichiometric amounts trimethylaluminium 108 
and enantiopure (R)-(+)-methylbenzylamine 109. The two diastereotopic secondary 
amines 110 and 111 could be separated by silica gel chromatography. Removal of 
the protecting group with palladium on charcoal under hydrogen atmosphere lead to 
desired products 112 and 113 in overall yields of 50%. The enantiomeric purity of the 
cis-amino alcohols was shown to be higher than 98% by 1H-NMR analysis of 
diastereomeric precursors 110 and 111. The absolute configuration of this novel 
compound was obtained by x-ray analysis of intermediates 110 and 111. Trans-
analogues 114-117 were prepared in the same manner starting from cyclohexene 
oxide and cyclopentene oxide in similar yields. Comparison of the optical rotation 
with reported values let assign the enantiomers[76].  
 
The two diastereoisomers are separated 
by  silica gel chromatography
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Scheme 25 Synthesis of chiral cis- and trans-amino alcohols 
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Modified cyclodextrins 118-127 were obtained from tosylated β-CD 68 in yields 
around 50%. The ligands were applied to ATH with Ru arene complexe 81 under 
standard conditions using p-Cl-acetophenone 86 (scheme 26). The model substrate 
was selected because the ee values could be determined easily by chiral HPLC 
chromatography. Furthermore the observed ee values of 87% with 92 leaves some 
room for improvement. 
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Scheme 26 Ligand screening with various chiral amino alcohols 
  
12 out of 15 ligands show good to excellent yields. The only unreactive amino 
alcohol is indanol with only 3% conversion. Scheme 26 is divided in two parts: 
ligands on the left side having alkyl groups looking to the back produce (S)-alcohols, 
ligands on the right side possessing bulky substituents looking to the front lead to 
(R)-products. It’s interesting to note that norephedrine derivative 121 is the only 
exception (28% ee, S). Cyclic trans-amino alcohols (119, 120, 126 and 127) are not 
competitive with open chained cis analogues indicated by very poor enantioselection 
reaching from racemic to 27% ee only. It’s not necessary to introduce bulkier alkyl 
groups than methyl. For example 124 bearing an isopropyl rest (38% ee, R) is less 
enantioselective than alaninol based 89 (62% ee, R) and 122 (92% ee, S) gives the 
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same ee value as 118 bearing less hindered substituents. So one can summarise 
that CD preorganizes the substrate in the hydrophobic cavity and the si- respectively 
re-face attack of the hydride is strongly affected by the stereo centres of the chiral 
side chains. The absolute configuration of the alcoholic product can be controlled by 
proper adjustment of the stereogenic centres of the amino alcohol motif. Only two 
examples lead to higher ee’s than β-CD-SAP 92. Cis-amino alcohols 122 and 118 
could improve the stereo outcome from 87% to 92%. Unfortunately both ligands have 
a disadvantage. 40% yield is not satisfying in case of norephedrine derived 122. And 
an increase of 5% ee doesn’t legitimate the additional expense of two more synthetic 
steps to obtain ligand 118.  
Two more ligands were prepared for the purpose of improving the system. 1,3-
amino alcohol 128 was linked to β-CD to see if a six membered chelate ring of the 
amino alcohol with the metal centre is better than the five membered described by 
Noyori[13]. Trifluoromethyl group was introduced in ligand 129 by reacting racemic 
1,1,1-trifluoro-3-amino-2-propanol with tosylate 68 to check the influence of an 
electron withdrawing group at the side chain. The reactivity was tested with aromatic 
standard ketone 86 under standard conditions (scheme 27). 
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 [RuCl2(C6H6)]2, H2O/DMF 3:1, 12h, r.t.
Ligands 128 and 129
Cl Cl
128, 7% ee, S
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β
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Scheme 27 ATH with β-CD bearing a γ–amino alcohol respectively a CF3 group 
  
 Both ligands 128 and 129 gave 1-(4-chlorophenyl)ethanol in lower yields 
(30%, 40% respectively) and poorer enantioselectivities (7% ee R, racemic 
respectively) than 79.  
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3.2.1.5 Aromatic vs. Aliphatic Standard Substrate 
 
Aliphatic model compound 6-methyl-5-ene-2-heptanone 98 which can be 
analyzed by chiral GC was reduced with six of the ligands mentioned above and 
compared with the results obtained with aromatic 86. Table 11 shows that the 
enantioselectivities of the two ketones are matching very well. This obvious trend is 
important because the risk to miss a good ligand for aliphatics is very small testing 
the ligands with aromatic substrate 86 which is easier to analyze with the equipment 
available in our laboratories.    
 
Ligand p-Cl-acetophenone, 86 6-methyl-5-ene-2-heptanone, 98
79, β-CD-AE 8% ee (R); 73% yield 27% ee (S); 52% yield 
92, β-CD-SAP 87% ee (S); 88% yield 88% ee (S); 90% yield 
90, β-CD-AR 62% ee (S); 70% yield 88% ee (S); 37% yield 
118, β-CD-SRDM 92% ee (S); 87% yield 90% ee (S); 60% yield 
125, β-CD-RSDM 25% ee (R); 99% yield 24% ee (R); 84% yield 
128, β-CD-AP 7% ee (S); 30% yield 13% ee (S); 30% yield 
 
Table 11 Aromatic 86 versus aliphatic 98 standard compound 
 
3.2.1.6 Substrate Scope 
 
 The substrate scope was extended by applying the new catalytic system to 
ketoesters. Quantitative conversions were observed for all four substrates, including 
one aromatic β-ketoester (130), two aromatic α-ketoesters (131 and 132) and 
aliphatic α-ketoester 133. The enhanced reactivity is probably caused by the higher 
electrophilicity of the carbonyl carbon due to electron withdrawing properties of the 
neighbouring ester functionality. The stereoselectivities remained on a moderate 
level reaching 57% ee as a maximum for 132. All reductions were performed under 
standard conditions using β-CD-SAP as a ligand (scheme 28). The ee values were 
determined by chiral HPLC chromatography. 
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Scheme 28 ATH to ketoesters 130-133 
 
ATH reactions are not limited to carbonyl compounds. Hydride transfer to the 
carbon-nitrogen double bond of imines results in chiral amines, which are important 
precursors for fine chemicals and agrochemicals in particular[2,13]. Hence β-CD based 
catalyst 92 was tested with aromatic imine 134 using slightly modified standard 
conditions. The reduction was performed in a water/methanol mixture 2:1 due to 
solubility problems of the substrate (scheme 29).  
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81,  [RuCl2(C6H6)]2, H2O/MeOH 2:1, 12h
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Scheme 29 ATH to prochiral imine 134  
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The reaction gave a mixture of five compounds as could be analyzed by HPLC 
chromatography. The peaks were identified as starting material 134 (20%), desired 
secondary amine 135 (20%), aniline 136 (30%), acetophenone 85 (20%) and alcohol 
137 (10%). This means that imine 134 is hydrolyzed under basic conditions and the 
corresponding ketone 85 reacts further to (S)-137 in 77% ee as could be 
demonstrated earlier. The optical yield of the secondary amine 135 is very poor (8%, 
R). The loss of chiral induction compared to the reduction of carbonyl bonds can be 
addressed to the weaker H bond and there from less distinctive preorganization of 
the substrate in the hydrophobic cavity of CD.        
 
Compounds 138-141 were synthesised to discover if it’s possible to reduce 
unsymmetrical diketones regioselectively, like enzymes can do[47] (scheme 30). 3-
Methylbut-3-en-1-ol 142 was transformed to bromide 143. Grignard reaction with 
benzaldehyde gave secondary alcohol 144 in 66% yield. Ozonolysis afforded 1,4-
hydroxyketone 138 which opened the way for the synthesis of diketone 139 via allylic 
oxidation and diol 140 via LiAlH4 reduction. Oxidation with manganese dioxide gave 
1,4-hydroxyketone 141 in 62%.   
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2) LiBr 2) benzaldehyde
138
140141
139
142 143 144
 
 
Scheme 30 Synthesis of diketone 139 and possible reduction products 
 
The reduction of diketone 139 was performed with stoichiometric amounts of 
NaBH4 respectively 10 mol% of β-CD-SAP 92 (scheme 31). NaBH4 produces much 
3 Results and Discussion  41 
more diol 140 than β-CD-SAP and the ratio of 141 to 138 is 24:4. This selectivity can 
be explained with electron donating properties of the phenyl ring which lowers the 
electrophilicity of the carbon close to the aromatic moiety. The ratio of 25:1 for 141 to 
138 using β-CD-SAP (four times as selective as NaBH4) suggests that the hydrogen 
bond from the amine of the ligand to the carbonyl oxygen closer to phenyl ring is less 
preferred than to the other one. This results in a considerable regioselective outcome 
of the reduction. 
 
O
O
OH
O
OH
OH
O
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25%
 90% ee, S 24%
5% 36%
H2O/DMF 3:1
 
 
Scheme 31 Regioselective reduction of aromatic diketone 139 
 
The reduction of aliphatic octan-2,4-dione 145 using β-CD-SAP was less 
regioselective. The ratio of the formation of 146 to 147 is only 3:2 (scheme 32). This 
result is not surprising since the difference in electrophilicity of the two carbonyl 
carbons is marginal. Again, only traces of diol 148 were produced demonstrating that 
hydroxylketones do not react further with β-CD-SAP. This is in contrast to 
conventional sodium borohydride reduction yielding predominantly diol 148. 
 
145 146, 43% ee, S
28% yield 148, yield < 1%
OO OOH OHO OHOH
catalyst:substrate:HCO2Na 
    1      :    10       :   100
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β
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Scheme 32 Regioselective reduction of aliphatic diketone 145 
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3.2.1.7 Structure Elucidation and Mechanistic Aspects 
 
The structure of β-CD ligands could be elucidated by 1H-NMR (1-D and 2-D), 
ESI mass spectroscopy and sometimes also with x-ray diffraction. The special 
analysis features of modified β-CD’s are discussed on the basis of β-CD-SAP 92.  
500 MHz 1H-NMR spectra were measured in D2O (solvent peak 4.79 ppm). All 
hydroxy protons are exchanged with deuterium and are therefore not visible (figure 
12). The region around 5.0 ppm shows all seven anomeric protons H1 of 92 which 
are characteristically shifted downfield and well separated from all other sugar 
protons (H3, H5, H6, H2 and H4) between 4.0 and 3.5 ppm. The doublet at 1.09 ppm 
with a coupling constant of 6.3 Hz belongs to the methyl group of the amino alcohol. 
The multiplet at 2.56 ppm corresponds to the two protons α to nitrogen. Three other 
resonances are separated from the huge sugar peak: Both H6 (2.81 and 3.02 ppm) of 
the modified sugar unit and one H4 (3.38 ppm) of a neighbouring glucose as could be 
revealed by additional 2-D experiments (COSY and TOCSY). The α-proton of the 
hydroxy group of the side chain is hidden under the sugar peak at 3.89 ppm.  
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Figure 12 1H-NMR spectroscopy of β-CD-SAP 92 
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Figure 13 ESI-MS with β-CD-SAP: top: positive mode; bottom: negative mode 
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The exact mass of β-CD-SAP 92 is (1191.43 g/mol). Since all amino alcohol 
modified β-CD’s are carrying nitrogen atoms which can easily be ionized, ESI-MS 
positive mode spectra showed usually good intensities (figure 13). Beside the 
molecule ion m/z = 1192.3 [M+H]+ it was possible to identify two other peaks: 
[M+Na]2+ at 607.6 and [M+Na]+ at 1214.3. Ionization in the negative mode shows m/z 
= 1190.4 [M-H]- and m/z = 594.7 [M-H]2-. 
The x-ray structure of β-CD-SAP clearly shows the newly formed covalent 
bond between the nitrogen of the amino alcohol and β-CD (figure 14 and 15). The 
absolute configuration of the stereo centre on the side chain is S. The cavity of β-CD 
is symmetric and the opening of the primary face is significantly smaller than on the 
secondary face. 
 
Figure 14 X-ray front view of β-CD-SAP 92   
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Figure 15 X-ray side view of β-CD-SAP 92   
 
 In addition to the three methods mentioned above modified CD’s were 
analyzed by TLC on silica gel in a very polar solvent system (EtOAc/i-
PrOH/NH4OH/H2O 7:7:5:4). The spots were visualized by spraying the plates with a 
solution of 250 ml ethanol and 6 g anisaldehyde in 2.5 ml concentrated sulphuric 
acid. In this way it was possible to follow the reaction as well as to get an idea of the 
purity of the products. HPLC analysis was not possible because the compounds are 
lacking a chromophore while GC analysis could not be performed due to unpractical 
high boiling points of CD.  
Formation of Ru chloro complex 149 (according to structure 80, page 26) from 
β-CD-SAP 92 and metal precursor 81 was demonstrated to be quantitative by 1H-
NMR measurements. Significant downfield shifts of several protons relative to free 
ligand 92 are shown in table 12. The two protons H6 belong to the primary alcohol of 
the modified sugar unit of β-CD and C1-H stands for the protons next to the nitrogen 
of the amino alcohol. A second argument for complex formation are the two peaks in 
the ESI-MS positive mode which could be identified as m/z = 1406 [149]+ and 1371 
[149-Cl]+. 
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Proton H’6 H’’6 C1-H’ C1-H’’ 
Shift (ppm) 0.56 0.51 0.36 0.51 
 
Table 12 1H-NMR downfield shifts of Ru complex 149 relative to 92 
 
Although all aromatic protons of the arene moiety in 149 appeared in a single 
singlet at 5.34 ppm one can not take this as an evidence for diastereopure metal 
complex formation, since one could not observe the other diastereomeric Ru 
complex. However, catalysis results with enantioselectivities up to 98% suggest an 
explicit dominance of one Ru diastereoisomer.  
Binding constants of p-Cl-acetophenone (1040 M-1) 86 and 1-(4-
chlorophenyl)ethanol (400 M-1) 150 with β-CD-SAP were measured by 1H-NMR 
titrations in D2O/DMF-d7. Protons H3 and H5 of β-CD which are pointed inside the 
cavity showed significant downfield shifts by increasing the guest concentration. The 
alcoholic product binds less than halve as strong as the starting material. This result 
is very essential for the catalytic process since a higher binding constant of the 
alcohol would inhibit the reaction by occupying the cavity of β-CD. The better binding 
affinities of 86 can be ascribed to the additional H bond from the carbonyl oxygen to 
the amino proton of the amino alcohol. A ROESY spectra of ligand 92 and p-tert.-
butylacetophenone 88 provided evidence that the substrate really enters the cavity. 
Strong cross peaks of H3 and H5 from β-CD could be observed with the tert.-butyl 
group of the ketone. Furthermore moderate respectively weak cross peaks were 
found for meta- and ortho protons of the aromatic ring, indicating that the carbonyl 
compound enters the cavity with the hydrophobic tert.-butyl rest ahead (scheme 33: 
left). 
N OH
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NOE
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NOE
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NOE
Cl
CH3
O
Cl
CH3
OH
D
β-CD-SAP 92, Ru arene 81
D2O/DMF-d7, HCOOD
triplet
H
 
 
 
Scheme 33 left: Substrate 88 enters the cavity; right: incorporation of D-  
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The Ru hydride signal of 151 could not be detected in the 1H-NMR spectra 
after addition of excess NaOOCH to 149. Nevertheless a hydride transfer from the 
metal to the substrate seems very likely since reduction of 86 in H2O and excess 
NaCOOD results in a triplet splitting of the alcoholic methyl group due to 
incorporation of deuterium (scheme 33: right). No alcohol is formed at all in the 
absence of NaCOOD.  
In contrast to Ru-H complex 83, Ru-Cl 80 species is stable in water under an 
air atmosphere for several hours (table 13). Addition of NaOOCH 12 hours after 
mixing Ru-Cl precursor 81 and β-CD-AE 79 followed by addition of the ketone 15 
minutes later (entry 3) lead to identical yield and ee’s in ATH under standard 
conditions as observed for standard procedures (entry 1). Whereas only 35% yield 
was gained when the Ru-H 83 was stirred for 12 hours before addition of the ketone 
(entry 2), indicating a decomposition of the active Ru-H species.  
 
Entry Addition of NaCOOH Addition of  Ketone Yield [%]/ee [%]
1 1 hour after mixing 79 and 81 15 minutes later 93/8 
2 1 hour after mixing 79 and 81 12 hours later 35/7 
3 12 hours after mixing 79 and 81 15 minutes later 94/8 
 
Table 13 Stability of Ru-Cl 80 and Ru-H 83 
 
Scheme 34 summarises experiments using unmodified β-CD. No product 
formation was observed for several test reductions using Ru precursor 81, 
aminoethanol 79 and stoichiometric amounts of free β-CD 52 or protected β-CD 152 
under various conditions. Since the reaction occurs only with covalently linked amino 
alcohols these results support the original concept: β-CD forms an inclusion complex 
with the ketone and thus brings the carbonyl bond in close proximity to the reactive 
metal centre where the stereoselective reduction occurs.   
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Scheme 34 Test experiments with free CD show no activity 
  
Proline was linked to the primary face of β-CD yielding tertiary amine 153 
which was applied to ATH under standard conditions (scheme 35). The fact that no 
product was formed at all is in good agreement with observations done by other 
groups[27,33]. The so called NH-effect postulates that ATH catalysts lacking a NH motif 
are totally inactive in the reduction process. This implies that the mechanism of our 
novel transformation resembles the metal-ligand bifunctional mechanism proposed 
by Noyori[27].  
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Scheme 35 Proline derivative 153 shows no reactivity in ATH 
 
As expected from reported results[12,37] Ru catalyst showed very poor reactivity 
changing the hydrogen source from formate to molecular H2 (table 14). A recent 
explanation is given in chapter 1.1.2[38,39]. Systems using an azeotropic mixture of 
Et3N/HCOOH or pure i-PrOH instead of NaCOOH failed as well and gave no product.  
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Substrate Ligand Solvent mol% Bar Yield [%]
p-Cl-acetophenone β-CD-SAP H2O/DMF 3:1 10 50 3 
p-Cl-acetophenone β-CD-SAP 1M KOH 10 50 0 
p-Cl-acetophenone β-CD-SAP i-PrOH/MeOH 10 50 2 
 
Table 14 Reductions with molecular hydrogen 
 
A back reaction from the alcohol to the ketone according to reversible MPV 
reaction can be excluded since no optical resolution at all occurred when racemic 1-
(4-chlorophenyl)ethanol 150 was applied to standard reduction conditions with β-CD-
SAP for 12 hours.  
 
3.2.2 Monosulfonated Diamines as Side Chains  
 
3.2.2.1 Catalysis Results with Monotosylated Diamines 
 
It was obvious to link monotosylated diamines to β-CD as well, because Ru 
catalysts bearing such ligands are known to be very reactive in ATH[12]. Modified β-
CD 154 was synthesised in two steps starting from achiral ethan-1,2-diamine 155 
(scheme 36). Monosulfonation[77] using tosylchloride 156 afforded 157 in low yield 
which is less nucleophilic than amino alcohols, due to electron withdrawing properties 
of the tosyl group. Therefore substitution with β-CD-Tos 68 was performed in the 
microwave at 80°C (constant irradiation with 100 watt) and gained β-CD-MTDA 154 
in 47%. The advantage of the microwave assisted substitution reaction is that the 
excess of nucleophile could be decreased from originally 80 times to 5 times, while 
the reaction time dropped down from 12 hours to 2 hours.   
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Scheme 36 Synthesis of β-CD-MTDA 154 
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With β-CD as the only chiral unit aromatic and aliphatic standard ketones 86 
and 98 could be reduced in 91% yield and 25% ee (S) respectively 68% yield and 
58% ee (S) within only 4 hours under standard conditions (scheme 37).   
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Scheme 37 ATH with monotosylated β-CD 154 
 
 The difference in reactivity between amino alcohol- and monotosylated 
diamine modified β-CD was investigated by comparing the conversions at several 
times. p-Cl-acetophenone 86 was reduced with ligands 79 and 154 under standard 
conditions (table 15). Monotosylated diamine analogue 154 reacts about three times 
faster than amino alcohol derived 79. 
 
 NH
β
OH
79
 
β
NH HN S
O
O
154
 
1h 18% conversion 64% conversion 
2h 39% conversion 84% conversion 
3h 58% conversion 90% conversion 
4h 77% conversion 91% conversion 
6h 86% conversion 91% conversion 
12h 93% conversion 91% conversion 
 
Table 15 Amino alcohol vs. monotosylated diamine 
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 Table 16 summarises some efforts which have been made in order to lower 
the catalyst loading using β-CD-MTDA 154 and standard reduction conditions. 
Respectable 56% yield was obtained with 5 mol% catalyst whereas it could be 
increased to 67% performing the reduction in a twice as concentrated solvent 
system. 34% yield was afforded decreasing the catalyst loading to 2% which 
corresponds to a turn over number of 17. 
 
Entry Ligand mol% Solvent  Yield [%] ee [%] 
1 β-CD-SAP 10 H2O/MeOH 3:1 (0.25 ml) 91 25 (S) 
2 β-CD-SAP 5 H2O/MeOH 3:1 (0.25 ml) 56 24 (S) 
3 β-CD-SAP 5 H2O/MeOH 3:1 (0.125 ml) 67 19 (S) 
4 β-CD-SAP 2 H2O/MeOH 3:1 (0.25 ml) 34 23 (S) 
5 β-CD-SAP 1 H2O/MeOH 3:1 (0.25 ml) 8  3 (S) 
 
Table 16 Efforts to decrease of catalyst loading 
 
 The acceleration of ATH with β-CD-MTDA 154 compared to 79 prompted the 
introduction of chirality in the side chain for the purpose of increasing the 
stereoselectivity. With the knowledge of the amino alcohol ligand system it was 
obvious to test monotosylated diamines with a chiral centre next to the tosyl motif. 
Such compounds are neither commercially available nor precedent in the literature 
and had to be prepared by opening of chiral tosylaziridines (scheme 38). (S)-Alanine 
158 was reduced with lithium aluminium hydride[78]. The hydroxy- and amino group of 
(S)-alaninol 159 were both tosylated to obtain intermediate 160 in 65% yield[79]. Ring 
closure under basic conditions lead to chiral tosylaziridine[79] 161, which was 
regioselectively opened with ammonia to get desired compound 162 in 46% overall 
yield. It’s noteworthy that the optical purity of 162 could be shown to be higher than 
98% by treatment with optical pure (R)-mosher chloride although the chiral centre is 
in β-position to mosher amide 163. 
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Scheme 38 Synthesis of chiral monotosylated diamines 
  
Compound 162, enantiomer 164 (derived from (R)-alanine) and valine based 
165 were all linked to β-CD in moderate yields using the same one step procedure as 
mentioned above. Unexpected poor reactivities in ATH were obtained with all three 
ligands (scheme 39). Since several efforts to get appropriate crystals for x-ray 
analysis of the Ru complex with ligands 166-168 failed it can only be speculated that 
the methyl respectively iso-propyl group affects somehow the proper formation of the 
five membered chelate ring with the metal and therefore significantly lowers the 
reactivity. However the absolute configuration of the alcoholic product is comparable 
with the amino alcohol system. 166 bearing a (S)-centre at the side chain leads to 
62% ee (S), 167 with the (R)-chirality results in 37% ee (R). In contrast to amino 
alcohol ligands the stereo outcome of the reduction could be enhanced with bulkier 
alkyl rest at the side chain from methyl 166 (62% ee, S) to iso-propyl 168 (92% ee, S) 
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Scheme 39 ATH with chiral monotosylated CD’s 166-168 
 
 The chiral centre was moved next to the amino nitrogen to ascertain if this 
change leads to a better reactivity. A seven step synthesis of free chiral 
monotosylated diamine 169 starting from cheap (R)-alanine 170 is illustrated in 
scheme 40. Reductive amination[80] with benzaldehyde 171 gained protected amino 
alcohol 172. Aziridine formation was observed under Mitsunobu conditions[80]. In 
contrast to tosylated aziridine 161 benzylaziridine 173 is electron rich and 
deactivated for nucleophilic ring opening. A saturated solution of ammonia in 
methanol failed to open the ring. So an excess of more nucleophilic TMSN3 in 
refluxing acetonitrile was used[81]. Reduction of azide 174 with lithium aluminium 
hydride[81] followed by tosylation of the primary amine in 175 and cleavage of the 
phenyl group in 176 gave free (R)-amine 169 in an overall yield of 13% and optical 
purity of > 98% (mosher method).   
 
3 Results and Discussion  54 
H2N OH
H
O
HN OHN OH
N
TMSN3HN N3
HN NH2 LiAlH4
HN NH-Ts H2N NH-Ts
Ph3P
DIAD
Ether
95%
Pd/C, H2
TsCl
EtN3
H2N OH
O LiAlH4 NaBH4
4d Reflux, 75%
60%
80%
70%
70%
80%
     1) NH3
2) Pd/C, H2
170
171
172
173
174
175
176
169
R
R
 
Scheme 40 Moving the stereo centre closer to β-CD 
  
 Compound 169 and (S)-enantiomer 177 were attached to β-CD and applied to 
ATH under standard conditions (scheme 41). Interestingly the yields increased to 
80% and 96% respectively. But unfortunately both ligands gave quasi racemic 
mixtures of the alcoholic product. The fact that a chiral centre next to the amino 
nitrogen shows a lower chiral induction than next to the sulfonated nitrogen is in 
agreement with the amino alcohol system. 
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Scheme 41 ATH with novel ligands 178 and 179 
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 It was decided to prepare cyclic monotosylated diamines bearing two chiral 
centres from commercially available trans-1,2-cyclohexyl-diamine[82] and attach them 
to β-CD (180 and 181). Surprisingly both ligands were totally inactive for the 
reduction of standard substrate 86 at 22°C even at elongated reaction times. 
However at 50°C one observed moderate yields and low ee’s (scheme 42). Due to 
this reaction acceleration at elevated temperatures also ligands 166 and 168 which 
showed good (62% ee, S) respectively excellent (92% ee, S) chiral induction at room 
temperature were tested at 50°C. Actually the yields increased up to 53% with 
significant loss of enantioselectivity. 
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Scheme 42 ATH at elevated temperatures 
 
 It could be demonstrated that monotosylated diamines linked to β-CD can also 
act as ligands in ATH to ketones. Indeed 154 (without a chiral centre at the side 
chain), 178 and 179 (with a chiral centre next to the amino nitrogen) revealed to be 
three times faster than their amino alcohol analogues. But the chiral induction with 
these ligands is very poor. In contrast to this ligands bearing a chiral centre in α-
position to the sulfonamide nitrogen 166-168 show good chiral induction but low 
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yields. At this point it is not clear why these structural similar compounds behave so 
differently in ATH in terms of the stereo outcome and reactivity. 
 
3.2.2.2 Catalysis Results with Monomesylated Diamines  
 
 Monomesylated diamines were introduced as a new ligand class. Mesylates 
are lacking an aromatic moiety which can theoretically form self assembled 
structures by inclusion complex formation of a tosyl rest of one ligand with the 
hydrophobic cavity of β-CD of another one and thus inhibit the reduction. 
Monomesylated diamines were prepared as described in scheme 43. Mesylation of 
the hydroxy and amino group of amino alcohols followed by aziridine ring closure 
under basic condition afforded intermediate 182[79]. Ring opening with a saturated 
solution of ammonia in methanol had to be performed under diluted conditions to 
avoid the formation of bis- and tris by products. The free amines 183-185 were linked 
to β-CD in the microwave as described above. Achiral 183 had to be prepared in the 
same manner since direct mesylation of ethan-1,2-diamine gave exclusively 
undesired dimesylated product.   
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Scheme 43 Synthesis of monomesylated diamines 
 
 Scheme 44 summarises the catalysis results with β-CD modified ligands 186-
188 under standard conditions. They show comparable reactivities and 
stereoselectivities as their monotosylated analogues 154, 166 and 168. Ligand 186 
without chirality on the side chain gives the alcohol in respectable 62% yield, 
whereas the introduction of a chiral centre next to the sulfonamide nitrogen again 
dramatically decreases the yield to 15% respectively 8%. Valine derived 188 gave 
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better ee’s than 187 having a less bulky methyl substituent, which is in agreement 
with observations made with 168 and 166.  
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Scheme 44 ATH with monomesylated diamines 
 
 With these results in hand one can argue that the aromatic ring in 
monotosylated ligands is not responsible for the low reactivity of ligands 168-168. In 
other words: self assembling of the ligands seems very unlikely.  
 
3.2.2.3 Catalysis Results with Monotriflated Diamines  
 
 Triflate has stronger electron withdrawing properties than mesylates or 
tosylates[83]. With the aim of increasing the reduction rate even more, a monotriflated 
diamine was linked to β-CD. The synthesis was much more problematic and started 
again from an amino alcohol (scheme 45). Treatment of 189 with triflic anhydride at   
-78°C gave directly valine based aziridine 190 without isolation of reactive 
intermediate 191[79]. Aziridine 190 is an unstable compound and could not be 
chromatographed or dried properly. Decomposition was observed below 500 mbar. 
In fact triethylamine acted as nucleophile and opened the aziridine ring as could be 
demonstrated by ESI-MS analysis (m/z = 536 [192]+). So crude product 190 was 
dried for 5 minutes at 650 mbar and tried to open directly with ammonia. A lot of bis- 
193 and tris 194 side product was observed. So the strategy was changed and the 
aziridine opened regioselectively with benzylamine followed by deprotection to 
desired compound 195 in an overall yield of 48% (for three steps) as a white powder. 
Free amine 195 could not be attached to β-CD using conventional microwave 
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conditions which were applied for tosylates and mesylates. The remaining proton at 
the sulfonamido nitrogen is so acidic that it’s probably located on the amino 
functionality. The resulting positively charged nitrogen is no more nucleophilic at all. 
Addition of superstoichiometric amounts Hünig base was necessary to get a proper 
reaction with β-CD. 
 The corresponding aziridine intermediate of the non chiral triflate analogue 
starting from aminoethanol 78 was so unstable that it could not be isolated.   
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Scheme 45 Synthesis of chiral monotriflated diamine 195 
  
 The reactivity of 196 in ATH was very poor but comparable with other 
monosulfonated diamine ligands bearing a chiral centre in α-position to the 
sulfonamido nitrogen. 5% yield and 76% ee (S) were  observed for the reduction of 
standard ketone 86 (scheme 46). ATH with the free monotriflate lacking the β-CD unit 
resulted in 5% yield and 88% ee (S). So the CD moiety lowers the enantioselectivity 
and is therefore useless for this ligand class. 
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Scheme 46 ATH with monotriflated 196 
 
3.2.3 α-Pycolyl Amines Side Chains 
 
3.2.3.1 Catalysis Results with α-Pycolyl Amines 
 
 Replacing the OH- respectively the NHSO2R functionality of the side chain by 
a pyridine ring leads to α-pycolyl amines. It was mentioned in the introduction part of 
this thesis[45] that such structures can also serve as ligands for Ru catalysed ATH. 
Commercially available non chiral pyridin-2-ylmethanamine 197 was directly linked to 
β-CD yielding ligand 198 in 48%. Initial ATH experiments at room temperature 
showed only very poor activity (scheme 47). The yield increased only slightly by 
heating till 60°C but got quantitative at 70°C. 
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Scheme 47 ATH with α-pycolyl amine attached to β- CD 
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 Since it was suggested that the active Ru complex is only formed at higher 
than 70°C, β-CD-ampy 198, Ru arene 81 and excess sodium formate 82 were stirred 
for 1 hour at 70°C in H2O/DMF 3:1 prior to use in catalytic reactions. After cooling 
down to 22°C respectively 50°C one could observe somewhat better yields after 
three days (table 17). Lowering the catalyst loading to 5% gave unsatisfying 18% 
yield. 
 
Entry Ligand mol% 1h at 70°C   
prior to use 
T during 
catalysis
Yield [%] ee [%] Time
1 β-CD-ampy 10 yes 70 99 42 (S) 6h 
2 β-CD-ampy 10 yes 50 18 46 (S) 3d 
3 β-CD-ampy 10 yes 22 6 58 (S) 3d 
4 β-CD-ampy 5 no 70 18 28 (S) 3d 
 
Table 17 ATH 1h at 70°C prior catalysis is started 
 
However β-CD-ampy having no chirality at the side chain showed already 
respectable 58% ee (S) at 22°C. This result encouraged the introduction of a chiral 
centre in the pyridyl moiety by enzymatic resolution with candida antarctica lipase B 
(CALB). Racemic pyridine derivative 199 was synthesised in two steps and good 
yield according a literature procedure[84] (scheme 48). CALB selectively transformed 
the (R)-amine to the amide 200 leaving enantiomerically pure free (S)-amine 201[85]. 
200 was hydrolyzed to the free (R)-amine 202 in the presence of 6M HCl without loss 
of optical purity as could be demonstrated by mosher method.   
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Scheme 48 Synthesis of chiral α-pycolyl amines 201 and 202 
3 Results and Discussion  61 
Another pair of pycolyl enantiomers was prepared starting from 8-
aminoquinoline 203. Acetylation followed by hydrogenation gained 
tetrahydroquinoline 204 in 40% yield (scheme 49)[86]. Hydrolysis in aqueous HCl 
gave racemic amine 205 which was resolved with CALB as described above yielding 
free (S)-amine 206 in 93% ee and the (R)-enantiomer 207 in 94% ee[85].      
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Scheme 49 Synthesis of chiral tetrahydroquinolines 206 and 207   
 
Free amines 201, 202, 206 and 207 were attached to β-CD in the microwave 
as discussed earlier. New ligands 208-211 were applied to ATH under standard 
conditions (scheme 50). Because all four ligands showed very poor reactivities at 
22°C (1-3% yield) the catalyses were performed at 70°C again. Quantitative 
conversions and enantioselectivities up to 60% were observed. (R)-configuration at 
the pycolyl moiety leads to (S)-alcohols and (S)-chirality in the ligand gains the (R)-
product. 211 represents the only exception but can be neglected due to the low ee 
value of 12%. The absolute configurations are in agreement with amino alcohol- and 
monosulfonated diamine analogues.  
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Scheme 50 ATH with chiral α-pycolyl amines 
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Apparently steric modification can only influence the stereo outcome but not 
accelerate the reduction process. So it was decided to change the electronic 
properties of the pycolyl ligand. Since direct chlorination of α-pycolyl amine 197 with 
NCS failed compound 212 was prepared in three steps as illustrated in scheme 51. 
Allylic bromination[87] of chloropyridine 213 gave a mixture of mono- and 
dibrominated intermediate 214. Gabriel reaction including nucleophilic attack of 
potassium phtalimide followed by hydrazinolysis gave (6-chloropyridin-2-
yl)methanamine 212 in 30% overall yield[87].   
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Scheme 51 Synthesis of halogenated α-pycolyl amines 
 
 Compound 212 and fluorinated analogue 215 (derived from 2-fluoro-6-
methylpyridine[87]) were both connected to β-CD to test their reactivity towards ATH. 
Catalytic results with chloro- 216 and fluoro modified β-CD 217 are summarised in 
table 18. Neither Cl-216 nor F-217 is more reactive than non halogenated β-CD-
ampy 198. Despite the low yield entry 1 is a remarkable result. Asymmetric 
inductions higher than 50% ee with β-CD as the only chiral unit are quite rare[70].  
 
Entry Ligand mol% T [°C] Yield [%] ee [%] Time 
1 Cl-216 10 22 7 70 (S) 3d 
2 Cl-216 10 50 9 56 (S) 1d 
3 Cl-216 10 70 51 42 (S) 1d 
4 F-217 10 22 9 57 (S) 3d 
5 F-217 10 70 62 28 (S) 1d 
 
Table 18 ATH with halogenated α-pycolyl amines 
 
 At this point it was decided to change the strategy and no more attach the side 
chains on the primary face but on the secondary face. 
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3.3 CD modified on Secondary Face 
3.3.1 Amino Alcohols as Side Chains  
  
 As explained in chapter 1.2.2.3 the cavity of β-CD’s modified on the secondary 
face is not symmetric[67]. Thus it was decided to link the side chains, which have 
been linked successfully to the primary face, to the secondary face as well. It was 
assumed that a desymmetrization of the cavity changes the binding properties of the 
guest and therefore influences the stereo outcome of the reduction. Importantly, it 
could not be predicted whether this leads to better or worse stereoselectivities, since 
the influence of this distortion is still not explored properly nowadays[70]. 
Aminoethanol 78 was attached to the secondary face of β-CD as illustrated in 
scheme 52. β-CD was selectively protected on the primary face by treatment with 
TBDMSCl in pyridine[65]. Hepta protected 218 is soluble in various organic solvents 
which simplifies the purification procedure drastically. 218 could be chromatographed 
on silica gel using a mixture of ethyl acetate/ethanol/water as eluent. Deprotonation 
of the hydroxy group at position 2 followed by tosylation with 1-tosyl-1,2,4-triazole 
lead to monosulfonated 71 in moderate yield[65]. However a lot of starting material 
could be isolated and reused. Treatment with sodium ethylate in ethanol gave 
manno-epoxide 70 in 90% yield. The modified sugar unit is no more of glucose type 
because the stereo centre at position 3 has been inverted. Confirmation of the 
manno unit arose from 1H-NMR experiments and the coupling constant between H1 
and H2 (JH1H2 = 0 Hz). In addition to this 13C-NMR spectra showed solely two peaks 
(53.2 ppm and 49.2 ppm) in the epoxide region indicating that there is only one 
isomer present[65]. Manno epoxide 70 was opened regioselectively with aminoethanol 
yielding protected β-CD 219. Evidence for the 1C4 conformation of the altrose unit in 
219 rests on the coupling constant of the two di-axial protons H1 and H2 (JH1H2 = 7.3 
Hz) which is about three times the value observed for the di-equatorial situation 
(JH1H2 = 2.3 Hz)[88]. Accordingly, the initially formed 4C1 conformation flips over to the 
more stable 1C4 form changing the interior of β-CD to a distorted ellipsoid cavity. 
Deprotection[89] of all seven silyl ethers with tetrabutyl ammonium fluoride in THF 
followed by purification by RP-18 chromatography gave β-CD modified at position 3 
220 in an overall yield of 17% (five steps). 
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Scheme 52 Synthesis of β-CD modified on the secondary face 
 Initial catalytic reactions were performed with protected 219 in various organic 
solvents to check if the distortion can really enhance the ee’s in ATH to standard 
ketone 86. Excellent 86% ee (S) were observed in methanol (scheme 53). This is an 
intriguing result since β-CD is the only chiral unit in the catalytic system. The lower 
chiral induction in less polar CH2Cl2 or CH3CN is not surprising, since hydrophobic 
guests form stronger inclusion complexes with β-CD in polar solvents like water or 
alcohols[50]. The poor yields in CH2Cl2 and CH3CN can be explained by solubility 
problems of sodium formate in the corresponding solvents.   
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Scheme 53 ATH with protected CD 219 modified on the secondary face 
 
 With this promising result in hand deprotected β-CD-AE-2F 220 was applied to 
ATH under standard conditions. Distortion of the cavity was again proven by 1H-NMR 
measurements. A selective TOCSY experiment in D2O revealed that JH1H2 is 6.6 Hz. 
Table 19 summarises efforts to optimize the reaction conditions. Catalysis with 10 
mol% of catalyst at room temperature gives 79% yield and 91% ee (S). This is a 
dramatically increase compared to non chiral aminoethanol linked to the primary face 
of β-CD (8% ee, R). Quantitative yields were observed at 50°C with a slight loss of 
enantioselectivity. Decreasing the catalyst loading to 5 mol% lead to 30% yield at 
22°C respectively 78% yield at 50°C. Identical temperature and catalyst loading 
dependency was observed for three other substrates including two aliphatics. 
 
Entry Ligand mol% Solvent T [°C] Yield [%] ee [%]
1 β-CD-AE-2F 10 H2O/DMF 3:1 (0.25ml) 22 79 91 (S)
2 β-CD-AE-2F 10 H2O/DMF 3:1 (0.25ml) 50 99 89 (S)
3 β-CD-AE-2F 10 H2O (0.25ml) 22 48 92 (S)
4 β-CD-AE-2F 5 H2O/DMF 3:1 (0.25ml) 22 30 93 (S)
5 β-CD-AE-2F 5 H2O/DMF 3:1 (0.25ml) 50 78 89 (S)
6 β-CD-AE-2F 5 H2O/DMF 3:1 (0.125ml) 22 30 92 (S)
 
Table 19 ATH with deprotected 220 under various conditions  
 
 β-CD-AE-2F 220 was tested with three aromatic and seven aliphatic ketones 
to explore the substrate scope. The catalysis results performed in H2O/DMF 3:1 at 
50°C with 10 mol% of catalyst are shown in scheme 54. The ee’s of most substrates 
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are around 90%, reaching a maximum value of 98% (S) for the reduction of geranyl 
acetone 97. Only 2-hexanone 222 was reduced in moderate ee’s (70%, S). All 
alcoholic products showed (S)-configuration and the yields correlate with solubilities 
of the substrates in H2O/DMF. It’s worth mentioning that the ee values with ligand 
220 bearing non chiral aminoethanol on the secondary face are on the same high 
level as observed with chiral amino alcohols linked to the primary face (ligand 92). 
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Scheme 54 ATH with various aromatic and aliphatic ketones. 
 
 These nice results prompted the insertion of chirality in the side chain with the 
aim of improving the stereoselection even more. For this purpose (S)-1-amino-2-
propanol and the (R)-enantiomer were attached to the secondary face of β-CD as 
described earlier. The result shown in scheme 55 was kind of unexpected. Both 
catalysts 223 and 224 lead to the (S)-alcohol in 92% ee respectively 62% ee.  
 
H2O/DMF 3:1, 12h, 50°C
catalyst:substrate:HCO2Na 
    1      :    10       :   100
81 [RuCl2(C6H6)]2 β
NH
OH
Cl
O
223, ee: 92%, S
yield: 82%
Cl
OH
β
NH
OH
ligand 223 or 224
224, ee: 62%, S
yield: 94%  
 
Scheme 55 ATH with chiral amino alcohols attached to 2° face of β-CD 
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In contrast to primary face modified CD catalysts the chiral centre at the side 
chain of β-CD-AE-2F 220 seems to play an inferior role and chiral induction is mainly 
caused by the β-CD unit. To demonstrate that the distortion of the CD cavity is 
responsible for the enhanced stereo outcome, compound 225 was synthesised 
bearing aminoethanol at position 3 with an intact symmetric cavity (scheme 56).  
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Scheme 56 Synthesis of symmetric modified CD 225 
 
 Unprotected β-CD was sulfonated selectively at position 3 using 2-
naphtalenesulfonyl chloride 226[90]. This reaction is a little bit odd because the 
hydroxy proton at position 3 is less acidic than the one at position 2[55]. However 
regioselective sulfonation in 227 could be proven with elucidation of allo-epoxide 
structure 228. In contrast to manno-epoxide 70 coupling constant between H1 and H2 
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is JH1H2 = 3.3 Hz which is in agreement with an equatorial-axial conformation[90]. 
Epoxide opening with amino ethanol gave a 9:1 mixture of β-CD modified at position 
3 (225) respectively position 2 (229)[66]. The two regioisomers could be separated by 
chromatography on RP-18 with a gradient system H2O/MeOH. 225 offers a 
symmetric cavity since all seven sugars are of 4C1 glucose type. On the other hand 
the modified sugar unit of compound 229 flips to the more stable 1C4 conformation 
resulting in a desymmetrization of the cavity. Since latter compound was obtained 
only in very small amounts catalytic reactions were exclusively performed with ligand 
225. Only 15% ee (S) was obtained for the reduction of standard ketone 86 with 
ligand 225 (scheme 57). Since this chiral induction is much lower than with ligand 
220 (89% ee, S) one can assume that the distortion of the cavity really enhances the 
stereo outcome of the reduction by modifying the inclusion complex formation in a 
positive way.   
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Scheme 57 ATH with secondary face modified CD with a non distorted cavity 
 The yield was also significantly lower with 225 than with 220. Obviously, the 
nitrogen of the amino alcohol attached to a sugar unit with glucose 4C1 conformation 
is pointed to another direction than to one with altrose 1C4 conformation. It can be 
speculated that the combination of the two inclusion complex forming interactions 
(hydrophobic interaction of cavity/substrate and additional H bond of substrate to N-
H) do not fit nicely due to inappropriate geometries.  
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3.3.2 Monosulfonated Diamines and α-pycolyl Amines as Side Chains  
  
With the knowledge in hand that a distorted cavity enhances the 
enantioselectivities it was decided to attach achiral monotosylated diamine 157 and 
α-pycolyl amine 197 to the secondary face of β-CD as described earlier. Surprisingly, 
both ligands were inactive in ATH to ketone 86 at 50°C (scheme 58). 
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Scheme 58 ATH with ligands 230 and 231 
  
As a result of the poor reactivities and low stereoselectivities of ligands 230 
and 231 in ATH the project was continued with a new ligand class (see chapter 3.3.3)   
3.3.3 Alkyl Amines as Side Chains  
 
With respect to the two following findings it was decided to prepare ligands 
bearing alkyl amines on the secondary face of β-CD: Firstly, 1H-NMR experiments of 
Ru complex β-CD-AE-2F 220 revealed no chemical shifts for any proton of the ligand 
which is in contrast to metal complexes with β-CD’s modified on the primary face 
(see chapter 3.2.1.7). Secondly, ligand 220 offers more than just one β-amino 
alcohol motif. Thus the metal can theoretically bind in three different modes, two of 
them involving oxygen atoms of CD’s glucose unit (figure 16). 
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Figure 16 Three possible binding modes with ligand 220 
  
Accordingly methyl amine was linked to β-CD as described above yielding 
new ligand 232. If this ligand was inactive in ATH one could exclude the two 
proposed binding modes incorporating hydroxy groups of the β-CD unit (figure 16; 
middle and right structure). Moreover it would demonstrate conventional complex 
formation of the metal with the amino alcohol side chain as observed for the primary 
face. Interestingly, quantitative conversion and 86% ee (S) was observed using 
ligand 232 in ATH reaction under standard conditions (scheme 59). 
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Scheme 59 ATH with methyl amine derived CD 232 
 
 Furthermore the 1H-NMR spectra of Ru complex 233 in D2O showed 
noticeable downfield shifts of several protons (table 20, scheme 60). As expected H3 
(0.63 ppm) and N-CH3 (0.38 ppm) show the largest downfield shifts relative to free 
ligand 232. Downfield shifts of 0.14 (H1), 0.23 (H2) and 0.22 (H4) are in agreement 
with proposed binding mode shown on the very right in scheme 60.   
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Proton H1 H2 H3 H4 H5 N-CH3 
Shift (ppm) 0.14 0.23 0.63 0.22 0.01 0.38 
 
Table 20 Downfield shifts of several protons of Ru complex 233 relative to 232 
 
 In addition to this, 1-D and 2-D 1H-NMR spectra of Ru cymene complex 234 
were measured. The downfield shifts relative to free ligand 220 are in the same 
range as observed for the arene analogue. Moreover metal complex 233 showed 
similar catalytic properties (97% yield and 63% ee (S) at 50°C). Importantly, the 
presence of a methyl- and especially of an isopropyl group on the aromatic ring 
facilitates the interpretation of the spectra (scheme 60; left side). HMQC spectra 
showed cross peaks of diastereotopic CH3 isopropyl carbons at 22.2 ppm 
respectively 23.3 ppm to the protons at 1.54 ppm respectively 1.52 ppm. Only two 
supplementary cross peaks with intensities of less than 5% appeared in the same 
region and thus evidence that one main complex is formed.  
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Scheme 60 Left: Ru cymene complex; right two possible Ru arene binding modes 
 
 Hence it was concluded that Ru coordinates to N-H and the adjacent OH 
group at C-2 of the altrose unit (scheme 61; right structure). The stereo outcome of 
the reduction of standard ketone 86 with amino ethanol based ligand 220 is only 3% 
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higher than with methyl amine ligand 232. So it can be assumed that ATH performed 
with amino alcohol ligand 220 involves a mixture of the proposed three complexes 
which are specified in figure 16. Since the enantioselectivities are almost identical a 
main species according to the methyl amine analogue is very likely. This finding 
explains the poor reactivity of monotosylated- and α-pycolyl diamines. The bulky 
tosyl- respectively pyridine rest disturbs the formation of the Ru complex 
incorporating a hydroxy group of β-CD and therefore lowers the activity dramatically.  
In order to exclude similar binding modes on the other face of β-CD, methyl 
amine was attached to the primary face as well. Reduction of standard ketone 86 
gave no alcohol after 3 days at 50°C. Thus incorporation of a hydroxy group from β-
CD in the reactive Ru complex can be ruled out for the primary face. 
 Unlike amino alcohol modified β-CD’s, the structure of the active catalyst could 
be elucidated for methyl amine based CD. That’s why several alkyl amines were 
linked to the secondary face of β-CD in order to get more sophisticated ligands for 
ATH. Scheme 61 summarises the catalytic results of novel ligands 235-238. Neither 
a primary amine in 235 nor a bulkier alkyl chain in 236 and 237 nor a phenyl rest in 
238 could improve the stereoselectivity of the reduction compared to initially 
prepared methyl amine β-CD 232.  
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Scheme 61 ATH with alkyl amines attached to the secondary face of β-CD 
 
Optimization of β-CD-AM-2F 232 carrying a methyl amine group is shown in 
table 21. As expected aromatic 86 and aliphatic standard substrate 98 behave 
similar. Best results for both substrates were obtained at room temperature using 10 
mol% catalyst loading.  
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Entry Ligand mol% Substrate Solvent T [°C] Yield [%] ee [%]
1 β-CD-AM-2F 10 aromatic 86 H2O/DMF 3:1 4 4 89 (S)
2 β-CD-AM-2F 10 aromatic 86 H2O/DMF 3:1 22 99 86 (S)
3 β-CD-AM-2F 10 aromatic 86 H2O/DMF 3:1 50 99 83 (S)
4 β-CD-AM-2F 5 aromatic 86 H2O/DMF 3:1 22 49 86 (S)
5 β-CD-AM-2F 5 aromatic 86 H2O/DMF 3:1 50 83 82 (S)
6 β-CD-AM-2F 10 aliphatic 98 H2O/DMF 3:1 22 98 86 (S)
7 β-CD-AM-2F 10 aliphatic 98 H2O/DMF 3:1 50 99 84 (S)
 
Table 21 Optimization of ATH with ligand β-CD-AM-2F 232 
 
 β-CD-AM-2F 232 was applied to ATH of various aromatic and notorious 
difficult aliphatic substrates under optimized conditions mentioned above (scheme 
62). Generally, the yields are better with β-CD-AM-2F 232 than with β-CD-SAP 92. 
Eight out of fourteen substrates showed quantitative yield, the six remaining ones 
moderate till good yield. Especially the yields of ketones bearing long alkyl chains 
could be improved. All alcoholic products show (S)-configuration and only two 
substrates are reduced with less than 82% ee. There is a trend that the bigger the 
difference between the two linear alkyl chains attached to the carbonyl functionality 
the higher the enantioselectivities. Example given, 3-octanone 239 (77% ee) is worse 
than 2-octanone 95 (89% ee) or 2-hexanone 222 (74% ee) is worse than 2-octanone 
95 (89% ee) and this again worse than 2-nonanone 221 (93% ee). Highest 
enantioselectivities are observed for aromatic 88 (96% ee) and aliphatic 100, 97 and 
(all 93% ee). Thus the stereo outcome is comparable to the one performed with β-
CD-SAP 92 bearing a chiral amino alcohol side chain on the primary face and β-CD-
AE-2F 220 carrying a non chiral amino alcohol on the secondary face. This is a 
remarkable result since CD is the only chiral unit in β-CD-AM-2F 232.  
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Scheme 62 ATH to several ketones under optimized conditions 
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4 Summary 
 
 A novel ATH catalyst comprising of Ru(II) complexes linked to both faces of β-
CD is presented. The huge advantage of this system is that it is possible to reduce 
aromatic as well as notorious difficult aliphatic ketones in good to excellent 
enantioselectivities (scheme 63). The catalytic reactions were performed in aqueous 
solution in the presence of 10 mol% catalyst and excess sodium formate. 
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Scheme 63 Ru(II) complexes of β-CD’s modified on primary and secondary face  
 
 Initial studies were performed with ligand 79 carrying non chiral aminoethanol 
on the primary face of β-CD synthesised in one step from monotosylated β-CD 68. 
The stereoselection varying from 6% ee (R) to 47% (R) for various aromatic carbonyl 
compounds was addressed to preorganization of the substrate in the hydrophobic 
cavity of β-CD such that si addition of the hydride to the carbonyl group is preferred in 
the reactive complex.  
 Screening of several chiral amino alcohols revealed that β-CD-SAP 92 bearing 
relatively little sterically demanding chiral methyl group serves as excellent ligand for 
the ATH to various aromatic and challenging aliphatic ketones (scheme 64). A 
drastically increase of enantioselectivities up to 97% ee (S) was observed in a 
mixture of H2O/DMF 3:1 with moderate to good conversions. The chiral centre in α-
position to the hydorxy group at the side chain has a strong influence on the stereo 
outcome. Furthermore the catalytic system was able to reduce β-ketoesters 
enantioselectively and diketones regioselectively.   
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Scheme 64 ATH of aromatic and aliphatic ketones with β-CD-SAP 79 
 
 A number of monosulfonated diamines and α-pycolyl amines were connected 
to the primary face of β-CD and applied to ATH. Neither of them could improve β-CD-
SAP 79 in terms of reactivity and stereoselectivity. A selection of these ATH ligands 
is shown in scheme 65.  
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Scheme 65 ATH with monosulfonated and α-pycolyl derived ligands 
 
 In continuing studies amino alcohols were linked in five steps and overall 
yields up to 20% to the secondary face of β-CD. It was anticipated that the stereo 
outcome of ATH reactions with such ligands would differ from the one’s observed 
with ligands modified on the primary face due to a distortion of the hydrophobic cavity 
of β-CD. This desymmetrization is caused by a conformational change of the 
modified sugar ring from 4C1 to more stable 1C4. Interestingly enantioselectivities up 
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to 98% (S) were achieved using β-CD-AE-2F 220 carrying non chiral amino ethanol 
on the secondary face. This is a striking result since asymmetric reactions using β-
CD’s as the only chiral unit are rarely exceeding 50% ee.  
 In addition to this it was found that methyl amine attached to the secondary 
face of β-CD act as excellent ligand in ATH reactions. It could be demonstrated that 
Ru binds to the amino nitrogen and the hydroxyl group at position 2 of the modified 
sugar unit. Various aromatic and aliphatic ketones were reduced in exquisite yields 
and enantioselectivities around 90% (scheme 66). 
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Scheme 66 ATH with methyl amine linked to the secondary face of β-CD 
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5 Experimental Part 
5.1 General  
5.1.1 Abbreviations 
AIBN azobisisobutyronitrile 
Alox aluminium oxide 
CALB candida antarctica lipase B  
CCl4 tertrachloromethane 
CuSO4 copper sulfate 
DCM dichloromethane 
DIAD diisopropyl azodicarboxylate 
DMAP N,N-dimethylpyridin-4-amine 
DMSO dimethylsulfoxide 
Et3N triethylamine 
EtOAc ethyl acetate  
EtOH ethanol   
H2SO4 sulfuric acid 
HCl hydrochloric acid 
Hx hexane  
K2CO3 potassium carbonate 
KBr potassium bromide 
KOH potassium hydroxide 
LiAlH4 lithium aluminiumhydride 
MeOH methanol 
Na2SO4 sodium sulfate 
NaHCO3 sodium bicarbonate 
NaOH sodium hydroxide 
NBS N-bromosuccinimide 
NH4Cl ammonium chloride  
Pd/C palladium on charcoal 
Si2O silica gel 
TBAF tetrabutylammonium fluoride 
TBME tert.-butylmethylether 
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5.1.2 Solvents and Chemicals 
 
Reagents were used as received from Fluka AG, Acros Organics and Aldrich Chemie 
unless otherwise stated. Chemicals of the quality purum, purum p.a. or > 98% were 
used without further purification. 6-O-monotosyl-β-CD 68 was purchased from 
CycloLab Ltd (Budapest, Hungary). Dichloro(benzene)ruthenium (II) dimer 81 was 
purchased from Strem. Mono-3-deoxy heptakis(6-O-tert.-butyldimethylsilyl)-3-amino-
β-CD 235 was available in the group and used without further purification. 
Solvents for chromatography and extractions were distilled prior to use. Dry 
dichloromethane (CH2Cl2) was distilled from CaH2, diethyl ether (Et2O) and 
tetrahydrofuran (THF) from Na/benzophenone. All freshly dried solvents were stored 
over activated molecular sieves (4Å). Further solvents (dimethylformamide, 
dimethylsolfoxide, methanol, ethanol) used for reactions corresponded to the quality 
puriss p.a., abs., over Molecular Sieves from Fluka AG. HPLC-grade solvents were 
purchased and used for analytical HPLC on chiral phase (Chiracel OD-H). Degassed 
solvents for catalysis under oxygen-free condition were obtained by five freeze-
pump-thaw cycles in high-vacuum. 
For an inert atmosphere Argon 56 (< 4 ppm other gases) from Carbagas AG 
(Lenzburg, Switzerland) or Argon 6.0 (<1.5 ppm other gases) from PanGas AG 
(Dagmersellen, Switzerland) were used. 
5.1.3 Materials and Instruments 
Solvents were removed with a Büchi (Switzerland) rotary evaporator (Waterbath 461, 
Rotavapor RE 111 and Vauum Controller 168) and a MZ 2C membrane pump 
(Vacuubrand). For cooling a mixture of EtOH and water was kept at 2oC with a UKW 
300 thermostat (Vacuubrand). 
For weighing compounds and reagents Mettler (Switzerland) balances P1200 (>1g), 
AE 163 (<1g), and AX205 (<100mg) were used. 
A high-vacuum pump D5E from Trivac (Köln, Germany) was used for drying 
compounds and degassing solvents.  
Slow addition of reagents to a reaction mixture was achieved with a Precidor 5003 
syringe pump (Informs HT, Switzerland). 
For all non-aqueous reactions glassware was dried with a heat gun for several 
minutes under vacuum, and the atmosphere was exchanged by three cycles of 
evacuating and flushing with argon. 
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Melting points (mp) were determined on a büchi 510 apparatus and are 
uncorrected. 
 
Chromatographic Methods 
Analytical thin layer chromatography (TLC) was performed on 0.25 mm precoated 
glass plates (5×10 cm, silica gel 60 F254, Merck AG, Germany), 0.25 mm precoated 
glass plates (5×10 cm, aluminium oxide 60 F254, Merck AG, Germany), or on 0.25 
mm precoated glass plates (5×10 cm, RP-18 F254s, Merck AG, Germany). 
Compounds were detected at 254 nm (UV) or at 366 nm (fluorescence). For 
carbohydrates, compounds were visualized by p-anisaldehyde dip (6 g                      
p-anisaldehyde and 3 ml concentrated sulphuric acid in 250 ml ethanol). Description: 
(solvent): Rf.  
For normal phase column chromatography silica gel 60 from Merck (0.040-0.063 
mm, 230-400 mesh) or aluminum oxide 90 from Merck (standardized (activity II-III), 
0.063-0.2 mm, 70-230 mesh) were used. For reversed phase column 
chromatography, RP-18 silica gel (fully endcapped) from Fluka (0.040-0.063mm, 
230-400 mesh) was used. For ion-exchange column chromatography, Amberlite 
CG-50 from Fluka (weak acidic, H+-Form, 100-200 mesh) or Amberlite IRA-68 
(weakly basic, free base) were washed five times with nanopure water prior to use. 
Flash chromatography was performed under pressure with an aquarium pump. 
Analytical chiral phase HPLC (ee determination) was performed with a Chiralcel 
OD-H column using HPLC-grade solvents on a Agilent 1100 Series HPLC system 
with Solvent degasser G1322A, BinPump G1312A, Autosampler G1313A, 
Thermostatic column housing G1316A, Diode array UV detector G1315B. All 
samples were filtrated prior to injection.  
 
Spectroscopic Methods 
Ultra Violet-Visible absorption spectras (UV/Vis) were recorded on an Agilent 
8453 Diode Array spectrophotometer using optical 110 QS Hellma cuvettes (10 mm 
light path). Description: UV/Vis (solvent): wavelength of maxima (λmax) in nm (relative 
extinction coefficient in %). 
Infrared spectras (IR) were measured on a Perkin-Elmer 1600 series FTIR 
spectrometer in KBr or on a FTIR-8400S from SHIMADZU. Description: IR (medium): 
wavenumbers of transmission maxima in cm-1. 
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Electron spray ionization mass spectras (ESI-MS) were recorded on a Bruker 
Esquire 3000plus. Description: ESI-MS (solvent): mass peaks in m/z (relative intensity 
in %). Peaks with an intensity of less than 5% were not considered. 
 
1H-Nuclear magnetic resonance spectroscopy (1H-NMR) was performed using 
either a Bruker av250 (250MHz), Bruker DPX-NMR (400MHz), Bruker DRX-500 
(500MHz) or Bruker DRX-600 (600MHz) spectrometer. Solvents for NMR were 
obtained from Cambridge Isotope Laboratories (Andover, MA, USA). CDCl3 was 
filtered through basic alumina prior to use. All spectra were recorded at 298 K. 
COSY, TOCSY, NOESY and ROESY were recorded if necessary. Selective TOCSY 
experiments were performed by Dr. Daniel Häussinger. Descripition: 1H-NMR 
(frequency, solvent): δH in ppm relative to TMS or residual solvent peaks (CDCl3: 
7.26, D2O: 4.79). Peak multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet; coupling constants J in Hertz. 
13C-Nuclear magnetic resonance spectroscopy (13C-NMR) was 1H-decoupled and 
recorded on a Bruker DPX-NMR (100MHz) or Bruker DRX-500 (125 MHz) 
spectrometer. For the assignment of carbons ATP, DEPT, HETCOR, HMQC and 
HMBC experiments were carried out. Descripition: 13C-NMR (frequency, solvent):     
δC in ppm relative to residual solvent peaks. 
19F-Nuclear magnetic resonance spectroscopy (19F-NMR) was recorded on a 
Bruker DPX-NMR (400MHz). 
Single crystal X-ray structures were determined by Dr. Markus Neuburger and Dr. 
Silvia Schaffner in the chemical crystallography laboratory of the inorganic 
department. Data collection was carried out on a Nonius KappaCCD diffractometer 
using the COLLECT software suite. The usual corrections were applied. No 
absorption correction was determined. The structures were solved by direct method 
using the program DIRDIF-99. Anisotropic least-squares refinement was carried out 
on all non-hydrogen atoms using the program CRYSTALS. Hydrogen atoms were in 
calculated positions. 
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5.2 Synthesis 
5.2.1 Synthesis of Cyclodextrin Side Chains 
5.2.1.1 Amino alcohols 
(1S,2S)-2-((R)-1-phenylethylamino)cyclohexanol (241) and (1R,2R)-2-((R)-1-
phenylethylamino)cyclohexanol (242)[75] 12.4 ml of a 2M solution of 
trimethylaluminium in heptane (24.82 mol, 1.0 eq.) were added slowly 
to 3.15 ml (R)-(+)-methylbenzylamine (24.82 mol, 1.0 eq.) in 20 ml 
DCM at -5°C. After stirring for an additional hour at 0°C, 2.56 g 
cyclohexeneoxide (26.10 mol, 1.05 eq.) dissolved in 20 ml DCM were 
added over a period of 30 minutes to the cold solution and let stir for 
3 h at 0°C and 18 h at r.t. The white suspension was then cooled to 0°C and 4.4 g 
NaF were added. 2.8 ml water were added very carefully and the solution was stirred 
for 90 minutes at r.t. After filtration over Celite and washing with DCM, the organic 
phase was dried over K2CO3 and concentrated. The crude product was purified by 
column chromatography (SiO2, Hx/EtOAc/Et3N 1:1:0.1), yielding 1.45 g 242 (25% 
yield) and 1.34 g 241 (23% yield) as white solids.  
(1S,2S): TLC (SiO2, Hx/EtOAc/Et3N 1:1:0.1): Rf = 0.38; 1H-NMR (400 MHz, CDCl3): 
7.19-7.32 (m, 5H, Har); 3.83 (q, J = 6.3, 1H, PhCH(CH3)NH); 3.00 (m, 1H); 2.25 (m, 
1H, CH2); 1.97 (m, 1H); 1.86 (m, 1H); 1.63 (m, 2H); 1.60 (d, J = 6.3, 3H, CH3); 1.20-
1.58 (m, 3H) 0.76 (m, 1H); 13C-NMR (100 MHz, CDCl3): 147.2, 128.9, 127.5, 126.9, 
74.5, 62.0, 55.6, 33.4, 31.7, 25.8, 24.7, 23.9 ; ESI-MS (MeOH): positive ion mode: 
220 (100, [M+H]+) 
(1R,2R): TLC (SiO2, Hx/EtOAc/Et3N 1:1:0.1): Rf = 0.31; 1H-NMR (400 MHz, CDCl3): 
7.18-7.32 (m, 5H, Har); 3.92 (q, J =  6.6, 1H, PhCH(CH3)NH); 3.06 (m, 1H); 2.10 (m, 
2H, CH2); 1.89-1.92 (m, 2H); 1.27 (d, J = 6.6, 3H, CH3); 1.16 (m, 2H); 1.00-1.04 (m, 
2H) 0.80-0.84 (m, 1H); 13C-NMR (100 MHz, CDCl3): 145.8, 129.0, 127.4, 127.1, 74.6, 
60.5, 54.5, 33.4, 30.9, 26.2, 25.5, 24.6; ESI-MS (MeOH): positive ion mode: 220 
(100, [M+H]+)   
(1R,2R)-2-aminocyclohexanol (115)[75] 1.0 g 241 (4.57 mmol) was dissolved in 50 
ml MeOH and stirred for 4 h under a hydrogen atmosphere in the presence 
of 0.30 g Pd/C. The mixture was filtrated over Celite and basic alox, 
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yielding 0.51 g 115 (85% yield) as a yellow oil. 
TLC (SiO2, EtOAc/MeOH/NH4OH 8:1:1): Rf = 0.18; 1H-NMR (400 MHz, CDCl3): 3.10 
(m, 1H, CHOH); 2.40 (m, 1H, CHNH); 1.80-1.96 (m, 2H); 1.60-1.66 (m, 2H); 1.09-
1.21 (m, 4H); 13C-NMR (100 MHz, CDCl3): 75.6, 57.5, 34.8, 34.0, 25.5, 25.0; ESI-MS 
(MeOH): positive ion mode: 116 (100, [M+H]+) 
(1S,2S)-2-aminocyclohexanol (114)[75] 1.0 g 241 (4.57 mmol) were dissolved in 50 
ml MeOH and stirred for 4 h under a hydrogen atmosphere in the presence 
of 0.30 g Pd/C. The mixture was filtrated over Celite and basic alox, 
yielding 0.53 g 114 (86% yield) as a yellow oil. 
TLC (SiO2, EtOAc/MeOH/NH4OH 8:1:1): Rf = 0.18; 1H-NMR (400 MHz, CDCl3): 3.10 
(m, 1H, CHOH); 2.40 (m, 1H, CHNH); 1.80-1.96 (m, 2H); 1.60-1.66 (m, 2H); 1.09-
1.21 (m, 4H); 13C-NMR (100 MHz, CDCl3): 75.6, 57.5, 34.8, 34.0, 25.5, 25.0; ESI-MS 
(MeOH): positive ion mode: 116 (100, [M+H]+) 
(1S,2S)-2-((R)-1-phenylethylamino)cyclopentanol (243) and (1R,2R)-2-((R)-1-
phenylethylamino)cyclopentanol (244)[75] 29.2 ml of a 2M solution 
of trimethylaluminium in heptane (58.31 mol, 1.0 eq.) were added 
slowly to 7.07 g (R)-(+)-methylbenzylamine (58.31 mol, 1.0 eq.) in 35 
ml DCM at -5°C. After stirring for an additional hour at 0°C, 5.15 g 
cyclopenteneoxide (61.22 mol, 1.05 eq.) dissolved in 35 ml DCM 
were added over a period of 30 minutes to the cold solution and let 
stir for 3 h at 0°C and 18 h at r.t. The white suspension was then cooled to 0°C and 
10.3 g NaF were added. 3.3 ml water were added very carefully and the solution was 
stirred for 90 minutes at r.t. After filtration over Celite and washing with DCM, the 
organic phase was dried over K2CO3 and concentrated. The crude product was 
purified by column chromatography (SiO2, Hx/EtOAc/Et3N 1:1:0.1), yielding 2.91 g 
244 (31% yield) and 2.73 g 243 (29% yield) as white solids.  
(1R,2R): TLC (SiO2, Hx/EtOAc/Et3N 1:1:0.1): Rf = 0.29 ; 1H-NMR (400 MHz, DMSO-
d6): 7.21-7.33 (m, 4H, Har); 7.10-7.15 (m, 1H, Har); 4.41 (d, J = 4.1, 1H, OH); 3.72-
3.84 (m, 2H, PhCH(CH3)NH and CHOH); 2.58-2.62 (m, 1H, CHNH); 1.75-1.82 (m, 
1H); 1.54-1.62 (m, 1H); 1.45-1.51 (m, 2H); 1.29-1.38 (m, 1H); 1.20 (d, J = 6.6, 3H, 
CH3); 1.01-1.11 (m, 1H); 13C-NMR (100 MHz, DMSO-d6): 146.6, 128.9, 127.3, 127.0, 
79.1, 65.4, 57.3, 33.0, 31.5, 24.6, 20.9; ESI-MS (MeOH): positive ion mode: 206 
(100, [M+H]+) 
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(1S,2S): TLC (SiO2, Hx/EtOAc/Et3N 1:1:0.1): Rf = 0.22 ; 1H-NMR (400 MHz, DMSO-
d6): 7.22-7.32 (m, 4H, Har); 7.11-7.18 (m, 1H, Har); 4.43 (d, J = 4.0, 1H, OH); 3.70 (q, 
J = 6.6, 1H, PhCH(CH3)NH); 3.59-3.64 (m, 1H, CHOH); 2.42-2.54 (m, 1H, CHNH); 
1.68-1.75 (m, 2H); 1.42-1.58 (m, 2H); 1.21-1.34 (m, 2H); 1.22 (d, J = 6.6, 3H, CH3); 
13C-NMR (100 MHz, DMSO-d6): 146.8, 129.0, 127.3, 127.2, 77.9, 64.1, 56.3, 33.1, 
30.0, 25.7, 21.1; ESI-MS (MeOH): positive ion mode: 206 (100, [M+H]+) 
(1R,2R)-2-aminocyclopentanol (117)[75] 0.35 g 244 (1.80 mmol) were dissolved in 
15 ml MeOH and stirred for 4 h under a hydrogen atmosphere in the 
presence of 0.30 g Pd/C. The mixture was filtrated over Celite and basic 
alox, yielding 0.14 g 117 (87% yield) as a yellow oil. 
TLC (SiO2, EtOAc/MeOH/NH4OH 2:1:0.05): Rf = 0.13; 1H-NMR (400 MHz, CDCl3): 
3.50-3.53 (m, 1H, CHOH); 2.70-2.74 (m, 1H, CHNH); 1.77-1.84 (m, 2H); 1.52-1.56 
(m, 2H); 1.31-1.37 (m, 1H); 1.11-1.19 (m, 1H); 13C-NMR (100 MHz, CDCl3): 79.8, 
60.3, 32.6, 32.3, 20.8; ESI-MS (MeOH): positive ion mode: 124 (100, [M+H]+) 
(1S,2S)-2-aminocyclopentanol (116)[75] 0.50 g 243 (2.59 mmol) were dissolved in 
20 ml MeOH and stirred for 4 h under a hydrogen atmosphere in the 
presence of 0.34 g Pd/C. The mixture was filtrated over Celite and basic 
alox, yielding 0.19 g 116 (84% yield) as a yellow oil. 
TLC (SiO2, EtOAc/MeOH/NH4OH 2:1:0.05): Rf = 0.13; 1H-NMR (400 MHz, CDCl3): 
3.50-3.53 (m, 1H, CHOH); 2.70-2.74 (m, 1H, CHNH); 1.77-1.84 (m, 2H); 1.52-1.56 
(m, 2H); 1.31-1.37 (m, 1H); 1.11-1.19 (m, 1H); 13C-NMR (100 MHz, CDCl3): 79.8, 
60.3, 32.6, 32.3, 20.8; ESI-MS (MeOH): positive ion mode: 124 (100, [M+H]+) 
(2S,3R)-3-((R)-1-phenylethylamino)butan-2-ol (110) and (2R,3S)-3-((R)-1-
phenylethylamino)butan-2-ol (111)[75] 13.8 ml of a 2M solution of 
trimethylaluminium in heptane (27.50 mol, 1.0 eq.) were added slowly 
to 3.34 g (R)-(+)-methylbenzylamine (27.50 mol, 1.0 eq.) in 15 ml DCM 
at -5°C. After stirring for an additional hour at 0°C, 2.01 g trans-
epoxybutane (28.90 mol, 1.05 eq.) dissolved in 15 ml DCM were added 
over a period of 30 minutes to the cold solution and let stir for 3 h at 
0°C and 40 h at r.t. The white suspension was then cooled to 0°C and 4.8 g NaF 
were added. 3.0 ml water were added very carefully and the solution was stirred for 
90 minutes at r.t. After filtration over Celite and washing with DCM, the organic phase 
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was dried over K2CO3 and concentrated. The crude product was purified by column 
chromatography (SiO2, Hx/EtOAc/Et3N 2:1:0.075), yielding 2.05 g 111 (37% yield) 
and 1.34 g 110 (24% yield) as white solids. 
(2S,3R): TLC (SiO2, Hx/EtOAc/Et3N 1:1:0.16): Rf = 0.33; 1H-NMR (400 MHz, CDCl3): 
7.20-7.38 (m, 5H, Har); 3.85-3.95 (m, 1H, PhCH(CH3)NH); 3.48-3.54 (m, 1H, CHOH); 
2.49-2.56 (m, 1H, CHNH); 1.36 (d, J = 6.6, 3H, PhCHCH3); 1.02 (d, J = 6.3, 3H, 
PhCH(CH3)NH); 0.98 (d, J = 6.6, 3H, CH3CHOH); 13C-NMR (100 MHz, CDCl3):146.1, 
128.9, 127.4, 127.0, 69.1, 55.8, 55.4, 25.5, 18.0, 14.8 
(2R,3S): TLC (SiO2, Hx/EtOAc/Et3N 1:1:0.16): Rf = 0.38; 1H-NMR (400 MHz, CDCl3): 
7.18-7.42 (m, 5H, Har); 3.74-3.91 (m, 2H, PhCH(CH3)NH and CHOH); 2.51-2.54 (m, 
1H, CHNH); 1.33 (d, J = 6.8, 3H, PhCH(CH3)NH); 1.02 (d, J = 6.3, 3H, CH3CHNH); 
0.88 (d, J = 6.6, 3H, CH3CHOH); 13C-NMR (100 MHz, CDCl3): 146.2, 129.0, 127.4, 
126.9, 66.5, 55.3, 54.7, 25.0, 18.2, 15.1 
(2R,3S)-3-aminobutan-2-ol (113)[75] 0.60 g 111 (3.11 mmol) were dissolved in 30 ml 
MeOH and stirred for 3 days under a hydrogen atmosphere in the presence 
of 0.15 g Pd/C. The mixture was filtrated over Celite and basic alox, yielding 
0.14 g 113 (51% yield) as a yellow oil. 
TLC (SiO2, Hx/EtOAc/Et3N 2:1:0.05): Rf = 0.07; 1H-NMR (400 MHz, CDCl3): 3.64-
3.66 (m, 1H, CHOH); 2.94-2.96 (m, 1H, CHNH); 1.10 (d, J = 6.3, 3H, CH3CHOH); 
1.01 (d, J = 6.6, 3H, CH3CHNH); 13C-NMR (100 MHz, CDCl3): 71.0, 51.5, 17.9, 17.8 ; 
ESI-MS (MeOH): positive ion mode: 90 (100, [M+H]+) 
(2S,3R)-3-aminobutan-2-ol (112)[75] 1.12 g 110 (5.70 mmol) were dissolved in 45 ml 
MeOH and stirred for 3 days under a hydrogen atmosphere in the presence 
of 0.28 g Pd/C. The mixture was filtrated over Celite and basic alox, yielding 
0.34 g 112 (66% yield) as a yellow oil. 
TLC (SiO2, Hx/EtOAc/Et3N 2:1:0.05): Rf = 0.07; 1H-NMR (400 MHz, CDCl3): 3.64-
3.66 (m, 1H, CHOH); 2.94-2.96 (m, 1H, CHNH); 1.10 (d, J = 6.3, 3H, CH3CHOH); 
1.01 (d, J = 6.6, 3H, CH3CHNH); 13C-NMR (100 MHz, CDCl3): 71.0, 51.5, 17.9, 17.8 ; 
ESI-MS (MeOH): positive ion mode: 90 (100, [M+H]+) 
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5.2.1.2 Monotosylated Diamines 
N-tosylethane-1,2-diamine (157)[77] 10.00 g ethane-1,2-diamine 155 (0.17 mol, 3.0 
eq.) were dissolved in 20 ml of benzene. 10.57 g tosylchloride 
156 (0.06 mol, 1.0 eq.) dissolved in 40 ml of benzene were added 
dropwise under vigorous stirring. The yellowish precipitate was filtered off and stirred 
in 25 ml 1M HCl. After filtration, the white crystals were dissolved in another 25 ml 1M 
HCl and filtrated. The filtrate was basified with 1M NaOH precipitation of white 
crystals. After filtration and washing with ice-water one gained 3.11 g of 157 (8.5 % 
yield) as white crystals. 
TLC (SiO2, Hx/TBME 1:1): Rf = 0.11; 1H-NMR (400 MHz, CDCl3): 7.75 (d, J = 8.3, 
2H, Har); 7.31 (d, J = 8.3, 2H, Har); 2.96 (t, J = 5.1, 2H); 2.79 (t, J = 5.1, 2H); 2.43 (s, 
3H, CH3); 13C-NMR (100 MHz, CDCl3): 143.8, 137.3, 130.1, 127.5, 45.8, 41.2, 21.9; 
ESI-MS (MeOH): positive ion mode: 215 (75, [M+H]+); 237 (100, [M+Na]+); 429 (26, 
[2M+H]+); 451 (54, [2M+Na]+)  
(S)-2-(tosylamino)propyl-4-methylbenzenesulfonat (160)[79] 2.08 g (S)-2-amino-1-
propanol 159 (27.70 mmol, 1.0 eq.) were dissolved in 7.5 ml of 
pyridine. 10.54 g tosylchloride (55.30 mmol, 2.0 eq.) dissolved in 30 
ml of pyridine were added dropwise over a period of 30 minutes at 
0°C. After stirring for an additional hour at 0°C, the solution was 
allowed to come to r.t. and stirred for 18 h. The pyridine was evaporated under 
reduced pressure, the brownish residue dissolved in 75 ml of water and extracted 
three times with TBME. The combined organic phases were washed with 4 x 50 ml 
5%-H2SO4, 50 ml sat. CuSO4, water, sat. NaHCO3 and brine. After drying over 
Na2SO4, the crude product was purified by column chromatography (SiO2, Hx/EtOAc 
3:1) yielding 6.82 g 160 (64% yield) as white crystals. 
TLC (SiO2, Hx/TBME 3:1): Rf = 0.21; 1H-NMR (400 MHz, CDCl3): 7.70 (m, 4H, Har); 
7.36 (d, J = 8.1, 2H, Har); 7.28 (d, J = 8.1, 2H, Har); 4.67 (d, J = 8.1, 1H, NH); 3.92 (m, 
1H, CH2OH); 3.84 (m, 1H, CH2OH); 3.53 (m, 1H, CHNH); 2.47 (s, 3H, ArCH3); 2.42 
(s, 3H, ArCH3); 1.08 (d, J = 6.8, 3H, CH3); ESI-MS (MeOH): positive ion mode: 406 
(100, [M+Na]+); 789 (68, [2M+Na]+) 
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(S)-2-methyl-1-tosylaziridine (161)[79] 0.22 g KOH (10.98 mmol, 3.0 eq.) dissolved 
in 3 ml of MeOH was added over a period of 15 minutes to a solution of 1.40 
g 160 (3.66 mmol, 1.0 eq.) in 15 ml of MeOH. The solution was stirred for 30 
min, before quenching with 10 ml of water. The aqueous phase was 
extracted three times with TBME, the combined organic phases washed with 
sat. ammonium chloride, water, sat. NaHCO3 and brine. After drying over 
Na2SO4 the solvent was evaporated and the crude product purified by column 
chromatography (SiO2, Hx/EtOAc 3:1), yielding 0.62 g 161 (80% yield) as white 
crystals. 
TLC (SiO2, Hx/TBME 3:1): Rf = 0.41; 1H-NMR (400 MHz, CDCl3): 7.82 (d, J = 8.3, 
2H, Har); 7.34 (d, J = 8.3, 2H, Har); 2.82 (m, 1H, CHNH); 2.61 (d, J = 7.1, 1H, 
CH2NH); 2.45 (s, 3H, ArCH3); 2.02 (d, J = 4.6, 1H, CH2NH); 1.26 (d, J = 5.6, 3H, 
CH3); 13C-NMR (100 MHz, CDCl3): 144.8, 135.8, 130.1, 128.2, 36.3, 35.1, 22.0, 17.2; 
ESI-MS (MeOH): positive ion mode: 234 (79, [M+Na]+); 445 (100, [2M+Na]+) 
(S)-N-2-tosylpropane-1,2-diamine (162) 2.60 g 161 (12.04 mmol) dissolved in 50 ml 
of MeOH were added to 160 ml of a saturated solution of 
ammonia in MeOH at 0°C over a period of 2 h. The mixture was 
then stirred at r.t. overnight. The ammonia was removed by 
bubbling nitrogen through the solution and the solvent under reduced pressure. The 
crude product was recrystallized three times in toluene, to yield 2.33 g 162 (83% 
yield, ee was shown to be 99% (S) by mosher amidation) as white crystals. 
TLC (SiO2, 2:1 Hx/TBME): Rf = 0; 1H-NMR (400 MHz, CDCl3): 7.77 (d, J = 8.3, 2H, 
Har); 7.30 (d, J = 8.3, 2H, Har); 5.00 (broad, 1H, NH); 3.20 (m, 1H, CHNH); 2.68 (dxd, 
J = 4.3, 10.0, 1H, CH2NH2); 2.50 (dxd, J = 6.8, 12.1, 1H, CH2NH2); 2.43 (s, 3H, 
ArCH3); 1.03 (d, J = 6.8, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 143.7, 138.2, 130.1, 
127.5, 51.9, 47.4, 21.9, 19.4; ESI-MS (MeOH): positive ion mode: 229 (100, [M+H]+); 
457 (15, [2M+H]+); EA: calculated for C10H16N2O2S: C 52.61, H 7.06, N 12.27, O 
14.02; found: C 52.68, H 6.94, N 12.06, O 13.83 
(R)-2-(tosylamino)propyl-4-methylbenzenesulfonate (245)[79] 1.04 g (R)-2-amino-
1-propanol (13.82 mmol, 1.0 eq.) was dissolved in 3.8 ml of 
pyridine. 5.27 g tosylchloride (27.66 mmol, 2.0 eq.) dissolved in 15 
ml of pyridine was added dropwise over a period of 30 minutes at 
0°C. After stirring for an additional hour at 0°C, the solution was 
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allowed to come to r.t. and stirred for 18 h. The pyridine was evaporated under 
reduced pressure, the brownish residue dissolved in 75 ml of water and extracted 
three times with TBME. The combined organic phases were washed with 4 x 25 ml 
5%-H2SO4, 25 ml sat. CuSO4, water, sat. NaHCO3 and brine. After drying over 
Na2SO4, the crude product was purified by column chromatography (SiO2, Hx/EtOAc 
3:1) yielding 6.82 g 245 (80% yield) as white crystals. 
TLC (SiO2, Hx/TBME 3:1): Rf = 0.21; 1H-NMR (400 MHz, CDCl3): 7.70 (m, 4H, Har); 
7.36 (d, J = 8.1, 2H, Har); 7.28 (d, J = 8.1, 2H, Har); 4.67 (d, J = 8.1, 1H, NH); 3.92 (m, 
1H, CH2OH); 3.84 (m, 1H, CH2OH); 3.53 (m, 1H, CHNH); 2.47 (s, 3H, ArCH3); 2.42 
(s, 3H, ArCH3); 1.08 (d, J = 6.8, 3H, CH3); ESI-MS (MeOH): positive ion mode: 406 
(100, [M+Na]+); 789 (68, [2M+Na]+) 
(R)-2-methyl-1-tosylaziridine (246)[79] 1.90 g KOH (33.16 mmol, 3.0 eq.) dissolved 
in 9 ml of MeOH was added over a period of 15 minutes to a solution of 4.23 
g 245 (11.08 mmol, 1.0 eq.) in 45 ml of MeOH. The solution was stirred for 
30 min, before quenching with 10 ml of water. The aqueous phase was 
extracted three times with TBME, the combined organic phases washed with 
sat. ammonium chloride, water, sat. NaHCO3 and brine. After drying over Na2SO4 the 
solvent was evaporated and the crude product purified by column chromatography 
(SiO2, Hx/EtOAc 3:1), yielding 1.14 g 246 (47% yield) as white crystals. 
TLC (SiO2, Hx/TBME 3:1): Rf = 0.41; 1H-NMR (400 MHz, CDCl3): 7.82 (d, J = 8.3, 
2H, Har); 7.34 (d, J = 8.3, 2H, Har); 2.82 (m, 1H, CHNH); 2.61 (d, J = 7.1, 1H, 
CH2NH); 2.45 (s, 3H, ArCH3); 2.02 (d, J = 4.6, 1H, CH2NH); 1.26 (d, J = 5.6, 3H, 
CH3); 13C-NMR (100 MHz, CDCl3): 144.8, 135.8, 130.1, 128.2, 36.3, 35.1, 22.0, 17.2; 
ESI-MS (MeOH): positive ion mode: 234 (79, [M+Na]+); 445 (100, [2M+Na]+) 
(R)-N-2-tosylpropane-1,2-diamine (164) 1.14 g 246 (5.02 mmol) dissolved in 24 ml 
of MeOH was added to 70 ml of a saturated solution of ammonia 
in MeOH at 0°C over a period of 2 h. The mixture was then stirred 
at r.t. overnight. The ammonia was removed by bubbling nitrogen 
through the solution and the solvent under reduced pressure. The crude product was 
recrystallized three times in toluene, to yield 0.99 g 164 (81% yield, ee was shown to 
be 99% (R) by mosher amidation) as white crystals. 
TLC (SiO2, 2:1 Hx/TBME): Rf = 0; 1H-NMR (400 MHz, CDCl3): 7.77 (d, J = 8.3, 2H, 
Har); 7.30 (d, J = 8.3, 2H, Har); 5.0 (broad, 1H, NH); 3.20 (m, 1H, CHNH); 2.68 (dxd,  
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J = 4.3, 4.5, 1H, CH2NH2); 2.50 (dxd, J = 6.8, 7.1, 1H, CH2NH2); 2.43 (s, 3H, ArCH3); 
1.03 (d, J = 6.8, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 143.7, 138.2, 130.1, 127.5, 
51.9, 47.4, 21.9, 19.4; ESI-MS (MeOH): positive ion mode: 229 (100, [M+H]+); 457 
(15, [2M+H]+); EA: calculated for C10H16N2O2S: C 52.61, H 7.06, N 12.27, O 14.02; 
found: C 52.69, H 6.96, N 12.08, O 13.82 
(S)-3-methyl-2-(tosylamino)butyl-4-methylbenzenesulfonate (247)[79] 1.50 g (S)-2-
amino-3-methylbutan-1-ol (14.54 mmol, 1.0 eq.) was dissolved in 
4.0 ml of pyridine. 3.77 g tosylchloride (29.08 mmol, 2.0 eq.) 
dissolved in 15 ml of pyridine was added dropwise over a period of 
30 minutes at 0°C. After stirring for an additional hour at 0°C, the 
solution was allowed to come to r.t. and stirred for 18 h. The 
pyridine was evaporated under reduced pressure, the brownish residue dissolved in 
75 ml of water and extracted three times with TBME. The combined organic phases 
were washed with 4 x 50 ml 5%-H2SO4, 50 ml sat. CuSO4, water, sat. NaHCO3 and 
brine. After drying over Na2SO4, the crude product was purified by column 
chromatography (SiO2, Hx/EtOAc 2:1) yielding 3.62 g 247 (61% yield) as white 
crystals. 
TLC (SiO2, Hx/TBME 3:1): Rf = 0.42; 1H-NMR (400 MHz, CDCl3): 7.72 (d, J = 8.1, 
2H, Har); 7.68 (d, J = 8.0, 2H, Har); 7.35 (d, J = 8.1, 2H, Har); 7.25 (d, J = 8.0, 2H, Har); 
4.80 (d, J = 8.1, 1H, NH); 3.99 (m, 1H, CH2OH); 3.78 (m, 1H, CH2OH); 3.15 (m, 1H, 
CHNH); 2.46 (s, 3H, ArCH3); 2.41 (s, 3H, ArCH3); 1.38 (hp, J = 6.8, 1H, CH); 0.83 (d, 
J = 6.8, 3H, CH3); 0.72 (d, J = 6.8, 3H, CH3); ESI-MS (MeOH): positive ion mode: 412 
(90, [M+H]+); 434 (100, [M+Na]+) 
(S)-2-isopropyl-1-tosylaziridine (248)[79] 0.81 g KOH (12.78 mmol, 3.0 eq.) 
dissolved in 8 ml of MeOH was added over a period of 15 minutes to a 
solution of 1.75 g 247 (4.26 mmol, 1.0 eq.) in 40 ml of MeOH. The solution 
was stirred for 30 min, before quenching with 10 ml of water. The aqueous 
phase was extracted three times with TBME, the combined organic phases 
washed with sat. ammonium chloride, water, sat. NaHCO3 and brine. After 
drying over Na2SO4 the solvent was evaporated and the crude product purified by 
column chromatography (SiO2, Hx/EtOAc 3:1), yielding solid 0.97 g 248 (95% yield). 
TLC (SiO2, Hx/TBME 3:1): Rf = 0.52; 1H-NMR (400 MHz, CDCl3): 7.85 (d, J = 12.8, 
2H, Har); 7.33 (d, J = 12.8, 2H, Har); 2.62 (d, J = 11.2, 1H, CHNH); 2.52 (m, 1H, 
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CH2NH); 2.44 (s, 3H, ArCH3); 2.10 (d, J = 7.5, 1H, CH2NH); 1.40 (hp, J = 11.2 , 1H, 
CH); 0.90 (d, J = 11.0, 3H, CH3); 0.79 (d, J = 11.0, 3H, CH3); 13C-NMR (100 MHz, 
CDCl3): 144.8, 135.5, 130.0, 128.5, 46.7, 33.1, 30.5, 22.1, 20.0, 19.5; ESI-MS 
(MeOH): positive ion mode: 262 (100, [M+Na]+); 501 (51, [2M+Na]+) 
(S)-3-methyl-N-2-tosylbutane-1,2-diamine (165) 0.97 g 248 (4.06 mmol) dissolved 
in 18 ml of MeOH was added to 50 ml of a saturated solution of 
ammonia in MeOH at 0°C over a period of 2 h. The mixture was 
then stirred at r.t. overnight. The ammonia was removed by 
bubbling nitrogen through the solution and the solvent under reduced pressure. The 
crude product was washed with 50 ml hexane, to yield 0.90 g 165 (87% yield, ee was 
shown to be 99% (S) by mosher amidation) as white crystals. 
TLC (SiO2, 2:1 Hx/TBME): Rf = 0; 1H-NMR (400 MHz, CDCl3): 7.76 (d, J = 8.4, 2H, 
Har); 7.29 (d, J = 8.4, 2H, Har); 4.98 (broad, 1H, NH); 2.94 (m, 1H, CHNH); 2.65 (dxd, 
J = 6.1, 13.1, 1H, CH2NH2); 2.55 (dxd, J = 4.6, 13.2, 1H, CH2NH2); 2.42 (s, 3H, 
ArCH3); 1.75 (hp, J = 6.6, 1H, CH); 0.74-0.83 (m, 6H, 2xCH3); 13C-NMR (100 MHz, 
CDCl3): 143.6, 138.6, 130.0, 127.5, 61.4, 42.6, 30.3, 21.9, 19.1, 18.9; ESI-MS 
(MeOH): positive ion mode: 257 (100, [M+H]+)  
(S)-2-(benzylamino)propan-1-ol (249)[80] 1.04 g (S)-2-aminopropan-1-ol (13.83 
mmol, 1.0 eq.) and 1.55 ml benzaldehyde 171 (15.21 mmol, 1.1 eq) 
were refluxed in 16 ml of toluene with a Dean-Stark Condenser for 5 h. 
After evaporation of the solvent, the resulting yellowish oil was 
dissolved in 15 ml of EtOH and cooled down to 0°C. 1.30 g sodium boronhydride 
(34.57 mmol, 2.5 eq.) were added and the mixture acidified to pH 2 with 3M HCl. 
After stirring for 14 h at r.t., water was removed at the rotavap, the residue dissolved 
in 30 ml 1M HCl and five times extracted with 20 ml of DCM. The aqueous phase 
was basified to pH 13 with 1M NaOH and extracted five times with DCM. The 
combined organic phases were dried over Na2SO4 and purified by column 
chromatography (alox neutral, DCM/Hx 1:1) yielding 1.83 g 249 (80% yield) as a 
colourless oil. 
TLC (alox neutral, 1:1 DCM/Hx): Rf = 0.32 ; 1H-NMR (400 MHz, CDCl3): 7.23-7.38 
(m, 5H, Har); 3.84 (d, J = 13.0, 1H, CH2Ph); 3.71 (d, J = 13.0, 1H, CH2Ph);  3.55 (dxd, 
J = 4.0, 10.6, 1H, CH2OH); 3.23 (dxd, J = 7.0, 10.6, 1H, CH2OH); 2.71 (m, 1H, 
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CHNH); 1.10 (d, J = 6.5, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 140.5, 128.7, 128.3, 
127.3, 65.7, 53.9, 51.3, 17.4  
(S)-1-benzyl-2-methylaziridine (250)[80] 1.83 g 249 (11.08 mmol, 1.0 eq.) and 4.36 g 
triphenylphosine (16.62 mmol, 1.5 eq.) were dissolved in 30 ml diethylether. 
3.44 ml DIAD (16.62 mmol, 1.5 eq.) were added dropwise over a period of 
45 minutes at a temperature between 5-10°C and then stirred at r.t. over 
night. The red solution was filtered and washed with 30 ml ether/hexane (1:1). The 
filtrate was extracted twice with 20 ml 1M HCl and the aqueous phase basified to     
pH 13 with 5M NaOH. After extracting five times with ether, the combined organic 
phases were dried over Na2SO4. The solvent was removed under reduced pressure 
and the crude product purified by column chromatography (alox neutral, DCM/Hx 1:1) 
yielding 0.86 g 250 (47% yield) as a colourless oil. 
TLC (alox neutral, 1:1 DCM/Hx): Rf = 0.19; 1H-NMR (400 MHz, CDCl3): 7.27-7.38 (m, 
5H, Har); 3.48 (d, J = 13.6, 1H, CH2Ph); 3.43 (d, J = 13.6, 1H, CH2Ph);  1.61 (d,         
J = 3.6, 1H, CH2OH); 1.54 (m, 1H, CH2OH); 1.42 (d, J = 3.6, 1H, CHNH); 1.23 (d,       
J = 5.5, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 139.7, 128.5, 128.0, 127.0, 64.9, 
35.2, 35.0, 18.5 
(S)-1-azido-N-benzylpropan-2-amine (251)[81] 0.38 ml trimethylsilyl azide (2.72 
mmol, 2.0 eq.) and 0.20 g 250 (1.36 mmol, 1.0 eq.) were refluxed in     
5 ml of acetonitril for 5 days. The red solution was adjusted to pH 1 with 
1M HCl and stirred for 1 h. After the solution was basified to pH 9 with 
NaHCO3, the aqueous solution was extracted three times with DCM. 
The combined organic phases were dried over Na2SO4. The solvent was evaporated 
and the crude product purified by column chromatography (SiO2, EtOAc/Hx 3:1) 
yielding 0.40 g 251 (27% yield) as a colourless oil. 
TLC (SiO2, EtOAc/Hx 3:1): Rf = 0.40; 1H-NMR (400 MHz, CDCl3): 7.24-7.33 (m, 5H, 
Har); 3.83 (d, J = 13.0, 1H, CH2Ph); 3.73 (d, J = 13.6, 1H, CH2Ph);  3.33 (dxd, J = 6.4, 
12.1, 1H, CH2OH); 3.21 (dxd, J = 4.8, 12.1, 1H, CH2OH); 1.54 (broad, 1H, NH); 2.89 
(m, 1H, CHNH); 1.17 (d, J = 6.4, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 140.2, 
128.7, 128.6, 128.3, 56.8, 52.2, 51.4, 18.5 
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(S)-N-2-benzylpropane-1,2-diamine (252)[81] 560 mg 251 (2.96 mmol, 1.0 eq.) 
were dissolved in 5 ml diethylether. 90 mg LiAlH4 (2.37 mmol, 0.8 eq.) 
were added slowly and the mixture stirred for 3 h at r.t. The reaction 
was quenched with sat. NaHCO3, extracted three times with 20 ml 
ether and dried over Na2SO4. 232 mg 252 (47% yield) were obtained 
after evaporation of the solvent and used without further purification. 
TLC (SiO2, EtOAc/Hx 3:1): Rf = 0; 1H-NMR (400 MHz, CDCl3): 7.18-7.34 (m, 5H, Har); 
3.87 (d, J = 13.1, 1H, CH2Ph); 3.73 (d, J = 12.9, 1H, CH2Ph); 2.52-2.77 (m, 3H, 
2xCH2 and CH); 1.05 (m, J = 6.6, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 140.9, 
128.6, 128.3, 127.0, 54.6, 51.5, 47.6, 18.5; ESI-MS (MeOH): positive ion mode: 165 
(100, [M+H]+) 
(S)-N-(2-(benzylamino)propyl)-4-methylbenzenesulfonamide (253) 0.27 g 156 
(1.41 mmol, 1.0 eq.) diluted in 5 ml DCM were slowly added 
to a solution containing 0.23 g 252 (1.41 mmol, 1.0 eq.) and 
0.20 ml triethylamine (1.41 mmol, 1.0 eq.) in 15 ml DCM at 
0°C. After stirring for 2.5 h at r.t., the solvent was removed and the crude product 
purified by column chromatography (SiO2, DCM/MeOH/Et3N 100:5:1) yielding 0.39 g 
253 (77% yield) as a white powder.   
TLC (SiO2, DCM/MeOH/Et3N 100:5:1): Rf = 0.37; 1H-NMR (400 MHz, CDCl3): 7.71 
(d, J = 6.7, 2H, Har); 7.23-7.32 (m, 7H, Har); 3.67 (d, J = 13.0, 1H, CH2Ph); 3.54 (d,    
J = 13.0, 1H, CH2Ph); 2.98 (dxd, J = 3.8, 11.9, 1H, CH2OH); 2.77 (m, 1H, CHNH); 
2.70 (dxd, J = 6.9, 11.8, 1H, CH2OH); 2.47 (s, 3H, ArCH3); 1.06 (d, J = 6.3, 3H, CH3) 
 
(S)-N-(2-aminopropyl)-4-methylbenzenesulfonamide (177) 0.12 g 253 (0.36 mmol) 
was dissolved in 3 ml MeOH and stirred for 12 h in the presence 
of 0.35 g Pd/C under a hydrogen atmosphere. After filtration over 
Celite and evaporation of the solvent, the crude product was purified by column 
chromatography (basic alox, DCM/MeOH 100:5), yielding 0.48 g 177 (60% yield) as a 
yellow oil. 
TLC (alox basic, DCM/MeOH 100:5): Rf = 0.30; 1H-NMR (400 MHz, CDCl3): 7.71 (d, 
J = 8.4, 2H, Har); 7.27 (d, J = 7.9, 2H, Har); 2.96 (m, 1H, CHNH2); 2.89 (dxd, J = 4.1, 
12.5, 1H, CH2); 2.60 (dxd, J = 4.3, 12.6, 1H, CH2); 2.77 (m, 2H, CH2NH); 1.00 (d,      
J = 6.4, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 143.4, 137.1, 129.8, 127.1, 50.8, 
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46.4, 21.6, 21.5; ESI-MS (MeOH): positive ion mode: 229 (65, [M+H]+); 251 (81, 
[M+Na]+); 457 (38, [2M+H]+); 479 (100, [2M+Na]+); negative ion mode: 227 (100, M-) 
(R)-2-(benzylamino)propan-1-ol (172)[80] 2.08 g (R)-2-aminopropan-1-ol (27.66 
mmol, 1.0 eq.) and 3.10 ml benzaldehyde (30.42 mmol, 1.1 eq) were 
refluxed in 30 ml of toluene with a Dean-Stark Condenser for 5 h. After 
evaporation of the solvent, the resulting yellowish oil was dissolved in 
30 ml of EtOH and cooled down to 0°C. 2.60 g sodium boronhydride 
(69.14 mmol, 2.5 eq.) was added and the mixture acidified to pH 2 with 3M HCl. After 
stirring for 14 h at r.t., water was removed at the rotavap, the residue dissolved in    
30 ml 1M HCl and five times extracted with 20 ml of DCM. The aqueous phase was 
basified to pH 13 with 1M NaOH and extracted five times with DCM. The combined 
organic phase were dried over Na2SO4 and purified by column chromatography (alox 
neutral, DCM/Hx 1:1) yielding 3.95 g 172 (86% yield) as a colourless oil. 
TLC (alox neutral, 1:1 DCM/Hx): Rf = 0.32 ; 1H-NMR (400 MHz, CDCl3): 7.23-7.38 
(m, 5H, Har); 3.84 (d, J = 13.0, 1H, CH2Ph); 3.71 (d, J = 13.0, 1H, CH2Ph);  3.55 (dxd, 
J = 4.0, 10.6, 1H, CH2OH); 3.23 (dxd, J = 7.0, 10.6, 1H, CH2OH); 2.71 (m, 1H, 
CHNH); 1.10 (d, J = 6.5, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 140.5, 128.7, 128.3, 
127.3, 65.7, 53.9, 51.3, 17.4  
(R)-1-benzyl-2-methylaziridine (173)[80] 3.95 g 172 (23.90 mmol, 1.0 eq.) and 9.40 g 
triphenylphosine (35.85 mmol, 1.5 eq.) were dissolved in 60 ml diethylether. 
7.63 ml DIAD (35.85 mmol, 1.5 eq.) were added dropwise over a period of 
45 minutes at a temperature between 5-10°C and then stirred at r.t. over 
night. The red solution was filtered and washed with 50 ml ether/hexane (1:1). The 
filtrate was extracted twice with 40 ml 1M HCl and the aqueous phase basified to pH 
13 with 5M NaOH. After extracting five times with ether, the combined organic 
phases were dried over Na2SO4. The solvent was removed under reduced pressure 
and the crude product purified by column chromatography (alox neutral, DCM/Hx 1:1) 
yielding 1.73 g 173 (50% yield) as a colourless oil. 
TLC (alox neutral, 1:1 DCM/Hx): Rf = 0.19; 1H-NMR (400 MHz, CDCl3): 7.27-7.38 (m, 
5H, Har); 3.48 (d, J = 13.6, 1H, CH2Ph); 3.43 (d, J = 13.6, 1H, CH2Ph);  1.61 (d,         
J = 3.6, 1H, CH2OH); 1.54 (m, 1H, CH2OH); 1.42 (d, J = 3.6, 1H, CHNH); 1.23 (d,      
J = 5.5, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 139.7, 128.5, 128.0, 127.0, 64.9, 
35.2, 35.0, 18.5 
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(R)-1-azido-N-benzylpropan-2-amine (174)[81] 11.29 ml trimethylsilyl azide (82.32 
mmol, 3.0 eq.) and 4.00 g 173 (27.12 mmol, 1.0 eq.) were refluxed in      
5 ml of acetonitrile for 4 days. The red solution was adjusted to pH 1 with 
1M HCl and stirred for 1 h. After the solution was basified to pH 9 with 
NaHCO3, the aqueous solution was extracted three times with DCM. The 
combined organic phases dried over Na2SO4. The solvent was evaporated and the 
crude product purified by column chromatography (SiO2, EtOAc/Hx 3:1) yielding 1.29 
g 174 (33% yield) as a colourless oil. 
TLC (SiO2, EtOAc/Hx 3:1): Rf = 0.40; 1H-NMR (400 MHz, CDCl3): 7.24-7.33 (m, 5H, 
Har); 3.83 (d, J = 13.0, 1H, CH2Ph); 3.73 (d, J = 13.6, 1H, CH2Ph);  3.33 (dxd, J = 6.4, 
12.1, 1H, CH2OH); 3.21 (dxd, J = 4.8, 12.1, 1H, CH2OH); 1.54 (broad, 1H, NH); 2.89 
(m, 1H, CHNH); 1.17 (d, J = 6.4, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 140.2, 
128.7, 128.6, 128.3, 56.8, 52.2, 51.4, 18.5 
(R)-N-2-benzylpropane-1,2-diamine (175)[81] 1.29 g 174 (6.79 mmol, 1.0 eq.) were 
dissolved in 10 ml diethylether. 0.21 g LiAlH4 (5.43 mmol, 0.8 eq.) 
were added slowly and the mixture stirred for 3 h at r.t. The reaction 
was quenched with sat. NaHCO3, extracted three times with 20 ml 
ether and dried over Na2SO4. 0.39 g 175 (35% yield) were obtained 
after evaporation of the solvent and used without further purification. 
TLC (SiO2, EtOAc/Hx 3:1): Rf = 0; 1H-NMR (400 MHz, CDCl3): 7.18-7.34 (m, 5H, Har); 
3.87 (d, J = 13.1, 1H, CH2Ph); 3.73 (d, J = 12.9, 1H, CH2Ph); 2.52-2.77 (m, 3H, 
2xCH2 and CH); 1.05 (m, J = 6.6, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 140.9, 
128.6, 128.3, 127.0, 54.6, 51.5, 47.6, 18.5; ESI-MS (MeOH): positive ion mode: 165 
(100, [M+H]+) 
(R)-N-(2-(benzylamino)propyl)-4-methylbenzenesulfonamide (176) 0.45 g 156 
(2.35 mmol, 1.0 eq.) diluted in 5 ml DCM were slowly added 
to a solution containing 0.39 g 175 (2.35 mmol, 1.0 eq.) and 
0.32 ml triethylamine (2.35 mmol, 1.0 eq.) in 15 ml DCM at 
0°C. After stirring for 2.5 h at r.t., the solvent was removed and the crude product 
purified by column chromatography (SiO2, DCM/MeOH/Et3N 100:5:1) yielding 0.39 g 
176 (77% yield) as a white powder.   
TLC (SiO2, DCM/MeOH/Et3N 100:5:1): Rf = 0.37; 1H-NMR (400 MHz, CDCl3): 7.71 
(d, J = 6.7, 2H, Har); 7.23-7.32 (m, 7H, Har); 3.67 (d, J = 13.0, 1H, CH2Ph); 3.54 (d,    
HN N3
HN NH2
HN HN S
O
O
5 Experimental Part  95 
J = 13.0, 1H, CH2Ph); 2.98 (dxd, J = 3.8, 11.9, 1H, CH2OH); 2.77 (m, 1H, CHNH); 
2.70 (dxd, J = 6.9, 11.8, 1H, CH2OH); 2.47 (s, 3H, ArCH3); 1.06 (d, J = 6.3, 3H, CH3) 
  
(R)-N-(2-aminopropyl)-4-methylbenzenesulfonamide (169) 0.12 g 176 (0.36 
mmol) was dissolved in 3 ml MeOH and stirred for 12 h in the 
presence of 0.35 g Pd/C under a hydrogen atmosphere. After 
filtration over Celite and evaporation of the solvent, the crude product was purified by 
column chromatography (basic alox, DCM/MeOH 100:5), yielding 0.48 g 169 (60% 
yield) as a yellow oil. 
TLC (alox basic, DCM/MeOH 100:5): Rf = 0.30; 1H-NMR (400 MHz, CDCl3): 7.71 (d, 
J = 8.4, 2H, Har); 7.27 (d, J = 7.9, 2H, Har); 2.96 (m, 1H, CHNH2); 2.89 (dxd, J = 4.1, 
12.5, 1H, CH2); 2.60 (dxd, J = 4.3, 12.6, 1H, CH2); 1.00 (d, J = 6.4, 3H, CH3);        
13C-NMR (100 MHz, CDCl3): 143.4, 137.1, 129.8, 127.1, 50.8, 46.4, 21.56, 21.55; 
ESI-MS (MeOH): positive ion mode: 229 (65, [M+H]+); 251 (81, [M+Na]+); 457 (38, 
[2M+H]+); 479 (100, [2M+Na]+); negative ion mode: 227 (100, M-) 
(1S,2S)-N-tosylcyclohexane-1,2-diamine (254)[82] 500 mg (S,S)-cyclohexane-1,2-
diamine (4.38 mmol, 1.5 eq.), 661 mg L-tartrate (4.38 mmol,     
1.5 eq.), 5.78 ml of 2M NaOH and 0.81 ml triethylamine were 
dissolved in 42 ml DCM and cooled down to 0°C. Then 0.56 g 
tosylchloride (2.91 mmol, 0.66 eq.) dissolved in 29 ml DCM were added over a period 
of 30 minutes. The mixture was stirred at r.t over night. The reaction mixture was 
washed three times with 50 ml 2M HCl. The aqueous phase was basified with 1M 
NaOH to pH 9, extracted three times with DCM and dried over Na2SO4. One obtained 
0.71 g 254 (60% yield) as white crystals. 
TLC (alox basic): Rf = 0.22; 1H-NMR (500 MHz, CDCl3): 7.77 (d, J = 8.3, 2H, Har); 
7.28 (d, J = 7.9, 2H, Har); 2.64 (dxt, J = 6.5, 10.2, 1H, CHNHTs); 2.37-2.41 (m, 4H 
ArCH3 and CHNH2); 1.93 (m, 1H, CH2); 1.75 (m, 1H, CH2); 1.57-1.63 (m, 2H, CH2); 
1.05-1.19 (m, 4H, CH2); 13C-NMR (126 MHz, CDCl3): 143.4, 138.0, 129.8, 127.2, 
60.4, 54.9, 35.5, 32.7, 25.0, 24.9, 21.7; ESI-MS (MeOH): positive ion mode: 269 
(100, [M+H]+); 291 (33, [M+Na]+); 537 (77, [2M+H]+); 559 (95, [2M+Na]+); negative 
ion mode: 267 (100, M-) 
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(1R,2R)-N-tosylcyclohexane-1,2-diamine (255)[82] 0.50 g (R,R)-cyclohexane-1,2-
diamine (4.38 mmol, 1.5 eq.), 0.66 g L-tartrate (4.38 mmol, 1.5 
eq.), 5.78 ml of 2M NaOH and 0.81 ml triethylamine were 
dissolved in 42 ml DCM and cooled down to 0°C. Then 0.56 g 
tosylchloride (2.91 mmol, 0.66 eq.) dissolved in 29 ml DCM were added over a period 
of 30 minutes. The mixture was stirred at r.t over night. The reaction mixture was 
washed three times with 50 ml 2M HCl. The aqueous phase was basified with 1M 
NaOH to pH 9, extracted three times with DCM and dried over Na2SO4. One obtained 
0.68 g 255 (58% yield) as white crystals. 
TLC (alox basic): Rf = 0.21; 1H-NMR (500 MHz, CDCl3): 7.76 (d, J = 8.2, 2H, Har); 
7.30 (d, J = 8.0, 2H, Har); 2.60 (m, 1H, CHNH2); 2.42 (s, 3H CH3); 2.33 (dxt, J = 4.1, 
10.5, 1H, CHNHTs); 1.91 (m, 1H, CH2); 1.83 (m, 1H, CH2); 1.60 (m, 2H, CH2); 1.05-
1.25 (m, 4H, CH2); 13C-NMR (126 MHz, CDCl3): 143.7, 138.2, 130.1, 127.5, 60.8, 
55.3, 36.1, 33.1, 25.3, 25.2, 22.0; ; ESI-MS (MeOH): positive ion mode: 269 (100, 
[M+H]+); 291 (24, [M+Na]+); 537 (66, [2M+H]+); 559 (90, [2M+Na]+); negative ion 
mode: 267 (100, M-) 
 
5.2.1.3 Monomesyltaed Diamines  
 
2-(methylsulfonamido)ethylmethanesulfonate (256)[79] 8.39 ml mesityl chloride 
(108.06 mmol, 2.2 eq.) were added dropwise over a period of 90 
minutes to a solution of 3.00 g aminoethanol (49.12 mmol, 1.0 eq.) and 
13.69 ml triethylamine (98.23 mmol, 2.0 eq.) in 300 DCM at -20°C. After stirring for 
14 h at -20°C, the cold solution was washed twice with 45 ml 0.1M HCl and once with 
60 ml sat. NaHCO3, and then dried over Na2SO4. The solvent was evaporated under 
reduced pressure and the crude product purified by column chromatography (SiO2, 
EtOAc/Hx 5:1), yielding 3.74 g of 256 (35% yield) as white crystals.      
TLC (SiO2, EtOAc/Hx 5:1): Rf = 0.25; 1H-NMR (400 MHz, CDCl3): 5.11 (s, 1H, NH); 
4.36 (m, 2H, CH2OMs); 3.50 (m, 2H, CH2NHMs); 3.09 (s, 3H, OSO2CH3); 3.02 (s, 3H, 
NHSO2CH3); 13C-NMR (100 MHz, CDCl3): 69.2, 42.8, 41.4, 38.0 
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1-(methylsulfonyl)aziridine (257)[79] 3.72 g 256 (17.20 mmol, 1.0 eq.) dissolved in 
60 ml THF were added dropwise to a suspension of 0.62 g sodium hydride 
(25.80 mmol, 1.5 eq.) in 25 ml THF at r.t. and then stirred for 3 h. After 
quenching with 12 ml EtOH and 25 ml water, the mixture was diluted with 70 
ml brine and 90 ml ether. The aqueous phase was extracted twice with ether and the 
combined organic phases dried over Na2SO4. After removal of the solvent, the crude 
product was purified by column chromatography (SiO2, EtOAc/Hx 3:2), yielding 1.66 
g 257 (80% yield) as a colourless liquid. 
TLC (SiO2, EtOAc/Hx 3:2): Rf = 0.29; 1H-NMR (400 MHz, CDCl3): 3.51-3.56 (m, 3H, 
CH2); 3.25-3.31 (m, 1H, CH2); 3.08 (s, 3H, NHSO2CH3); 13C-NMR (100 MHz, CDCl3): 
39.8, 27.2 
N-(2-aminoethyl)methanesulfonamide (183) 0.98 g 257 (8.06 mmol) dissolved in 
60 ml MeOH were added over a period of 6 h to a saturated solution of 
ammonia in 120 ml MeOH and stirred for 14 h at r.t. After evaporation of 
the solvent, the crude product was purified by column chromatography (basic alox, 
DCM/MeOH 5:1), yielding 1.00 g 183 (90% yield) as a yellow oil.  
TLC (basic alox, DCM/MeOH 5:1): Rf = 0.19; 1H-NMR (400 MHz, CD3CN): 3.14 (t,    
J =  2H, CH2); 2.97 (s, 3H, CH3); 2.72 (t, J = 6.8,  2H, CH2); 13C-NMR (100 MHz, 
CD3CN): 46.4, 41.9, 39.3; ESI-MS (MeOH): positive ion mode: 139 (28, [M+H]+); 161 
(100, [M+Na]+) 
(S)-1-(methylsulfonamido)propan-2-yl-methanesulfonate (258)[79] 4.72 ml mesityl 
chloride (60.92 mmol, 2.2 eq.) were added dropwise over a period of 
90 minutes to a solution of 2.08 g (S)-alaninol (27.70 mmol, 1.0 eq.) 
and 7.72 ml triethylamine (55.40 mmol, 2.0 eq.) in 175 DCM at -20°C. 
After stirring for 14 h at -20°C, the cold solution was washed twice with 15 ml 0.1M 
HCl and once with 20 ml sat. NaHCO3, and then dried over Na2SO4. The solvent was 
evaporated under reduced pressure and the crude product purified by column 
chromatography (SiO2, EtOAc/Hx 4:1), yielding 3.13 g of 258 (47% yield) as white 
crystals.      
TLC (SiO2, EtOAc/Hx 4:1): Rf = 0.27; 1H-NMR (400 MHz, CDCl3): 4.76 (d, J = 8.1, 
1H, NH); 4.26 (dxd, J = 4.3, 10.4, 1H, CH2OMs); 4.16 (dxd, J = 5.6, 10.5, 1H, 
CH2OMs); 3.86 (m, 1H, CHNHMs); 3.08 (s, 3H, OSO2CH3); 3.03 (s, 3H, NHSO2CH3); 
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1.33 (d, J = 6.8, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 72.4, 48.8, 42.0, 37.4, 18.4; 
ESI-MS (MeOH): positive ion mode: 254 (100, [M+Na]+); 485 (62, [2M+Na]+) 
(S)-2-methyl-1-(methylsulfonyl)aziridine (259)[79] 1.00 g 258 (4.33 mmol, 1.0 eq.) 
dissolved in 16 ml THF were added dropwise to a suspension of 0.16 g 
sodium hydride (6.49 mmol, 1.5 eq.) in 6 ml THF at r.t. and then stirred for    
3 h. After quenching with 4 ml EtOH and 10 ml water, the mixture was diluted 
with 20 ml brine and 30 ml ether. The aqueous phase was extracted twice with ether 
and the combined organic phases dried over Na2SO4. After removal of the solvent, 
the crude product was purified by column chromatography (SiO2, EtOAc/Hx 1:1), 
yielding 0.46 g 259 (77% yield) as a colourless liquid. 
TLC (SiO2, EtOAc/Hx 1:1): Rf = 0.40; 1H-NMR (400 MHz, CDCl3): 3.06 (s, 3H, 
NHSO2CH3); 2.82 (m, 1H, CH); 2.60 (d, J = 7.1, 1H, CH2); 2.08 (d, J = 4.5, 1H, CH2); 
1.35 (d, J = 5.8, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 40.1, 35.6, 34.7, 17.3 
(S)-N-(1-aminopropan-2-yl)methanesulfonamide (184) 0.46 g 259 (3.40 mmol) 
dissolved in 180 ml MeOH were added over a period of 9 h to a 
saturated solution of ammonia in 500 ml MeOH and stirred for 14 h at r.t. 
After evaporation of the solvent, the crude product was purified by 
column chromatography (basic alox, DCM/MeOH 5:1), yielding 0.41 g 184 (88% 
yield) as a yellow oil.  
TLC (basic alox, DCM/MeOH 5:1): Rf = 0.19; 1H-NMR (400 MHz, CDCl3): 3.45 (m, 
1H, CH); 3.00 (s, 3H, NHSO2CH3); 2.87 (dxd, J = 4.3, 12.9, 1H, CH2); 2.62 (dxd,       
J = 6.8, 13.0, 1H, CH2); 1.23 (d, J = 9.8, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 52.2, 
47.7, 42.4, 19.9; ESI-MS (MeOH): positive ion mode: 153 (100, [M+H]+); 175 (71, 
[M+Na]+)  
 
(S)-3-methyl-1-(methylsulfonamido)butan-2-yl-methanesulfonate (260)[79] 0.87 ml 
mesityl chloride (11.22 mmol, 2.2 eq.) were added dropwise over a 
period of 90 minutes to a solution of 0.53 g (S)-valinol (5.10 mmol, 1.0 
eq.) and 1.42 ml triethylamine (10.21 mmol, 2.0 eq.) in 40 DCM at          
-20°C. After stirring for 14 h at -20°C, the cold solution was washed twice with 10 ml 
0.1M HCl and once with 20 ml sat. NaHCO3, and then dried over Na2SO4. The 
solvent was evaporated under reduced pressure and the crude product purified by 
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column chromatography (SiO2, EtOAc/Hx 4:1), yielding 0.81 g of 260 (61% yield) as 
white crystals.      
TLC (SiO2, EtOAc/Hx 2:1): Rf = 0.43; 1H-NMR (400 MHz, CDCl3): 4.65 (d, J = 8.8, 
1H, NH); 4.25-4.33 (m, 2H, CH2OMs); 3.47 (m, 1H, CHNHMs); 3.08 (s, 3H, 
OSO2CH3); 3.04 (s, 3H, NHSO2CH3); 1.95 (m, 1H, CH); 1.01-1.03 (m, 6H, 
2xCH3);13C-NMR (100 MHz, CDCl3): 70.3, 58.8, 42.4, 37.9, 30.1, 19.6, 18.8 
(S)-2-isopropyl-1-(methylsulfonyl)aziridine (261)[79] 0.80 g 260 (3.09 mmol, 1.0 
eq.) dissolved in 15 ml THF were added dropwise to a suspension of 0.11 
g sodium hydride (4.63 mmol, 1.5 eq.) in 5 ml THF at r.t. and then stirred 
for 3 h. After quenching with 4 ml EtOH and 10 ml water, the mixture was 
diluted with 20 ml brine and 30 ml ether. The aqueous phase was extracted 
twice with ether and the combined organic phases dried over Na2SO4. After removal 
of the solvent, the crude product was purified by column chromatography (SiO2, 
EtOAc/Hx 1:1), yielding 0.46 g 261 (91% yield) as a colourless liquid. 
TLC (SiO2, EtOAc/Hx 3:1): Rf = 0.51; 1H-NMR (400 MHz, CDCl3): 3.06 (s, 3H, 
NHSO2CH3); 2.54-2.59 (m, 2H, CH2); 2.14 (d, J = 4.3, 1H, CHNSO2); 1.56 (m,  1H, 
CH); 1.06 (d, J = 6.6, 3H, CH3); 1.00 (d, J = 6.6, 3H, CH3); 13C-NMR (100 MHz, 
CDCl3): 46.0, 39.9, 32.7, 30.5, 20.2, 19.5 
(S)-N-(1-(benzylamino)-3-methylbutan-2-yl)-4-methylbenzenesulfonamide (262) 
0.15 g 261 (0.92 mmol, 1.0 eq.) dissolved in 5 ml MeOH was added 
over a period of 7 h to a solution of 1.00 ml benzylamine (9.20 
mmol, 10 eq.) in 1 ml MeOH. After stirring for 14 h, the solvent was 
removed at the rotavap and excess benzylamine by distillation 
(115°C, 28 mbar). The crude product was purified by column chromatography (SiO2, 
DCM/MeOH 6:1), yielding 0.21 g 262 (85% yield) as a white solid. 
TLC (SiO2, DCM/MeOH 6:1): Rf = 0.47; 1H-NMR (400 MHz, CDCl3): 7.25-7.37 (m, 
5H, Har); 3.79 (s, 2H, PhCH2); 3.21-3.25 (m, 1H, CHNSO2); 2.91 (s, 3H, NHSO2CH3); 
2.71-2.74 (m, 2H, CH2); 1.58 (m, 1H,  CH); 0.95 (d, J = 6.8, 3H, CH3); 0.93 (d,           
J = 6.8, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 140.1, 128.8, 128.6, 127.1, 59.4, 
53.9, 49.5, 41.4, 30.1, 19.7; ESI-MS (MeOH): positive ion mode: 271 (100, [M+H]+); 
293 (30, [M+Na]+) 
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(S)-N-(1-amino-3-methylbutan-2-yl)-4-methylbenzenesulfonamide (185) 0.36 g 
262 (1.33 mmol) was dissolved in 4 ml MeOH and stirred for 1 h under a 
hydrogen atmosphere in the presence of 0.05 g Pd/C. After evaporation 
of the solvent, the product was filtered over Celite, yielding 0.22 g 185 
(94%) and used without further purification. 
TLC (SiO2, DCM/MeOH 6:1): Rf = 0.09; 1H-NMR (400 MHz, CDCl3): 3.48 (m, 1H, 
CHNSO2CH3); 3.02 (s, 3H, NHSO2CH3); 2.80-2.85 (m, 2H, CH2); 1.86 (m, 1H,  CH); 
0.97 (d, J = 6.8, 6H, 2xCH3); 13C-NMR (100 MHz, CDCl3): 57.1, 42.4, 41.0, 30.0, 
17.9, 17,7; ESI-MS (MeOH): positive ion mode: 181 (51, [M+H]+); 203 (69, [M+Na]+); 
361 (41, [2M+H]+); 383 (100, [2M+Na]+); negative ion mode: 179 (100, M-) 
5.2.1.4 Monotriflated Diamines 
 
(S)-2-isopropyl-1-(trifluoromethylsulfonyl)aziridine (190)[79] 3.60 ml 
triflicanhydride (21.32 mmol, 2.2 eq.) were added at -78°C over a period of 
1 h to a solution containing 1.0 g (L)-valinol 189 (9.69 mmol, 1.0 eq.) and 
2.70 ml triethylamine (19.39 mmol, 2.0 eq.) in 40 ml of DCM. The solution 
was then stirred for 3 h at -40°C, 12 h at -20°C and 2 h at r.t. The red 
solution was then diluted with 40 ml DCM and successively washed with 0.1 M HCl 
and sat. Na2CO3. The solvent was removed after drying over Na2SO4, yielding 2.02 g 
190 (96% yield) as white crystals. The crude product was used without further 
purification. 
 
(S)-N-(2-(benzylamino)-3-methylbutyl)trifluoromethanesulfonamide (263) 0.70 g 
190 (3.23 mmol, 1.0 eq.) were dissolved in 3 ml MeOH. 2.84 ml 
benzylamine (26.00 mmol, 8.0 eq.) were added at 0°C over a 
period of 20 minutes and the solution was then stirred at r.t. for 4 
days. Excess of benzylamine was removed by distillation (77°C,   
6 mbar). The crude product was purified by column chromatography (SiO2, gradient 
starting with 100% Hx to Hx/EtOAc 1:1), yielding 0.51 g 263 (50% yield) as a 
colourless oil. 
TLC (SiO2, Hx/EtOAc 5:1): Rf = 0.46; 1H-NMR (400 MHz, CD3CN): 7.26-7.35 (m, 5H, 
Har); 3.80 (s, 2H, CH2Ph); 3.33 (m,  1H, CHNHTf); 2.90 (dxd, J = 7.2, 19.3, 1H, CH2); 
2.69 (dxd, J = 4.8, 12.9, 1H, CH2); 1.89 (m, 1H, CH(CH3)2); 0.92 (d, J = 10.2, 6H, 2x 
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CH3); 13C-NMR (100 MHz, CD3CN): 139.8, 129.0, 128.5, 127.8, 120.1, 61.1, 54.4, 
49.3, 30.8, 19.4, 19.0; 19F-NMR (376 MHz, CD3CN): -78.4 (s, 3F); ESI-MS (MeOH): 
positive ion mode: 325 (100, [M+H]+); 347 (28, [M+Na]+) 
   
(S)-N-(2-amino-3-methylbutyl)trifluoromethanesulfonamide (195) 80 mg 263 
(0.25 mmol) was dissolved in 5 ml MeOH and stirred for 3 h in the 
presence of 0.20 g Pd/C under a hydrogen atmosphere. Filtration over 
Celite and evaporation of the solvent, yielded 59 mg 195 (99% yield) 
as white crystals. 
TLC (alox basic, DCM/MeOH 100:5): Rf = 0.11; 1H-NMR (400 MHz, CD3CN): 3.17 
(m, 1H, CHNHTf); 2.85 (dxd, J = 6.4, 19.7, 1H, CH2); 2.60 (dxd, J = 10.6, 19.7, 1H, 
CH2); 2.77 (m, 1H, CHNH); 1.85 (m, 1H, CH(CH3)2); 0.92 (d, J = 10.2, 6H, 2xCH3); 
13C-NMR (100 MHz, CD3CN): 149.7, 57.1, 40.2, 31.1, 17.9; 19F-NMR (376 MHz, 
CD3CN): -79.0 (s, 3F); ESI-MS (MeOH): positive ion mode: 235 (100, [M+H]+); 
negative ion mode: 233 (100, M-); 489 (35, [2M+Na]-) 
5.2.1.5 α-Pycolyl Amines 
1-(pyridin-2-yl)ethanamine (199)[84] A solution of 2-acetylpyridine (25.00 g, 0.21 
mol, 1.0 eq.) and hydroxylamine hydrochloride (16.48 g, 0.24 mol, 1.15 eq.) 
in 100 ml of pyridine was heated to reflux for 6 h. After removing the 
solvent on a rotary evaporator, 400 ml of water was added, resulting in 
precipitation of the oxime in the form of white crystals which were isolated by vacuum 
filtration. The filtrate was extracted three times with 100 ml of TBME. The white solid 
was dissolved in TBME, combined with the extracts and dried over Na2SO4. After 
evaporation of the solvent, the crude product (25.85 g, 0.19 mol, 1.0 eq.) was 
dissolved in 345 ml of 95% EtOH. 230 ml acetic acid was added to the solution.     
233 g zinc dust (3.56 mol, 19.0 eq.) was added in 10 g increments over 2 h. The 
reaction mixture was stirred with an overhead mechanical stirrer for 12 h. The mixture 
was filtered, and the filtrate was concentrated under vacuum. Several portions of 
water were added and evaporated to remove acetic acid. The mixture was then 
basified with saturated aqueous KOH solution until a brown/yellow oil appeared on 
the surface of the mixture. The mixture was extracted with TBME, and the combined 
fractions were dried over Na2SO4. After removal of the solvent, the crude product 
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was distilled using a Kugelrohr apparatus, yielding 16.67 g 190 (66% yield over two 
steps). 
bp: 50°C at 0.08 mbar; 1H-NMR (500 MHz, CDCl3): 8.54 (m, 1H, Har); 7.64 (m, 1H, 
Har) 7.29 (m, 1H, Har); 7.15 (m, 1H, Har); 4.14 (qxd, J = 5.2, 2.6, 1H, CH); 1.42 (d,       
J = 6.7, 3H, CH3); 13C-NMR (126 MHz, CDCl3): 165.8, 149.2, 136.6, 121.8, 120.1, 
52.5, 24.5; ESI-MS (MeOH): positive ion mode: 123 (100, [M+H]+); 145 (32, [M+Na]+)   
N-(quinolin-8-yl)acetamide (264)[86] 2.00 g quinolin-8-amine 203 (13.87 mmol, 1.0 
eq.), 1.56 g acetic anhydride (15.26 mmol, 1.1 eq.), 1.54 g triethylamine 
(15.26 mmol, 1.1 eq.) and 0.34 g DMAP (2.77 mmol, 0.2 eq.) were stirred 
in 25 ml of DCM for 2 h. The mixture was washed with sat. NH4Cl and 
extracted two times with DCM. The combined organic phases were dried 
over Na2SO4. The crude product was purified by column chromatography (SiO2, 
DCM/MeOH 50:1) yielding 1.77 g 264 (69% yield) as white crystals. 
TLC (SiO2, DCM/MeOH 50:1): Rf = 0.30;  1H-NMR (500 MHz, CDCl3): 9.77 (broad, 
1H, NH); 8.74-8.80 (m, 2H, Har); 8.16 (m, 1H, Har); 7.41-7.56 (m, 3H, Har); 2.36 (s, 
3H, CH3); 13C-NMR (126 MHz, CDCl3): 169.0, 148.2, 138.3, 136.5, 134.6, 128.0, 
127.5, 121.7, 121.6, 116.5, 25.3 
 
 N-(5,6,7,8-tetrahydroquinolin-8-yl)acetamide (204)[86] 1.77 g 264 (9.51 mmol, 1.0 
eq.) and 0.11 g PtO2 (0.48 mmol, 0.05 eq.) were dissolved in 30 ml of 
trifluoroacetic acid and stirred at 60°C under a hydrogen atmosphere for 
3.5 h. After filtration of the catalyst, the filtrate was basified to pH 10 with 
1M KOH, extracted three times with DCM and dried over Na2SO4. After 
removal of the solvent, the crude product was purified by column chromatography 
(basic alox, DCM:MeOH 9:1) yielding 1.02 g of 204 (57% yield) as a white solid. 
TLC (basic alox, DCM/MeOH 100:1): Rf = 0.22; 1H-NMR (500 MHz, CDCl3): 8.40 (m, 
1H, Har); 7.42 (m, 1H, Har); 7.14 (m, 1H, Har); 6.51 (broad, 1H, NH); 4.87 (m, 1H, 
CHNH); 2.81 (m, 2H); 2.55 (m, 1H); 2.07 (s, 3H, CH3); 1.89 (m, 2H); 1.64 (m, 1H); 
13C-NMR (126 MHz, CDCl3): 170.6, 155.4, 147.0, 137.3, 133.2, 122.6, 51.3, 29.5, 
28.3, 23.9, 20.0; ESI-MS (MeOH): positive ion mode: 213 (49, [M+Na]+); 403 (100, 
[2M+Na]+) 
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5,6,7,8-tetrahydroquinolin-8-amine (205)[85] 1.02 g 204 (5.40 mmol) were refluxed 
for 2 h in 15 ml of 6M HCl. The mixture was cooled down and basified to 
pH 10 with 1M KOH, extracted three times with DCM and dried over 
Na2SO4. Resulting amine 205 was reacted with lipase without further 
purification. 
TLC (basic alox, DCM/MeOH 9:1): Rf = 0.44; 1H-NMR (500 MHz, CDCl3): 8.39 (d,     
J = 4.2, 1H, Har); 7.35 (d, J = 7.7, 1H, Har); 7.05 (m, 1H, Har); 3.99 (t, J = 7.6, 1H, 
CHNH2); 2.82 (m, 2H); 2.18 (m, 1H); 1.94 (m, 1H);, 1.85 (m, 1H); 1.70 (m, 1H); 13C-
NMR (126 MHz, CDCl3): 159.7, 147.2, 136.9, 131.7, 121.8, 51.5, 32.1, 29.1, 20.1 
  
(S)-1-(pyridin-2-yl)ethanamine (201)[85] 2.00 g 205 (16.38 mmol, 1.0 eq.) and 0.60 
g CALB (30% in weight) were stirred in 46 ml of EtOAc (479.90 mmol, 29.0 
eq.) at 60°C for 7 h. After filtration and washing with EtOAc, the solvent 
was removed under vacuum and the crude product applied to column 
chromatography (basic alox, gradient starting with 100% DCM to DCM/MeOH 9:1) 
yielding 0.66 g of the (S)-amine 201 (eluting second, ee = 99%, determined by 
Mosher amidation) and 0.74 g of the (R)-amide 200 (eluting first).  
TLC (basic alox, DCM/MeOH 100:1): Rf = 0.17; 1H-NMR (400 MHz, CDCl3): 8.54 (d, 
J = 7.6, 1H, Har); 7.66 (m, 1H, Har); 7.62 (m, 1H, Har); 7.26 (m, 1H, Har); 4.14 (q,         
J = 6.8, 1H, CH); 1.42 (d, J = 6.6, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 166.2, 
149.5, 137.0, 122.2, 120.5, 52.9, 24.9  
(R)-1-(pyridin-2-yl)ethanamine (202)[85] 0.74 g 200 were refluxed in 17 ml of 6M 
HCl for 2 h. The solution was basified with 1M KOH to pH 12, extracted 
three times with DCM and dried over Na2SO4. After evaporation of the 
solvent, the crude product was filtrated over a small basic alox column to 
yield 0.33 g of the (R)-amine 202 (ee = 97%, determined by Mosher amidation). 
TLC (basic alox, DCM/MeOH 100:1): Rf = 0.17; 1H-NMR (400 MHz, CDCl3): 8.54 (d, 
J = 7.6, 1H, Har); 7.66 (m, 1H, Har); 7.62 (m, 1H, Har); 7.26 (m, 1H, Har); 4.14 (q,         
J = 6.8, 1H, CH); 1.42 (d, J = 6.6, 3H, CH3); 13C-NMR (100 MHz, CDCl3): 166.2, 
149.5, 137.0, 122.2, 120.5, 52.9, 24.9  
(S)-5,6,7,8-tetrahydroquinolin-8-amine (207)[85] 0.90 g 205 (6.15 mmol, 1.0 eq.) 
and 0.28 g CALB (30% in weight) were stirred in a mixture of 2.36 ml 
EtOAc and 15.18 ml of i-PrOH at 60°C for 4 h. After filtration and washing 
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with EtOAc, the solvent was removed under vacuum and the crude product applied to 
column chromatography (basic alox, gradient starting with 100% DCM to DCM/MeOH 
12:1) yielding 0.24 g of the (S)-amine 207 (eluting second, ee = 93%, determined by 
Mosher amidation) and 0.31 g of the (R)-amide 265 (eluting first).  
TLC (basic alox, DCM/MeOH 100:1): Rf = 0.19 ; 1H-NMR (400 MHz, CDCl3): 8.38 (d, 
J = 4.0, 1H, Har); 7.35 (m, 1H, Har); 7.04 (m, 1H, Har); 3.99 (m, 1H, CHNH2); 2.75 (m, 
2H); 2.24 (m, 1H); 1.95 (m, 1H); 1.59 (m, 2H) 
(R)-5,6,7,8-tetrahydroquinolin-8-amine (206)[85] 0.31 g 265 were refluxed in 17 ml 
of 6M HCl for 2 h. The solution was basified with 1M KOH to pH 12, 
extracted three times with DCM and dried over Na2SO4. After evaporation 
of the solvent, the crude product was filtrated over a small basic alox 
column to yield 0.22 g of the (R)-amine 206 (ee = 94%, determined by Mosher 
amidation). 
TLC (basic alox, DCM/MeOH 100:1): Rf = 0.19; 1H-NMR (400 MHz, CDCl3): 8.38 (d, 
J = 4.0, 1H, Har); 7.35 (m, 1H, Har); 7.04 (m, 1H, Har); 3.99 (m, 1H, CHNH2); 2.75 (m, 
2H); 2.24 (m, 1H); 1.95 (m, 1H); 1.59 (m, 2H) 
5.2.1.6 Chlorinated and Fluorinated Pyridylamines 
 
2-(bromomethyl)-6-chloropyridine (214)[87] 2.61 ml (23.60 mmol, 1.0 eq.) 213 and 
5.88 g (33.04 mmol, 1.4 eq.) NBS were refluxed overnight in 50 ml CCl4 in 
the presence of 0.38 g (2.34 mmol, 0.1 eq.) of AIBN. The suspension was 
filtered and the solvent removed at reduced pressure. Remaining starting 
material was distilled off the solution with a Kugelrohr (1013 mbar, 87°C). The 
residue was purified by column chromatography (SiO2, gradient: starting with 
Hx/EtOAc 100:0 to Hx/EtOAc 10:1) to yield 1.36 g of compound 214 (28% yield) as a 
colourless liquid. 
TLC (SiO2, Hx/EtOAc 10:1): Rf = 0.44; 1H-NMR (400 MHz, CDCl3): 7.50 (m, 1H, Har); 
7.46 (d, 1H, Har); 7.23 (d, 1H, Har); 4.48 (s, 2H, CH2Br) 
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2-((6-chloropyridin-2-yl)methyl)isoindoline-1,3-dione (266)[87] A suspension of 
1.36 g 214 (8.69 mmol, 1.0 eq.), 1.69 g isoindoline-1,3-dione (9.13 
mmol, 1.05 eq.) and 3.60 g potassium carbonate (dried for four hours 
at high vacuum at 80°C; 26.07 mmol, 3.0 eq.) in 110 ml of acetonitrile 
was refluxed for 2 hours. The solvent was removed after filtration. The 
residue was dissolved in 50 ml DCM/H2O 1:1. The organic phase was separated and 
dried over Na2SO4. The crude product was purified by column chromatography (SiO2, 
Hx/EtOAc 2:1) to yield 1.48 g 266 (82% yield) as a white solid. 
TLC (SiO2, Hx/EtOAc 2:1): Rf = 0.39; mp: 152-153°C; 1H-NMR (500 MHz, CDCl3): 
7.89 (m, 2H, Har); 7.75 (m, 2H, Har); 7.59 (t, J = 7.7, 1H, Har); 7.21 (d, J = 8.0, 1H, 
Har); 7.13 (d, J = 7.9, 1H, Har); 4.98 (s, 2H, CH2); 13C-NMR (126 MHz, CDCl3): 168.1, 
156.5, 151.4, 139.5, 134.4, 132.2, 123.8, 123.4, 119.7, 42.7; IR (KBr): 3070w, 
2932w, 1713s; ESI-MS (MeOH): positive ion mode: 295 (100, [M+H]+); EA: 
calculated for C14H9N2O2Cl: C 61.66, H 3.33, N 10.27, O 11.73; found: C 61.67, H 
3.42, N 10.16, O not detectable 
 
(6-chloropyridin-2-yl)methanamine (212)[87] A solution of 1.43 g 266 (5.35 mmol, 
1.0 eq.) and 620 mg hydrazine monohydrate (12.31 mmol, 2.3 eq.) was 
stirred in 50 ml MeOH at 60°C for 12 hours. The solution was filtered and 
MeOH removed at reduced pressure. The residue was dissolved in DCM, 
washed three times with 1M NaOH and dried over Na2SO4. 563 mg of a colourless oil 
(74% yield) were used without further purification. 
TLC (basic Alox, DCM/MeOH 20:1): Rf = 0.55; 1H-NMR (400 MHz, CDCl3): 7.58 (t,    
J = 7.6, 1H, Har); 7.19 (m, 2H, Har); 3.91 (s, 2H, CH2); 1.63 (broad, 2H, NH2); 13C-
NMR (100 MHz, CDCl3): 163.3, 151.1, 139.3, 122.4, 119.7, 47.5; IR (KBr): 3364w, 
3287w, 1585s, 1582s, 1435m, 1312m, 1165m, 1134m; ESI-MS (MeOH): positive ion 
mode: 143 (100, [M+H]+); 165 (33, [M+Na]+)   
 
2-(bromomethyl)-6-fluoropyridine (267)[87] 2.79 ml (27.00 mmol, 1.0 eq.) 6-
fluoropyridine and 6.73 g (37.80 mmol, 1.4 eq.) NBS were refluxed 
overnight in 50 ml CCl4 in the presence of 0.44 g (2.70 mmol, 0.1 eq.) 
AIBN. After filtration and removal of the solvent, the residue was dissolved 
N Cl
NH2
N Cl
NO O
N F
Br
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in 50 ml toluene/water (1:1), extracted four times with toluene and dried over Na2SO4. 
After removal of toluene, the crude product (a 2:1 mixture of mono- and dibromo 
product, checked by 1H-NMR) was used without further purification. 
 
2-((6-fluoropyridin-2-yl)methyl)isoindoline-1,3-dione (268)[87] A suspension of 
3.27 g 267 (17.21 mmol, 1.0 eq.), 3.35 g isoindoline-1,3-dione (18.07 
mmol, 1.05 eq.) and 6.14 g potassium carbonate (dried for four hours 
at high vacuum at 80°C; 54.63 mmol, 2.6 eq.) in 180 ml of acetonitrile 
was refluxed for 2 hours. The solvent was removed after filtration. The 
residue was dissolved in 50 ml DCM/H2O 1:1. The organic phase was 
separated and dried over Na2SO4. The crude product was purified by column 
chromatography (SiO2, Hx/EtOAc 2:1) to yield 1.77 g 268 (40% yield; two steps) as a 
white solid. 
TLC (SiO2, Hx/EtOAc 2:1): Rf = 0.28; mp: 154-155°C; 1H-NMR (400 MHz, CDCl3): 
7.89 (m, 2H, Har); 7.74 (m, 3H, Har); 7.13 (m, 1H, Har); 6.80 (m, 1H, Har); 4.94 (s, 2H, 
CH2); 13C-NMR (100 MHz, CDCl3): 168.3, 163.2, 162.5, 154.9, 134.6, 132.5, 124.0, 
118.9, 108.7, 42.4; 19F-NMR (376 MHz, CDCl3): -67.7 (s, 1F); IR (KBr): 3464w, 
3078w, 2932w, 1767s, 1705s, 1605s, 1574s, 1420s, 1389s, 1119m; ESI-MS 
(MeOH): positive ion mode: 257 (100, [M+H]+); 279 (64, [M+Na]+); EA: calculated for 
C14H9N2O2F: C 65.62, H 3.54, N 10.93, O 12.49; found: C 65.54, H 3.64, N 10.85, O 
not detectable 
 
(6-fluoropyridin-2-yl)methanamine (215)[87] A solution of 1.77 g 268 (6.91 mmol, 
1.0 eq.) and 0.80 g  hydrazinemonohydrate (15.89 mmol, 2.3 eq.) were 
stirred in 50 ml MeOH at 60°C for 12 hours. The solution was filtered and 
MeOH removed at reduced pressure. The residue was dissolved in DCM, 
washed three times with 1M NaOH and dried over Na2SO4. 0.69 g of a colourless oil 
(80% yield) was used without further purification. 
TLC (basic Alox, DCM/MeOH 20:1): Rf = 0.32; 1H-NMR (500 MHz, CDCl3): 7.72 (m, 
1H, Har); 7.15 (m, 1H, Har); 6.77 (m, 1H, Har); 3.90 (s, 2H, CH2); 13C-NMR (126 MHz, 
CDCl3): 165.0, 161.7, 141.9, 118.6, 107.7, 47.5; 19F-NMR (376 MHz, CDCl3): - 68.9 
(s, 1F); IR (KBr): 3364br, 2917w, 2854w, 2361m, 1605s, 1574s, 1443s, 1265s, 
1219s; ESI-MS (MeOH): positive ion mode: 127 (100, [M+H]+); 149 (58, [M+Na]+); 
233 (10, [2M-F]+); 275 (8, [2M+Na]+)     
N F
NO O
N F
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5.2.2 Synthesis of Substrates for Catalysis 
5.2.2.1 Synthesis of racemic Alcohols 
Aromatic and aliphatic alcohols were synthezised with the following procedure: 1.0 
eq. of ketone were dissolved in diethylether and stirred for 30 minutes in the 
presence of 0.5 eq. LiAlH4. The mixture was quenched with 1M HCl. The organic 
phase was washed with water, dried over Na2SO4 and purified by column 
chromatography (SiO2, hexane/EtOAc). The purity was checked by 1H-NMR and GC. 
5.2.2.2 Synthesis of Diketones 
4-bromo-2-methylbut-1-ene (143) 11.60 ml methanesulfonyl chloride (0.15 mol, 1.5 
eq.) dissolved in 50 ml DCM was slowly added to a mixture of 8.50 g 3-
methyl-3-buten-1-ol 142 (0.10 mol, 1.0 eq.) and 21.00 ml triethylamine 
(0.15 mol, 1.5 eq.) in 200 ml DCM at 0°C. The mixture was stirred for additional 30 
minutes at r.t. before quenching with sat. NH4Cl. The organic phase was washed with 
3 x 100 ml NH4Cl, 100 ml brine and dried over Na2SO4. The solvent was removed in 
the dark to protect decomposition. The obtained yellowish oil was dissolved in 125 ml 
THF, 17.00 g lithium bromide (0.20 mol, 2.0 eq.) were added. The suspension was 
refluxed overnight, quenched with 100 ml water, washed with brine and dried over 
Na2SO4. One obtained 6.77 g 143 (47% yield, 2 steps) as a white solid.  
1H-NMR (500 MHz, CDCl3): 4.87 (s, 1H, CH2CH2CH(CH2)CH3); 4.65 (s, 1H, 
CH2CH2CH(CH2)CH3); 3.44 (t, J = 7.1, 2H, CH2); 2.57 (t, J = 7.1, 2H, CH2); 1.73 (s, 
3H, CH3) 
4-methyl-1-phenylpent-4-en-1-ol (144) 0.28 g magnesium (11.00 mmol, 1.0 
eq.) and 1/20 of 1.70 g 143 (11.00 mmol, 1.0 eq.) were 
suspended in 3 ml THF. The reaction vessel was heated with an 
air gun till the suspension got dingy. The remaining 19/20 143 were added and 
refluxed for 30 minutes. The mixture was cooled down to r.t. and 0.93 ml 
benzaldehyde (9.00 mmol, 0.8 eq.) dissolved in 1 ml THF were added. The 
mixture was refluxed for 1 h before quenching carefully with water and 6M 
HCl. The organic phase was washed with sat. NaHCO3 and dried over 
Br
OH
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Na2SO4. The crude product was purified by column chromatography (SiO2, 
Hx/EtOAc 8:1) yielding 1.27 g 144 (66% yield) as a colourless oil.  
TLC (SiO2, Hx/EtOAc 8:1): Rf = 0.19; 1H-NMR (500 MHz, CDCl3): 7.28-7.35 (m, 5H, 
Har); 4.74 (s, 1H, CH2CH2CH(CH2)CH3); 4.71 (s, 1H, CH2CH2CH(CH2)CH3); 4.69 
(dxd, J = 4.4, 6.2, 1H, CHOH); 2.14 (m, 1H, CH(OH)CH2CH2); 2.05 (m, 1H, 
CH(OH)CH2CH2); 1.95 (m, 1H, CH(OH)CH2CH2); 1.86 (m, 1H, CH(OH)CH2CH2); 
1.73 (s, 3H, CH3); 13C-NMR (126 MHz, CDCl3): 145.6, 144.8, 128.6, 127.7, 126.0, 
110.3, 74.4, 37.0, 34.1, 22.7; IR (NaCl): 3397br, 2956w, 2936w, 2908w, 2888w, 
1721s; EA: calculated for C12H16O: C 81.77, H 9.15, O 9.08; found: C 81.44, H 9.15, 
O 9.26 
5-hydroxy-5-phenylpentan-2-one (138) 1.28 g 144 (7.27 mmol, 1.0 eq.) were 
dissolved in 5 ml DCM and cooled down to -78°C. Ozone was 
bubbled through the solution till it turned blue (5 minutes). The 
bubbling was continued for 10 minutes. The remaining ozone was 
replaced by nitrogen, 2.29 g triphenylphosphine (8.72 mmol, 1.5 eq.) were added and 
the solution allowed to reach r.t. After removal of the solvent, the crude product was 
purified by column chromatography (SiO2, Hx/EtOAc 1:1), yielding 0.93 g 138 (72% 
yield) as a colourless oil.  
TLC (SiO2, Hx/EtOAc 1:1): Rf = 0.28; 1H-NMR (500 MHz, CDCl3): 7.28-7.34 (m, 5H, 
Har); 4.73 (m, 1H, CHOH); 2.56 (t, J = 7.3, 2H, CH2CO); 2.44 (broad, 1H, OH); 2.14 
(s, 3H, CH3); 2.03 (m, 2H, CH(OH)CH2); 13C-NMR (126 MHz, CDCl3): 209.6, 144.4, 
128.6, 127.7, 125.8, 73.6, 40.0, 32.7, 30.2; IR (NaCl): 3355br, 3074w, 3028w, 
2934w, 2858w, 2560w, 1714m, 1648m, 1452m; EA: calculated for C11H14O2: C 
74.13, H 7.92, O 17.95; found: C 73.79, H 7.97, O 18.50 
1-phenylpentane-1,4-dione (139) 0.25 g 138 (1.40 mmol, 1.0 eq.) and 0.25 g 
manganese(IV) oxide (2.88 mmol, 2.06 eq., dried at 250°C for 12 h) 
were refluxed in 25 ml DCM for 12 h. Remaining manganese salts 
were filtered off and the crude product was purified by column 
chromatography (SiO2, Hx/EtOAc 3:1) yielding 0.13 g 139 (51% yield) as a colourless 
oil.  
TLC (SiO2, Hx/EtOAc 3:1): Rf = 0.24; 1H-NMR (500 MHz, CDCl3): 7.97 (d, J = 7.1, 
1H, Har); 7.57 (m, 2H, Har); 7.46 (m, 2H, Har); 3.28 (t, J = 6.1, 2H, PhCOCH2); 2.88 (t, 
J = 6.0, 2H, CH2COCH3); 2.27 (s, 3H, CH3); 13C-NMR (126 MHz, CDCl3): 207.5, 
OH
O
O
O
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198.7, 136.7, 133.3, 128.7, 128.2, 37.2, 32.5, 30.2; IR (NaCl): 3393br, 3065w, 
3030w, 2936w, 2365w, 2339w, 1715m, 1685m, 1648m, 1449;  
1-phenylpentane-1,4-diol (140) 138 (1.96 mmol, 1.0 eq.) and 0.05 g LiAlH4 were 
stirred for 2 h in 4 ml THF at r.t. The mixture was quenched with 
water and 1M HCl, extracted three times with TBME and dried over 
Na2SO4. The crude product was purified by column chromatography 
(SiO2, Hx/TBME 4:5), yielding 0.21 g 140 (60% yield) as a colourless oil. 
TLC (SiO2, Hx/EtOAc 4:5): Rf = 0.22; 1H-NMR (500 MHz, CDCl3): 7.27-7.34 (m, 5H, 
Har); 4.71 (m, 1H, PhCHOH); 3.86 (m, 1H, CH(OH)HCH3); 1.83-1.91 (m, 2H, 
PhCH(OH)CH2); 1.56-1.66 (m, 3H, CH2CHOHCH3 and OH); 1.19 (d, J = 6.6, 3H, 
CH3); 13C-NMR (126 MHz, CDCl3): 144.9, 128.6, 127.7, 125.9, 74.7, 68.3, 36.1, 35.3, 
23.8; IR (NaCl): 3355br, 3074w, 3028w, 2934w, 2858w, 2560w, 1714m, 1648m, 
1452m; EA: calculated for C11H16O2: C 73.30, H 8.95, O 17.75; found: C 72.50, H 
9.07, O 18.27 
4-hydroxy-1-phenylpentan-1-one (141) 122 mg 140 1-phenylpentane-1,4-diol (0.68 
mmol, 1.0 eq.) and 118 mg manganese(IV) oxide (1.35 mmol, 2.0 
eq.) were refluxed in 5 ml toluene for 6 h. After filtration over Celite, 
the organic phase was dried over Na2SO4. The crude product was 
purified by column chromatography (SiO2, Hx/TBME 7:6), yielding 73 mg 141 (62% 
yield) as a colourless oil. 
TLC (SiO2, Hx/EtOAc 7:6): Rf = 0.26; 1H-NMR (500 MHz, CDCl3): 7.98 (m, 2H, Har); 
7.56 (m, 1H, Har); 7.46 (m, 2H, Har); 3.89 (m, 1H, CHOH); 3.15 (m, 2H, PhCOCH2); 
1,92-2.14 (m, 1H, CH2CH(OH)CH3); 1.81-1.91 (m, 2H, CH2CH(OH)CH3 and OH); 
1.25 (d, J = 6.2, 3H, CH3); 13C-NMR (126 MHz, CDCl3): 200.9, 137.0, 133.3, 128.7, 
128.2, 67.7, 35.1, 33.2, 24.0; IR (NaCl): 3390br, 3087w, 2939w, 2360w, 2342w 
 
 
 
 
O
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5.2.3 Synthesis of Cyclodextrins modified on Primary Face 
General procedures for the linkage of side chains to the primary face of β-
Cyclodextrin: 
 
Procedure A: Between 10 and 80 eq. of the amine and 1.0 eq. of mono-6-deoxy-6-
(O-tosyl)-β-cyclodextrin 68 were stirred at 80°C for 12 h, neat or in the presence of 
small amounts DMF (0.1-1.0 ml). DMF was removed under reduced pressure and the 
resulting yellowish oil dissolved in very little warm water. This solution was then 
poured into 15-150 ml of acetone (depending on the reaction scale). The precipitate 
was filtered off and washed with acetone. 
Procedure B: Between 2 and 15 eq. of the amine and 1.0 eq. of mono-6-deoxy-6-(O-
tosyl)-β-cyclodextrin 68 or mono-6-deoxy-(6-iodo)-β-cyclodextrin were dissolved in 
0.75 ml DMSO and stirred in a closed vessel in the microwave at 70-100°C (constant 
power 75-150 Watt). Reaction times varied between 1 and 4 hours. After removal of 
DMSO, the yellowish residue was treated as described below. 
 
General procedure for the purification of modified Cyclodextrins:  
 
Method A (recrystallization): Some modified cyclodextrins could be obtained in a 
reasonable pure form after 1-3 recrystallizations in water. This method is limited to 
reactions performed with more than 100 mg of mono-6-deoxy-6-(O-tosyl)-β-
cyclodextrin. Recrystallizations with smaller amounts led to unsatisfying yields.  
Method B (reprecipitation): The crystals obtained from the first precipitation were 
dissolved again in very little water and precipitated in an excess of acetone. This 
procedure was repeated 1-3 times. The precipitate can be washed with either 
acetone or small amounts of ice cold water. 
Method C (by chromatography): Modified cyclodextrins can be purified by reversed 
phase chromatography (silica gel 100 C-18) using water or a mixture of water and 
MeOH as eluent. Ion exchange resin (CG-50) can also be used to purify modified 
cyclodextrins, using water as eluent.   
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5.2.3.1 Linkage of Amino alcohols[71] 
mono-6-deoxy-6-[N-2-hydroxyethyl]-6-amino-β-cyclodextrin (β-CD-AE) (79) 
Following general procedure A, 394 mg 68 (0.31 mmol, 1.0 eq.) were 
stirred in 1.40 ml aminoethanol (21.40 mmol, 70 eq.) for 12 h at 70°C. 
After two precipitations in acetone and one recrystallization in water, 
one obtained 193 mg of pure 79 (53% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.26; mp: decomposition 
>275°C; [α] (c (H2O)= 0.63 M): +130°; 1H-NMR (500 MHz, D2O): 5.07 (m, 7H,  7xH1); 
3.81-3.99 (m, 26H, 7xH3, 7xH5 and 12xH6); 3.53-3.75 (m, 15H, 7xH2, 6xH4 and 
NHCH2CH2OH); 3.44 (dxd, J = 9.6, 9.6, 1H, H4); 3.08 (m, 1H, H6); 2.84 (m, 1H, H6); 
2.74 (m, 2H, NHCH2CH2OH); ESI-MS (MeOH): positive ion mode: 588.5 (67, 
[M+Na]2+); 1179 (100, [M+H]+); 1201 (72, [M+Na]+) 
 
mono-6-deoxy-6-[N-methyl]-6-amino-β-cyclodextrin (269) Following general 
procedure B, 30 mg 68 (0.02 mmol, 1.0 eq.) and 0.15 ml of 8M methyl 
amine in EtOH (1.16 mmol, 50 eq.) were stirred in 0.75 ml DMF in the 
microwave for 4 h at 90 °C. After removal of DMF and one precipitation 
in acetone, one obtained 16 mg of pure 269 (61% yield) as white 
crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.22; mp: decomposition 
>275°C; 1H-NMR (500 MHz, DMSO): 5.61-5.80 (m, 14H); 4.82  (s, 8H); 4.43 (m, 6H); 
3.51-3.74 (m, 28H); 2.26 (m, 3H, CH3); ESI-MS (MeOH): positive ion mode: 1149 
(100, [M+H)  
 
mono-6-deoxy-6-[N-(2,2-(S)-methyl-hydroxyethyl)]-6-amino-β-cyclodextrin (β-
CD-SAP) (92) Following general procedure A, 265 mg 68 (0.20 
mmol, 1.0 eq.) were stirred in 1.18 g (S)-1-aminopropan-2-ol (15.72 
mmol, 81 eq.) for 12 h at 70°C. After one precipitation in acetone and 
one recrystallization in water, one obtained 140 mg of pure 92 (59% 
yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.24; mp: decomposition 
>275°C; [α] (c (H2O)= 0.32 M): +136°; 1H-NMR (400 MHz, D2O): 5.02 (m, 7H,  7xH1);  
3.87-3.94 (m, 8H, 7xH3 and NHCH2CH(CH3)OH); 3.76-3.85 (m, 19H, 7xH5 and 
12xH6); 3.48-3.63 (m, 13H, 7xH2 and 6xH4); 3.38 (dxd, J = 9.6, 9.6, 1H, H4); 3.02 (d,  
NH
β
OH
NH
β
OH
N
H
β
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J = 10.9, 1H, H6); 2.81 (m, 1H, H6); 2.56 (m, 2H, NHCH2CH(CH3)OH); 1.09 (d,           
J = 6.3, 3H, CH3); ESI-MS (MeOH): positive ion mode: 607.5 (85, [M+Na]2+); 1193 
(100, [M+H]+); 1215 (78, [M+Na]+) 
 
mono-6-deoxy-6-[N-(2,2-(R)-methyl-hydroxyethyl)]-6-amino-β-cyclodextrin (β-
CD-RAP) (91) Following general procedure A, 215 mg 68 (0.17 mmol, 
1.0 eq.) were stirred in 1.00 g (R)-1-aminopropan-2-ol (13.30 mmol, 
81 eq.) for 12 h at 70°C. After three precipitations in acetone one 
obtained 91 mg of pure 91 (46% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.26; mp: decomposition 
>275°C; [α] (c (H2O)= 0.23 M): +158°; 1H-NMR (400 MHz, D2O): 5.01 (m, 7H,  7xH1);  
3.72-3.94 (m, 27H, 7xH3, 7xH5, 12xH6 and NHCH2CH(CH3)OH); 3.46-3.58 (m, 13H, 
7xH2 and 6xH4); 3.38 (dxd, J = 9.4, 9.4, 1H, H4); 3.05 (d, J = 12.9, 1H, H6); 2.72 (m, 
1H, H6); 2.51 (m, 2H, NHCH2CH(CH3)OH); 1.03 (d, J = 6.3, 3H, CH3); ESI-MS 
(MeOH): positive ion mode: 607.5 (83, [M+Na]2+); 1193 (100, [M+H]+); 1215 (77, 
[M+Na]+)    
 
mono-6-deoxy-6-[N-(1-(R)-methyl-2-hydroxyethyl)]-6-amino-β-cyclodextrin (β-
CD-AR) (90) Following general procedure A, 171 mg 68 (0.13 mmol, 
1.0 eq.) were stirred in 0.86 ml (R)-alaninol (10.83 mmol, 81 eq.) for 
12 h at 70°C. After one precipitation in acetone and one 
recrystallization in water, one obtained 93 mg of pure 90 (60% yield) 
as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.19; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 5.06 (d, J = 3.8, 1H,  H1);  5.00 (m, 6H,  6xH1);  
3.75-3.95 (m, 26H, 7xH3, 7xH5, 12xH6); 3.51-3.64 (m, 13H, 7xH2 and 6xH4); 3.35-
3.45 (m, 3H, H4 and NHCH(CH3)CH2OH); 3.16 (m, 1H, H6); 2.63-2.80 (m, 2H, H6 and 
NHCH(CH3)CH2OH); 0.98 (d, J = 6.6, 3H, CH3); ESI-MS (MeOH): positive ion mode: 
607.5 (77, [M+Na]2+); 1193 (100, [M+H]+); 1215 (77, [M+Na]+) 
 
mono-6-deoxy-6-[N-(1-(S)-methyl-2-hydroxyethyl)]-6-amino-β-cyclodextrin β-
CD-AS) (89) Following general procedure A, 198 mg 68 (0.15 mmol, 
1.0 eq.) were stirred in 1.0 ml (S)-alaninol (12.54 mmol, 81 eq.) for 12 
h at 70°C. After one precipitation in acetone and one recrystallization 
NH
β
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NH
β
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in water, one obtained 102 mg of pure 89 (57% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.21; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 5.08 (d, J = 3.8, 1H,  H1);  5.01 (m, 6H,  6xH1);  
3.75-3.95 (m, 26H, 7xH3, 7xH5, 12xH6); 3.48-3.61 (m, 13H, 7xH2 and 6xH4); 3.38-3.46 
(m, 3H, H4 and and NHCH(CH3)CH2OH); 2.75-3.05 (m, 3H, 2xH6 and 
NHCH(CH3)CH2OH); 1.00 (d, J = 6.6, 3H, CH3); ESI-MS (MeOH): positive ion mode: 
607.5 (80, [M+Na]2+); 1193 (100, [M+H]+); 1215 (75, [M+Na]+) 
 
mono-6-deoxy-6-[N-(1-(S)-isopropyl-2-hydroxyethyl)]-6-amino-β-cyclodextrin β-
CD-VAS) (124) Following general procedure A, 156 mg 68 (0.12 
mmol, 1.0 eq.) were stirred in 1.00 ml (S)-valinol (9.69 mmol, 81 eq.) 
for 12 h at 70°C. After one precipitation in acetone and one 
recrystallization in water, one obtained 72 mg of pure 124 (52% yield) 
as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.21; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 5.08 (d, J = 3.8, 1H,  H1);  5.00 (m, 6H,  6xH1); 
3.67-3.96 (m, 26H, 7xH3, 7xH5, 12xH6); 3.42-3.63 (m, 15H, 7xH2 and 6xH4 and 
NHCH(CH(CH3)2)CH2OH); 3.31-3.39 (dxd, J = 9.4, 9.4, 1H, H4); 3.06 (m, 1H, H6); 
2.75 (m, 1H, H6); 2.51 (m, 1H, NHCH(CH(CH3)2)CH2OH); 1.81 (m, 1H, 
NHCH(CH(CH3)2)CH2OH); 0.89 (d, J = 7.1, 3H, CH3); 0.82 (d, J = 7.0, 3H, CH3); ESI-
MS (MeOH): positive ion mode: 621.5 (100, [M+Na]2+); 1220 (41, [M+H]+); 1242 (18, 
[M+Na]+) 
 
mono-6-deoxy-6-[N-(1-(S)-methyl-2,2-(R)-phenyl-hydroxyethyl)]-6-amino-β-
cyclodextrin (123) Following general procedure A, 198 mg 68 
(0.15 mmol, 1.0 eq.) were stirred in 1.00 ml L-norephedrin (12.51 
mmol, 81 eq.) for 12 h at 70°C. After three precipitations in acetone, 
the crystals were washed with very little ice cold water. One 
obtained 51 mg of pure 123 (26% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.20; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 7.28-7.39 (m, 3H, Har); 7.18-7.26 (m, 2H, Har); 
4.95-5.07 (m, 7H,  7xH1); 4.51 (m, 1H, NHCH(CH3)CH(Ph)OH); 3.47-3.99 (m, 39H, 
7xH2, 7xH3, 6xH4, 7xH5, 12xH6); 3.28 (m, 1H, H4); 2.72-2.90 (m, 3H, 2xH6 and 
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NHCH(CH3)CH(Ph)OH); 1.09 (d, J = 6.6, 3H, CH3); ESI-MS (MeOH): positive ion 
mode: 646 (95, [M+Na]2+); 1268 (100, [M+H]+); 1290 (60, [M+Na]+) 
 
mono-6-deoxy-6-[N-(1-(R)-methyl-2,2-(S)-phenyl-hydroxyethyl)]-6-amino-β- 
cyclodextrin (122) Following general procedure A, 198 mg 68 
(0.15 mmol, 1.0 eq.) were stirred in 1.00 ml D-norephedrin (12.51 
mmol, 81 eq.) for 12 h at 70°C. After two precipitations in acetone 
and one recrystallization in water, one obtained 68 mg of pure 122 
(36% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.21; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 7.28-7.39 (m, 3H, Har); 7.18-7.26 (m, 2H, Har); 
4.97-5.08 (m, 7H,  7xH1); 4.47 (m, 1H, NHCH(CH3)CH(Ph)OH); 3.45-3.96 (m, 39H, 
7xH2, 7xH3, 6xH4, 7xH5, 12xH6); 3.25 (m, 1H, H4); 2.70-2.87 (m, 3H, 2xH6 and 
NHCH(CH3)CH(Ph)OH); 1.06 (d, J = 6.6, 3H, CH3); ESI-MS (MeOH): positive ion 
mode: 646 (93, [M+Na]2+); 1268 (100, [M+H]+); 1290 (63, [M+Na]+) 
 
mono-6-deoxy-6-[N-(1-(R)-2,2-(R)-hydroxy-cyclopentyl)]-6-amino-β-cyclodextrin 
(119) Following general Procedure A, 127 mg 68 (0.10 mmol, 1.0 eq.) 
were stirred in 500 mg 117 (4.95 mmol, 50 eq.) for 12 h at 70°C. After 
one precipitation in acetone, the crude product was purified by 
reversed phase chromatography using water as eluent. One obtained 
36 mg of pure 119 (30% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.23; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 5.01-5.08 (m, 7H, 7xH1); 3.70-3.97 (m, 27H, 7xH3, 
7xH5, 12xH6 and CH2CHOH); 3.50-3.63 (m, 13H, 7xH2 and 6xH4); 3.34-3.43 (m, 1H, 
H4); 3.12-3.21 (m, 1H, H6); 2.87-3.06 (m, 2H, H6 and NHCHCH2); 2.01-2.10 (m, 1H, 
NHCHCH2CH2CH2CHOH); 1.90-1.99 (m, 1H, NHCHCH2CH2CH2CHOH); 1.63-1.72 
(m, 2H, NHCHCH2CH2CH2CHOH); 1.50-1.59 (m, 1H, NHCHCH2CH2CH2CHOH); 
1.32-1.47 (m, 1H, NHCHCH2CH2CH2CHOH); ESI-MS (MeOH): positive ion mode: 
1218 (100, [M+H]+)  
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mono-6-deoxy-6-[N-(1-(S)-2,2-(S)-hydroxy-cyclopentyl)]-6-amino-β-cyclodextrin 
(127) Following general Procedure A, 50 mg 68 (0.04 mmol, 1.0 eq.) 
were stirred in 194 mg 116 (1.93 mmol, 50 eq.) for 12 h at 70°C. After 
one precipitation in acetone, the crude product was purified by 
reversed phase chromatography using water as eluent. One obtained 
17 mg of pure 127 (36% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.23; mp: decomposition 
>275°C; 1H-NMR (600 MHz, D2O): 5.09 (m, 1H, H1); 5.01-5.06 (m, 6H, 6xH1); 3.71-
3.98 (m, 27H, 7xH3, 7xH5, 12xH6 and CH2CHOH); 3.51-3.64 (m, 13H, 7xH2 and 
6xH4); 3.36-3.43 (m, 1H, H4); 3.00-3.05 (m, 1H, H6); 2.91-2.97 (m, 1H, NHCHCH2); 
2.77-2.84 (m, 1H, H6); 1.87-1.98 (m, 2H, NHCHCH2CH2CH2CHOH and 
NHCHCH2CH2CH2CHOH); 1.60-1.68 (m, 2H, NHCHCH2CH2CH2CHOH); 1.43-1.50 
(m, 1H, NHCHCH2CH2CH2CHOH); 1.28-1.36 (m, 1H, NHCHCH2CH2CH2CHOH); 
ESI-MS (MeOH): positive ion mode: 1218 (100, [M+H]+)  
 
mono-6-deoxy-6-[N-(1-(R)-2,2-(R)-hydroxy-cyclohexyl)]-6-amino-β-cyclodextrin 
(120) Following general procedure A, 75 mg 117 (0.06 mmol, 1.0 
eq.) were stirred in 337 mg 115 (2.91 mmol, 50 eq.) for 12 h at 
70°C. After one precipitation in acetone and one recrystallization in 
water, one obtained 32 mg of pure 120 (43% yield) as white 
crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.20; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 5.01-5.10 (m, 7H, 7xH1); 3.21-4.02 (m, 41H, 7xH2, 
7xH3, 7xH4, 7xH5, 12xH6 and CH2CHOH); 2.90-3.00 (m, 1H, H6); 2.68-2.82 (m, 1H, 
NHCHCH2); 2.27-2.37 (m, 1H, H6); 1.72-1.95 (m, 2H, NHCHCH2CH2CH2CH2CHOH 
and NHCHCH2CH2CH2CH2CHOH) 1.41-1.62 (m, 2H, NHCHCH2CH2CH2CH2CHOH 
and NHCHCH2CH2CH2CH2CHOH); 0.98-1.32 (m, 4H, NHCHCH2CH2CH2CH2CHOH); 
ESI-MS (MeOH): positive ion mode: 1232 (100, [M+H]+)  
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mono-6-deoxy-6-[N-(1-(S)-2,2-(S)-hydroxy-cyclohexyl)]-6-amino-β-cyclodextrin  
(126) Following general procedure A, 43 mg 68 (0.03 mmol, 1.0 eq.) 
were stirred in 310 mg 114 (2.69 mmol, 80 eq.) for 12 h at 70°C. 
After one precipitation, the crude product was purified by reversed 
phase chromatography using water as eluent. One obtained 18 mg 
of pure 126 (44% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.18; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 5.01-5.09 (m, 7H, 7xH1); 3.80-3.98 (m, 27H, 7xH3, 
7xH5, 12xH6 and CH2CHOH); 3.50-3.67 (m, 13H, 7xH2 and 6xH4); 3.38-3.47 (m, 1H, 
H4); 3.24-3.33 (m, 1H, H6); 2.54-2.64 (m, 1H, NHCHCH2); 2.37-2.47 (m, 1H, H6); 
1.86.1.98 (m, 2H, NHCHCH2CH2CH2CH2CHOH and NHCHCH2CH2CH2CH2CHOH) 
1.61-1.74 (m, 2H, NHCHCH2CH2CH2CH2CHOH and NHCHCH2CH2CH2CH2CHOH); 
1.13-1.33 (m, 3H, 1xNHCHCH2CH2CH2CH2CHOH and 
2xNHCHCH2CH2CH2CH2CHOH); 1.02-1.11 (m, 1H, NHCHCH2CH2CH2CH2CHOH); 
ESI-MS (MeOH): positive ion mode: 1232 (100, [M+H]+) 
 
mono-6-deoxy-6-[N-(1-(S)-methyl-2,2-(R)-methyl-hydroxyethyl)]-6-amino-β-
cyclodextrin (β-CD-RSDM) (125) Following general Procedure A, 51 
mg 68 (0.04 mmol, 1.0 eq.) and 280 mg 111 (3.14 mmol, 80 eq.) were 
stirred in 0.5 ml DMF for 12 h at 70°C. After three precipitations in 
acetone and washing with very little ice cold water, one obtained 34 
mg of pure 125 (73% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.21; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 5.01-5.09 (m, 7H,  7xH1); 3.73-3.97 (m, 26H, 
7xH3, 7xH5, 12xH6); 3.51-3.67 (m, 14H, 7xH2, 6xH4 and CH(CH3)OH); 3.37-3.46 (m, 
1H, H4); 2.98-3.06 (m, 1H, H6); 2.79-2.87 (m, 1H, NHCH(CH3)CH(CH3)OH); 2.62-
2.73 (m, 1H, H6); 1.13 (d, J = 6.7, 3H, CH(CH3)OH); 0.97 (d, J = 6.7, 3H, 
NHCH(CH3)); ESI-MS (MeOH): positive ion mode: 1206 (100, [M+H]+) 
 
mono-6-deoxy-6-[N-(1-(R)-methyl-2,2-(S)-methyl-hydroxyethyl)]-6-amino-β-
cyclodextrin (β-CD-SRDM) (118) Following general Procedure A, 
121 mg 68 (0.09 mmol, 1.0 eq.) and 335 mg 110 (3.76 mmol, 40 eq.) 
were stirred at 70°C for 12 h. After two precipitations in acetone and 
washing with very little ice cold water, one obtained 21 mg of pure 
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118 (19% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.22; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 5.01-5.09 (m, 7H, 7xH1); 3.75-4.04 (m, 26H, 7xH3, 
7xH5, 12xH6); 3.52-3.71 (m, 14H, 7xH2, 6xH4 and CH(CH3)OH); 3.42-3.51 (m, 1H, 
H4); 3.14-3.23 (m, 1H, H6); 2.65-2.79 (m, 2H, H6 and NHCH(CH3)CH(CH3)OH); 1.14 
(d, J = 6.5, 3H, CH(CH3)OH); 1.01 (d, J = 6.3, 3H, NHCH(CH3)); ESI-MS (MeOH): 
positive ion mode: 1206 (100, [M+H]+) 
 
mono-6-deoxy-6-[N-(1-(R)-2,2-(S)-hydroxy-indanyl)]-6-amino-β-cyclodextrin 
(121) Following general Procedure B, 50 mg 68 (0.04 mmol, 1 eq.) 
and 60 mg (1R,2S)-1-amino-2,3-dihydro-1H-inden-2-ol (0.40 mmol, 
10 eq.) were dissolved in 0.75 ml DMSO. The mixture was stirred in 
the microwave for 4 h at 80°C (90 Watt). After two precipitations in 
acetone, one obtained 16 mg of pure 121 (32% yield) as white 
crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.18; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 7.23-7.43 (m, 4H, Har); 5.02-5.11 (m, 7H, 7xH1); 
3.52-4.02 (m, 43H, 7xH2, 7xH3, 6xH4 7xH5, 12xH6,  NHCH, CHOH and PhCH2); 3.45-
3.51 (m, 1H, H4); 2.90-3.13 (m, 2H, 2xH6); ESI-MS (MeOH): positive ion mode: 1266 
(96, [M+H]+); 1288 (100, [M+Na]+) 
 
mono-6-deoxy-6-[N-(2,2-trifluoromethyl-hydroxyethyl)]-6-amino-β-cyclodextrin 
(129) Following general Procedure B, 75 mg 68 (0.06 mmol, 1 eq.) 
and 38 mg 1,1,1-trifluoro-3-amino-2-propanol (0.29 mmol, 5 eq.) 
were dissolved in 0.75 ml DMSO. The mixture was stirred in the 
microwave for 4 h at 80°C (120 Watt). After two precipitations in 
acetone, the crude product was purified over IRA-68 ion exchange resin using water 
as eluent. One obtained 37 mg of pure 129 (49% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.22; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 5.40 (m, 1H,  1xH1); 5.02-5.10 (m, 6H,  6xH1); 
3.75-4.00 (m, 26H, 7xH3, 7xH5 and 12xH6); 3.52-3.67 (m, 14H, 7xH2 and 6xH4 and 
and NHCH2CH(CF3)OH); 3.38-3-45 (m, 1H, H4); 2.72-3.12 (m, 4H, 2xH6 and 
NHCH2CH(CF3)OH); 19F-NMR (376 MHz, D2O): -79.80, -79.87; ESI-MS (MeOH): 
positive ion mode: 1247 (91, [M+H]+); 1269 (100, [M+Na]+) 
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mono-6-deoxy-6-[N-3-hydroxypropyl)]-6-amino-β-cyclodextrin (128)  Following 
general Procedure A 107 mg 68 (0.08 mmol, 1.0 eq.) and 500 mg 3-
amino-1-propanol (6.66 mmol, 80 eq.) were stirred at 70°C for 12 h. 
After three precipitations in acetone and washing with very little ice 
cold water, one obtained 34 mg of pure 128 (35% yield) as white 
crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.22; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 5.02-5.09 (m, 7H, 7xH1); 3.77-3.98 (m, 26H, 7xH3, 
7xH5 and 12xH6); 3.50-3.70 (m, 15H, 7xH2, 6xH4 and NHCH2CH2CH2OH); 3.40 (dxd, 
J = 9.6, 9.6, 1H, H4); 3.06 (m, 1H, H6); 2.82-2.91 (m, 1H, NHCH2CH2CH2OH); 2.67 
(m, 1H, H6); 2.51-2.60 (m, 2H, NHCH2CH2CH2OH and NHCH2CH2CH2OH); 1.67-1.78 
(m, 1H, NHCH2CH2CH2OH); ESI-MS (MeOH): positive ion mode: 1192 (100, [M+H]+); 
negative ion mode: 1190 (100, M-); 
5.2.3.2 Linkage of Monotosylated-, Monomesylated- and Monotriflated 
Diamines 
 
mono-6-deoxy-6-[N-2-tosylsulfonamidoethyl]-6-amino-β-cyclodextrin (β-CD-
MTDA) (154) Following general Procedure A, 113 mg 68 
(0.09 mmol, 1.0 eq.) and 1.5 g 157 (7.02 mmol, 80 eq.) were 
stirred in 1.0 ml DMF for 12 h at 70°C. After two 
precipitations in acetone and washing with very little ice cold 
water, one obtained 54 mg of pure 154 (47% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.17; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O, 315K): 7.78 (d, J = 8.2, 2H, Har); 7.65 (d, J = 8.0, 
2H, Har); 5.24 (d, J = 3.5, 1H, H1); 5.22 (d, J = 3.6, 1H, H1); 5.17 (d, J = 3.5, 1H, H1); 
5.14 (d, J = 3.3, 1H, H1); 5.09 (d, J = 3.6, 1H, H1); 5.02-5.07 (m, 2H, 2xH1); 3.60-4.14 
(m, 38H, 7xH2, 7xH3, 6xH4, 6xH5 and 12xH6); 3.53 (m, 1H); 3.26-3.31 (m, 1H, H4); 
3.18-3.25 (m, 1H, H5); 3.11-3.18 (m, 1H, CH2NHTs); 3.01-3.09 (m, 1H, CH2NHTs); 
2.81-2.88 (m, 1H, H6); 2.72-2.81 (m, 1H, H6); 2.67 (s, 3H, TsCH3); 2.52-2.61 (m, 1H, 
NHCH2); 2.37-2.47 (m, 1H, NHCH2); ESI-MS (MeOH): positive ion mode: 688.5 (77, 
[M+Na]2+); 1332 (15, [M+H]+); 1354 (100, [M+Na]+) 
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mono-6-deoxy-6-[N-(2,2-(S)-methyl-tosylsulfonamidoethyl)]-6-amino-β-
cyclodextrin (166) Following general Procedure A, 50 mg 
68 (0.04 mmol, 1.0 eq.) and 700 mg 162 (3.07 mmol, 80 
eq.) were stirred in 0.7 ml DMF for 12 h at 70°C. After three 
precipitations in acetone and one recrystallization in water, 
one obtained 14 mg of pure 166 (26% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.19; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 7.53 (d, J = 6.7, 2H, Har); 7.40 (d, J = 6.3, 2H, 
Har); 5.00 (d, J = 2.8, 1H, H1); 4.98 (d, J = 3.0, 1H, H1); 4.92 (d, J = 2.9, 1H, H1); 4.90 
(d, J = 3.0, 1H, H1); 4.80-4.84 (m, 3H, 3xH1); 3.26-3.96 (m, 37H, 7xH2, 7xH3, 6xH4, 
6xH5 and 12xH6); 3.13-3.19 (m, 1H, CH(CH3)NHTs); 2.92-3.05 (m, 2H, H5 and H4); 
2.49-2.57 (m, 2H, 2xH6); 2.57 (s, 3H, TsCH3); 1.90-1.98 (m, 2H, NHCH2); 1.05 (d,     
J = 5.3, 3H, CH3); ESI-MS (MeOH): positive ion mode: 695 (34, [M+Na]2+); 1345 
(100, [M+H]+); negative ion mode: 671 (55, M2-); 1343 (100, M-) 
 
mono-6-deoxy-6-[N-(2,2-(R)-methyl-tosylsulfonamidoethyl)]-6-amino-β-
cyclodextrin (167) Following general Procedure A, 68 mg 
162 (0.05 mmol, 1.0 eq.) and 960 mg 164 (4.21 mmol, 80 
eq.) were stirred in 0.9 ml DMF for 12 h at 70°C. After three 
precipitations in acetone, one obtained 47 mg of pure 167 
(66% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.21; mp: decomposition 
>275°C; 1H-NMR (400 MHz, D2O): 7.55 (d, J = 8.2, 2H, Har); 7.43 (d, J = 8.2, 2H, 
Har); 4.98-5.02 (m, 2H, 2xH1); 4.95 (d, J = 3.6, 1H, H1); 4.89 (d, J = 3.5, 1H, H1); 4.85 
(d, J = 3.6, 1H, H1); 4.81 (d, J = 3.3, 1H, H1); 4.77 (d, J = 3.0, 1H, H1); 3.35-3.95 (m, 
37H, 7xH2, 7xH3, 6xH4, 6xH5 and 12xH6); 3.13-3.19 (m, 1H, CH(CH3)NHTs); 2.91-3-09 
(m, 2H); 2.78-2-85 (s, 1H); 2.35-2.53 (m, 5H, TsCH3 and 2xH6); 2.18-2.32 (m, 2H, 
NHCH2); 1.09 (d, J = 6.5, 3H, CH3); ESI-MS (MeOH): positive ion mode: 673 (82, 
[M+H]2+); 1345 (100, [M+H]+) 1367 (67, [M+Na]+); negative ion mode: 671 (19, M2-); 
1343 (100, M-) 
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mono-6-deoxy-6-[N-(1-(R)-methyl-2-tosylsulfonamidoethyl)]-6-amino-β-
cyclodextrin (178) Following general Procedure B, 54 mg 68 
(0.04 mmol, 1.0 eq.) and 48 mg 169 (0.21 mmol, 5.0 eq.) 
were dissolved in 0.75 ml DMSO. The mixture was stirred in 
the microwave for 3 h at 85°C (120 Watt). After one 
precipitation in acetone, the crude product was purified over IRA-68 ion exchange 
resin using water as eluent. One obtained 18 mg of pure 178 (32% yield) as white 
crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.18; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 7.69 (d, J = 8.2, 2H, Har); 7.51 (d, J = 8.2, 2H, 
Har); 4.90-5.09 (m, 7H, 7xH1); 3.72-4.02 (m, 26H, 7xH3, 7xH5, and 12xH6); 3.50-3.70 
(m, 14H, 7xH2, 7xH4); 3.12-3.18 (m, 1H); 2.80-3.00 (m, 2H); 2.54 (s, 3H, TsCH3); 
2.40-2.44 (m, 2H); 1.03 (d, J = 6.6, 3H, CH3); ESI-MS (MeOH): positive ion mode: 
1345 (100, [M+H]+); negative ion mode: 1343 (100, M-) 
 
mono-6-deoxy-6-[N-(1-(S)-methyl-2-tosylsulfonamidoethyl)]-6-amino-β-
cyclodextrin (179) Following general Procedure B, 36 mg 
68 (0.03 mmol, 1.0 eq.) and 33 mg 177 (0.24 mmol, 5.0 eq.) 
were dissolved in 0.75 ml DMSO. The mixture was stirred in 
the microwave for 3 h at 85°C (120 Watt). After one 
precipitation in acetone, the crude product was purified over IRA-68 ion exchange 
resin using water as eluent. One obtained 20 mg of pure 179 (53% yield) as white 
crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.20; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 7.54 (d, J = 8.2, 2H, Har); 7.42 (d, J = 8.2, 2H, 
Har); 4.81-5.03 (m, 7H, 7xH1); 3.62-3.93 (m, 26H, 7xH3, 7xH5, and 12xH6); 3.36-3.57 
(m, 14H, 7xH2, 7xH4); 3.28-3.34 (m, 1H); 3.01-3.08 (m, 1H); 2.90-2.97 (m, 1H); 2.47-
2.76 (m, 3H);  2.42 (s, 3H, TsCH3); 0.88 (d, J = 6.5, 3H, CH3); ESI-MS (MeOH): 
positive ion mode: 1345 (100, [M+H]+); 1367 (83, [M+Na]+); negative ion mode: 1343 
(100, M-) 
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mono-6-deoxy-6-[N-(2,2-(S)-isopropyl-tosylsulfonamidoethyl)]-6-amino-β-
cyclodextrin (168) Following general Procedure A, 47 mg 
68 (0.04 mmol, 1.0 eq.) and 750 mg 165 (2.93 mmol, 80 eq.) 
were stirred in 0.7 ml DMF for 12 h. After two precipitations 
in acetone and washing with very little ice cold water, one 
obtained 25 mg of pure 168 (50% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.20; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 7.53 (d, J = 8.2, 2H, Har); 7.39 (d, J = 8.1, 2H, 
Har); 5.02 (d, J = 3.4, 1H, H1); 4.94-4.98 (m, 2H, 2xH1); 4.88 (d, J = 3.5, 1H, H1); 4.85 
(d, J = 3.3, 1H, H1); 4.82 (d, J = 3.7, 1H, H1); 4.80 (d, J = 2.7, 1H, H1); 3.32-4.02 (m, 
37H, 6xH2, 7xH3, 6xH4, 6xH5 and 12xH6); 3.23-3.28 (m, 1H); 3.15-3.20 (m, 1H, H2); 
3.00-3.09 (m, 2H, NHCH2  and H4); 2.90-2.95 (m, 1H, H5); 2.45-2.53 (m, 2H, 2xH6); 
2.43 (s, 3H, TsCH3); 2.12-2.22 (m, 1H, NHCH2); 1.73-1.77 (m, 1H, CH(CH3)2); 1.57-
1.63 (m, 1H, CHNHTs); 0.85 (d, J = 6.7, 3H, CH3); 0.63 (d, J = 6.9, 3H, CH3); ESI-MS 
(MeOH): positive ion mode: 1373 (50, [M+H]+); 1395 (100, [M+Na]+); negative ion 
mode: 1371 (100, M-) 
   
mono-6-deoxy-6-[N-(1-(R)-2,2-(R)-tosylsulfonamido-cyclohexyl)]-6-amino-β-
cyclodextrin (181) Following general Procedure A, 106 mg 
68 (0.09 mmol, 1.0 eq.) and 683 mg 255 (2.54 mmol, 30 eq.) 
were stirred in 0.5 ml DMF for 12 h. After three precipitations 
in acetone and washing with very little ice cold water, one 
obtained 63 mg of pure 181 (54% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.20; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 7.66 (d, J = 8.2, 2H, Har); 7.50 (d, J = 8.2, 2H, 
Har); 5.07-5.10 (m, 2H, 2xH1); 5.05 (d, J = 3.3, 1H, H1); 5.02 (d, J = 3.5, 1H, H1); 4.95-
4.98 (m, 2H, 2xH1); 4.92 (d, J = 3.3, 1H, H1); 3.45-4.10 (m, 40H, 7xH2, 7xH3, 7xH4, 
7xH5 and 12xH6); 3.10-3.20 (m, 2H, 2xH6); 2.76-2.88 (m, 1H, NHCH); 2.76-2.88 (m, 
1H, CHNHTs); 2.43 (s, 3H, TsCH3); 1.86-1.98 (m, 1H, cyclohexane ring); 1.73-1-85 
(m, 1H, cyclohexane ring); 1.53-1.65 (m, 2H, cyclohexane ring); 1.42-1.53 (m, 1H, 
cyclohexane ring); 1.27-1.42 (m, 3H, cyclohexane ring); ESI-MS (MeOH): positive ion 
mode: 1407 (100, [M+Na]+); negative ion mode: 1383 (100, M-) 
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mono-6-deoxy-6-[N-(1-(S)-2,2-(S)-tosylsulfonamido-cyclohexyl)]-6-amino-β-
cyclodextrin (180) Following general Procedure A, 74 mg 
68 (0.06 mmol, 1.0 eq.) and 480 mg 254 (1.79 mmol, 30 eq.) 
were stirred in 0.5 ml DMF for 12 h. After three precipitations 
in acetone and washing with very little ice cold water, one 
obtained 36 mg of pure 180 (44% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.18; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 7.65 (d, J = 8.1, 2H, Har); 7.48 (d, J = 8.2, 2H, 
Har); 4.91-5.10 (m, 7H, 7xH1); 3.41-4.11 (m, 40H, 7xH2, 7xH3, 7xH4, 7xH5 and 12xH6); 
3.10-3.30 (broad, 3H, 2xH6 NHCH); 2.45-2.52 (m, 4H, TsCH3 and CHNHTs); 1.51-
1.81 (m, 4H, cyclohexane ring); 1.12-1.41 (m, 4H, cyclohexane ring); ESI-MS 
(MeOH): positive ion mode: 1407 (100, [M+Na]+); negative ion mode: 1383 (100, M-) 
 
mono-6-deoxy-6-[N-methylsulfonamidoethyl)]-6-amino-β-cyclodextrin (186) 
Following general Procedure B, 70 mg 68 (0.05 mmol, 1.0 eq.) 
and 60 mg 183 (0.44 mmol, 8.0 eq.) were dissolved in 0.75 ml 
DMSO. The mixture was stirred in the microwave for 2 h at 85°C 
(90 Watt). After one precipitation in acetone, the crude product 
was purified over IRA-68 ion exchange resin using water as eluent. One obtained 37 
mg of pure 186 (40% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.21; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 5.01-5.10 (m, 7H, 7xH1); 3.79-4.01 (m, 26H, 7xH3, 
7xH5 and 12xH6); 3.53-3.68 (m, 13H, 7xH2 and 6xH4); 3.38-3.42 (m, 1H, H4); 3.17-
3.23 (m, 2H, CH2Ms); 3.04-3.12 (m, 4H, H6 and MsCH3); 2.75-2.85 (m, 3H, H6 and  
2xNHCH2); ESI-MS (MeOH): positive ion mode: 1255 (100, [M+H]+); 1277 (57, 
[M+Na]+); negative mode: 1253 (100, M-) 
 
mono-6-deoxy-6-[N-(2,2-(S)-methyl-methylsulfonamidoethyl)]-6-amino-β-
cyclodextrin (187) Following general Procedure B, 125 mg 68 
(0.09 mmol, 1.0 eq.) and 74 mg 184 (0.49 mmol, 5.0 eq.) were 
dissolved in 0.75 ml DMSO. The mixture was stirred in the 
microwave for 2h at 85°C (100 Watt). After one precipitation in 
acetone, the crude product was purified over IRA-68 ion exchange resin using water 
as eluent. One obtained 86 mg of pure 187 (70% yield) as white crystals. 
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TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.22; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 4.99-5.09 (m, 7H, 7xH1); 3.77-4.00 (m, 26H, 7xH3, 
7xH5 and 12xH6); 3.51-3.69 (m, 13H, 7xH2 and 6xH4); 3.38-3.43 (m, 1H, H4); 3.17-
3.23 (m, 2H, CHMs); 3.04-3.12 (m, 4H, H6 and MsCH3); 2.75-2.85 (m, 3H, H6 and 
2xNHCH2); 0.88 (d, J = 6.5, 3H, CH3) ESI-MS (MeOH): positive ion mode: 1269 (100, 
[M+H]+); 1291 (60, [M+Na]+) 
 
mono-6-deoxy-6-[N-(2,2-(S)-isopropyl-methylsulfonamidoethyl)]-6-amino-β-
cyclodextrin (188) Following general Procedure B, 59 mg 68 
(0.04 mmol, 1.0 eq.) and 66 mg 185 (0.37 mmol, 8.0 eq.) were 
dissolved in 0.75 ml DMSO. The mixture was stirred in the 
microwave for 2 h at 80°C (90 Watt). After one precipitation in 
acetone, the crude product was purified over IRA-68 ion 
exchange resin using water as eluent. One obtained 27 mg of pure 188 (47% yield) 
as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.20; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 5.00-5.10 (m, 7H, 7xH1); 3.50-4.20 (m, 41H, 7xH2, 
7xH3, 6xH4, 7xH5 and 14xH6); 3.41-3.47 (m, 1H, H4); 3.16 (s, 3H, MsCH3); 3.01-3.15 
(broad, 2H, CHMs); 2.10-2.20 (m, 2H, NHCH2); 1.82-1.91 (m, 1H, CH(CH3)2); 0.90-
1.01 (m, 6H, 2xCH3); ESI-MS (MeOH): positive ion mode: 1295 (100, [M+H]+); 
negative mode: 1297 (100, M-) 
 
mono-6-deoxy-6-[N-(2,2-(S)-isopropyl-trifluoromethylsulfonamidoethyl)]-6-
amino-β-cyclodextrin (196) Following general Procedure B, 59 
mg 68 (0.05 mmol, 1.0 eq.), 222 mg 195 (0.95 mmol, 20 eq.) and 
0.18 ml ethyldiisopropylamine (1.04 mmol, 22 eq.) were 
dissolved in 0.75 ml DMSO. The mixture was stirred in the 
microwave for 3 h at 85°C (100 Watt). After two precipitations in 
acetone, one obtained 34 mg of pure 196 (53% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.17; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 5.03-5.10 (m, 7H, 7xH1); 4.17-4.26 (m, 1H, H5); 
3.70-4.05 (m, 25H, 7xH3, 6xH5 and 12xH6); 3.52-3.69 (m, 14H, 7xH2, 6xH4 and 1xH6); 
3.44-3.51 (m, 1H, H4); 3.20-3.27 (m, 2H, H6 and CHNHMs); 3.04-3.12 (m, 1H, 
NHCH); 2.87-2.93 (m, 1H, NHCH); 1.70-1.77 (m, 1H, CH(CH3)2);  0.86-0.97 (m, 6H, 
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2xCH3); ESI-MS (MeOH): positive ion mode: 1373 (100, [M+Na]+); negative mode: 
1349 (100, M-) 
5.2.3.3 Linkage of α-Pycolyl Amines 
 
mono-6-deoxy-6-[N-(N-2-pyridyl)-methyl]-6-amino-β-cyclodextrin (β-CD-ampy) 
(198) Following general Procedure A, 170 mg 68 (0.14 mmol, 1.0 
eq.) and 0.46 ml pyridin-2-ylmethanamine 197 (4.37 mmol, 30 eq.) 
were stirred for 12 h. After three precipitations in acetone, one 
obtained 80 mg of pure 198 (48% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.20; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 8.49 (d, J = 4.6, 1H, H6py); 7.87 (dxt, J = 1.8, 7.8, 
1H, H4py); 7.44 (d, J = 7.8, 1H, H3py); 7.41 (dxd, J = 5.2, 7.2, 1H, H5py); 5.04-5.12 (m, 
7H, 7xH1); 3.74-4.02 (m, 28H, 7xH3, 7xH5,12xH6 and NHCH2); 3.54-3.70 (m, 13H, 
7xH2 and 6xH4); 3.36-3.42 (m, 1H, H4); 3.00-3.07 (m, 1H, H6); 2.82-2.91 (m, 1H, H6); 
ESI-MS (MeOH): positive ion mode: 1225 (100, [M+H]+)  
 
mono-6-deoxy-6-[N-(1-(R)-methyl-pyridylmethyl]-6-amino-β-cyclodextrin (208) 
Following general Procedure A, 80 mg 68 (0.06 mmol, 1.0 eq.) and 
236 mg 202 (1.93 mmol, 30 eq.) were stirred in 0.2 ml DMF for 12 
h at 70°C. After three precipitations in acetone, one obtained 51 
mg of pure 208 (64% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.22; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 8.45 (d, J = 4.7, 1H, H6py); 7.80 (dxt, J = 1.5, 7.9, 
1H, H4py); 7.33-7.39 (m, 2H, H3py and H5py); 4.95-5.05 (m, 7H, 7xH1); 3.40-3.98 (m, 
40H, 7xH2, 7xH3, 6xH4, 7xH5, 12xH6 and NHCH); 3.22-3.30 (m, 1H, H4); 2.70-2.90 
(broad, 2H, 2xH6); 1.31 (d, J = 5.9, 3H, CH3); ESI-MS (MeOH): positive ion mode: 
1239 (66, [M+H]+); 1261 (100, [M+Na]+)    
 
mono-6-deoxy-6-[N-(1-(S)-methyl-pyridylmethyl]-6-amino-β-cyclodextrin (209) 
Following general Procedure A, 52 mg 68 (0.04 mmol, 1.0 eq.) and 
151 mg 201 (1.23 mmol, 30 eq.) were stirred in 0.2 ml DMF for 12 
h at 70°C. After three precipitations in acetone, one obtained 21 
mg of pure 209 (41% yield) as white crystals. 
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TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.22; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 8.50 (d, J = 4.7, 1H, H6py); 7.90 (dxt, J = 1.7, 7.8, 
1H, H4py); 7.33-7.41 (m, 2H, H3py and H5py); 4.92-5.12 (m, 7H, 7xH1); 3.40-4.05 (m, 
39H, 7xH2, 7xH3, 6xH4, 6xH5, 12xH6 and NHCH); 3.22-3.37 (m, 2H, H4 and H5); 2.50-
2.90 (broad, 2H, 2xH6); 1.33 (d, J = 6.0, 3H, CH3); ESI-MS (MeOH): positive ion 
mode: 1261 (100, [M+Na]+); negative ion mode: 1237 (100, M-)    
 
mono-6-deoxy-6-[N-(1-(R)-5,6,7,8-tetrahydroquinolin-8-amine)]-6-deoxy-β-
cyclodextrin (210) Following general Procedure A, 56 mg 68 (0.05 
mmol, 1.0 eq.) and 200 mg 206 (1.36 mmol, 30 eq.) were stirred in 
0.2 ml DMF for 12 h at 70°C. After three precipitations in acetone, 
one obtained 22 mg of pure 210 (39% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.22; mp: 
decomposition >275°C; 1H-NMR (500 MHz, D2O): 8.23 (d, J = 4.9, 1H, H6py); 7.48 (d, 
J = 7.9, 1H, H4py); 7.14 (dxd, J = 4.9, 7.9,  1H, H5py); 4.97-5.09 (m, 7H, 7xH1); 3.36-
3.99 (m, 39H, 7xH2, 7xH3, 6xH4, 6xH5, 12xH6 and NHCH); 3.27-3.33 (m, 1H, H4); 
3.02-3.08 (d, J = 11.4, 1H, H5); 2.60-2.71 (m, 3H, 2xH6 and NHCHCH2CH2CH2Car); 
2.41-2.48 (m, 1H, NHCHCH2CH2CH2Car); 1.98-2.07 (m, 1H, NHCHCH2CH2CH2Car); 
1.75-1.85 (m, 1H, NHCHCH2CH2CH2Car); 1.98-2.07 (m, 2H, NHCHCH2CH2CH2Car); 
ESI-MS (MeOH): positive ion mode: 1265 (100, [M+H]+); 1287 (100, [M+Na]+); 
negative ion mode: 1263 (100, M-) 
 
mono-6-deoxy-6-[N-(1-(S)-5,6,7,8-tetrahydroquinolin-8-amine)]-6-deoxy-β-
cyclodextrin (211) Following general Procedure A, 67 mg 68 (0.05 
mmol, 1.0 eq.) and 238 mg 207 (1.62 mmol, 30 eq.) were stirred in 
0.2 ml DMF for 12 h at 70°C. After three precipitations in acetone, 
one obtained 35 mg of pure 211 (51% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.22; mp: 
decomposition >275°C; 1H-NMR (500 MHz, D2O): 8.39 (d, J = 4.6, 1H, H6py); 7.64 
(m, 1H, H4py); 7.33 (dxd, J = 4.9, 7.9,  1H, H5py); 4.99-5.11 (m, 7H, 7xH1); 3.50-4.02 
(m, 39H, 7xH2, 7xH3, 6xH4, 6xH5, 12xH6 and NHCH); 3.39-3.48 (m, 1H, H4); 3.20-3.29 
(m, 1H, H5); 2.65-3.00 (m, 4H, 2xH6 and NHCHCH2CH2CH2Car); 2.13-2.22 (m, 1H, 
NHCHCH2CH2CH2Car); 1.89-2.01 (m, 1H, NHCHCH2CH2CH2Car); 1.70-1.85 (m, 2H, 
NHCHCH2CH2CH2Car); ESI-MS (MeOH): positive ion mode: 1265 (100, [M+H]+)  
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mono-6-deoxy-6-[N-(3-chloro-N-2-pyridyl)-methyl]-6-amino-β-cyclodextrin (216) 
Following general Procedure A, 75 mg 68 (0.06 mmol, 1.0 eq.) 
and 258 mg 212 (1.81 mmol, 30 eq.) were stirred in 0.2 ml DMF 
for 12 h at 70°C. After three precipitations in acetone, one 
obtained 35 mg of pure 216 (51% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.23; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 7.87 (t, J = 7.9, 1H, H4py); 7.37-7.42 (m, 2H, H3py 
and H5py); 4.95-5.10 (m, 7H, 7xH1); 3.45-4.10 (m, 40H, 7xH2, 7xH3, 6xH4, 6xH5, 
12xH6 and NHCH2); 3.32-3.39 (m, 2H, H4 and H5); 2.80-3.13 (broad, 2H, 2xH6); ESI-
MS (MeOH): positive ion mode: 1259 (18, [M+Na]+); 1281 (100, [M+Na]+);  
 
 mono-6-deoxy-6-[N-(3-fluoro-N-2-pyridyl)-methyl]-6-amino-β-cyclodextrin (217) 
Following general Procedure A, 103 mg 68 (0.08 mmol, 1.0 eq.) 
and 260 mg 215 (2.06 mmol, 25 eq.) were stirred in 0.5 ml DMF for 
12 h at 70°C. After one precipitation in acetone, the crude product 
was purified by reversed phase chromatography using water as 
eluent. One obtained 25 mg of pure 217 (25% yield) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O 7:7:5:4): Rf = 0.21; mp: decomposition 
>275°C; 1H-NMR (500 MHz, D2O): 8.03 (dxd, J = 7.9, 8.0, 1H, H4py); 7.39 (dxd,         
J = 1.9, 7.7, 1H, H3py); 7.14 (dxd, J = 1.6, 8.2, 1H, H5py); 5.00-5.14 (m, 7H, 7xH1); 
3.48-4.02 (m, 42H, 7xH2, 7xH3, 6xH4, 6xH5, 14xH6 and NHCH2); 3.39-3.45 (m, 2H, H4 
and H5); ESI-MS (MeOH): positive ion mode: 645.5 (81, [M+Na]2+); 1243 (67, 
[M+H]+); 1265 (67, [M+Na]+); negative mode: 620 (75, M2-); 1241 (100 M-) 
   
5.2.4 Synthesis of Cyclodextrin modified on Secondary Face[65] 
 
heptakis(6-O-tert.-butyldimethylsilyl)-β-CD (218) To a solution of dry β-CD 52 
(1.00 g, 0.88 mmol) in dry pyridine (20 ml) was added the solution of 
TBDMSCl (1.19 g, 7.50 mmol) in 10 ml pyridine dropwise over a 
period of  90 minutes at 0oC. The reaction mixture was stirred at room 
temperature for 20 h and then poured into ice-water and stirred 
vigorously for 10 minutes. The resulting precipitate was filtered, washed with ice-
water and dissolved in ethyl acetate. The organic solution was washed with 1M HCl, 
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saturated NaHCO3, brine and dried over Na2SO4. The resulting crude product was 
purified by column chromatography (SiO2, EtOAc/EtOH/H2O = 50:4:2) yielding 1.31 g 
218 (77% yield) as a white solid. 
TLC (SiO2, EtOAc/EtOH/H2O = 50:7:4): Rf = 0.38; 1H-NMR (400 MHz, Toluene-D8): 
7.25 (s, 7H, C(3)-OH), 5.83 (s, 7H, C(2)-OH), 4.93 (d, J = 3.3, 7H, C(1)-H), 4.31 (t,    
J = 9.1, 7H, C(3)-H), 4.07 (dxd, J = 11.0, 3.0, 7H, C(6)-H), 3.88 (d, J = 11, 7H, C(6)-
H), 3.78 (d, J = 9.5, 7H, C(5)-H), 3.72 (dxd, J = 9.6, 3.5, 7H, C(2)-H), 3.63 (t, J = 9.1, 
7H, C(4)-H), 1.02 (s, 63H, CH3C), 0.2-0.18 (42H, CH3Si); 13C-NMR (100 MHz, 
Toluene-D8): 102.8 (C(1)), 82.69 (C(4)), 74.36 (C(2)), 74.13 (C(3)), 73.02 (C(5)), 
62.49 (C(6)), 26.26 (CH3C), 18.71 (CH3C), -4.66 (CH3Si), -4.84 (CH3Si); ESI-MS 
(CH2Cl2/MeOH): positive ion mode: 989.7 (67, [M+2Na]2+); 1956.1 (100, [M+Na]+) 
 
mono(2-O-tosyl) heptakis(6-O-tert.-butyldimethylsilyl)-β-CD (71) 5.50 g 218 (2.84 
mmol, 1.0 eq.) were dissolved in 35 ml THF. After 
addition of 114 mg NaH (2.84 mmol, 1.0 eq., 60% 
suspension in oil), the mixture was stirred at 50°C for 2 
h. 635 mg 1-tosyl-1,2,4-triazole (2.84 mmol, 1.0 eq.) 
dissolved in 20 ml THF were added over a period of 4 h 
at r.t. The mixture was stirred for 12 h at r.t. THF was 
removed under reduced pressure and the residue dissolved in EtOAc. The organic 
phase was washed with water, 1M HCl, brine, saturated NaHCO3, and dried over 
Na2SO4. The resulting crude product was purified by column chromatography (SiO2, 
EtOAc/EtOH/H2O = 50:5:1.5) yielding 1.72 g 71 (29% yield) as a white solid. 
TLC (SiO2, EtOAc/EtOH/H2O = 50:7:4): Rf = 0.45; 1H-NMR (500 MHz, Toluene-D8): 
8.18 (d, J = 10.1, 2H, Har); 7.08-7.18 (2H, Har hidden by solvent); 6.98-7.06 (s, 1H, 
C(3)-OH); 6.84 (s, 1H, C(3)-OH); 6.68 (s, 1H, C(3)-OH); 6.50 (s, 1H, C(3)-OH); 5.92 
(s, 1H, C(2)-OH); 5.83 (s, 1H, C(2)-OH); 5.66 (s, 1H, C(2)-OH); 5.59 (broad, 1H, 
C(2)-OH); (m, 2H, C(2)-OH); 5.42 (s, 1H, C(2)-OH); 5.08 (s, 1H, H1); 4.94 (s, 5H, H1); 
4.80 (s, 1H, H1); 4.55-4.67 (m, 3H); 4.47-4.54 (m, 1H, H2); 3.59-4.41 (m, 43H); 3.38-
3.50 (broad, 1H, H2); 3.09 (t, J = 6.8, 1H, H4); 2.16 (s, 3H, CH3); 0.91-1.15 (m, 63H, 
CH3C), 0.11-0.29 (m, 42H, CH3Si); ESI-MS (CH2Cl2/MeOH): positive ion mode: 1067 
(14, [M+2Na]2+); 2110 (100, [M+Na]+); negative ion mode: 2087 (100, M-) 
 
O
OO
HO OH
OTBMDS
O
OO
OTBMDS
HO O
S
O
O
5 Experimental Part  128 
mono-manno-(2A,3A-anhydro) heptakis(6-O-tert.-butyldimethylsilyl)-β-CD (70) 
2.20 71 (1.05 mmol, 1.0 eq.) and 79 mg sodium ethylate 
(1.16 mmol, 1.1 eq.) were refluxed in 10 ml EtOH for    
16 h. The reaction mixture was poured into 25 ml 
icewater and filtered. The resulting crude product was 
purified by column chromatography (SiO2, ethyl acetate/EtOH/H2O = 50:4:2) yielding 
1.72 g 70 (83% yield) as a white solid. 
TLC  (SiO2, EtOAc/EtOH/H2O = 50:4:2): Rf = 0.38; 1H-NMR (400 MHz, CDCl3): 6.61-
6.63 (m, 2H); 6.57 (s, 1H); 6.32 (s, 1H); 6.24 (s, 1H); 5.30 (s, 1H); 5.25 (s, 1H); 5.20 
(s, 2H, H1); 5.17 (s, 1H); 4.97-4.99 (m, 2H); 4.89-4.92 (m, 5H); 4.37 (d, J = 9.9, 1H, 
H6); 3.51-4.00 (m, 42 H); 3.37 (d, J = 3.3, 1H, H3); 3.19 (d, J = 3.3, 1H, H2); 0.87 (m, 
63H, CH3C), 0.03 (m, 42H, CH3Si); 13C-NMR (126 MHz, CDCl3): 102.3, 102.3, 102.1, 
102.0, 101.4, 99.4, 96.3, 81.9, 81.5, 81.4, 80.8, 78.4, 77.4, 73.8, 73.7, 73.7, 73.6, 
73.6, 73.5, 72.9, 72.7, 72.6, 72.6, 72.4, 72.3, 72.0, 69.9, 68.6, 64.0, 62.0, 61.7, 61.6, 
61.6, 61.4, 53.2, 49.2, 26.0, 18.4-18.6, (-5.0)-(-4.9); ESI-MS (CH2Cl2/MeOH): positive 
ion mode: 1938 (100, [M+Na]+); negative ion mode: 1915 (100, M-) 
 
mono-3-(O-naphtyl)-β-CD (227) 3.50 g β-Cyclodextrin 52 (3.10 mmol, 1.0 eq.) were 
dissolved in 50 ml 30% aqueous acetonitrile and 
adjusted to pH 12 with 2M NaOH. 3.5 g β-
naphtalenesulfonyl chloride 226 (15.43 mmol, 5.0 eq.) 
were added and stirred at 40°C till the pH value dropped 
down to 8. After filtration, the filtrate was purified by RP-
18 chromatography (gradient: 150 ml water only to 20% 
acetonitril), yielding 250 mg 227 (yield 6%) as a white powder.   
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.56; 1H-NMR (500 MHz, 
D2O): 8.59 (s, 1H); 8.20 (d, J = 9.0, 1H); 8.10 (m, 1H); 8.01 (d, J = 7.6, 1H); 7.95 (d,  
J = 7.6, 1H); 7.70-7.81 (m, 2H); 4.88-5.11 (m, 7H, 7xH1); 4.02-4.17 (m, 2H); 3.62-
4.00 (m, 38H); 3.27-3.40 (m, 2H); ESI-MS (MeOH): positive ion mode: 1347 (100, 
[M+Na]+); negative ion mode: 1323 (100, M-) 
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mono-allo-(2A,3A-anhydro) heptakis(6-O-tert.-butyldimethylsilyl)-β-CD (228)  250 
mg 227 (0.19 mmol) were stirred in 25 ml water 
containing 62 mg K2CO3 for 4 h at r.t. The solution was 
neutralized using 1M HCl and purified by RP-18 
chromatography (gradient: 150 ml water only to 5% 
acetonitril), yielding 193 mg 228 (yield 93%) as a white powder.   
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.12; 1H-NMR (500 MHz, 
D2O): 5.33 (d, J =3.4, 1H, H1); 5.01-5.10 (m, 6H, 6xH1); 4.09-4.14 (dxd, J = 1.9, 9.4, 
1H); 3.55-4.02 (m, 41H); ESI-MS (MeOH): positive ion mode: 1139 (100, [M+Na]+); 
negative ion mode: 1115 (100, M-) 
5.2.4.1 Linkage of Amino alcohols, Monotosylated Diamines, α-Pycolyl Amines 
and Alkyl Amines  
mono-3-deoxy-3-[N-2-hydroxyethyl] heptakis(6-O-tert.-butyldimethylsilyl)-3-
amino-β-CD (219). 145 mg 70 (0.08 mmol, 1.0 eq.) and 
0.11 ml aminoethanol 79 (1.98 mmol, 25 eq.) were 
refluxed for 3 h in 1.0 ml ethanol. The solvent was 
removed at reduced pressure, the residue dissolved in 
DCM and washed with water. The organic phase was 
dried over Na2SO4 and purified by column 
chromatography (SiO2, EtOAc/EtOH/H2O = 50:7:4), yielding 90 mg 219 (yield 60%) 
as white crystals.  
TLC (SiO2, EtOAc/EtOH/H2O = 50:7:4 Rf = 0.21; 1H-NMR (500 MHz, CDCl3): 4.86-
4.94 (m, 5H, 5xH1); 4.82 (d, J = 3.6, 1H, H1); 4.50 (d, J = 7.3, 1H, H1); 3.43-4.13 (m, 
43 H); 2.70-2.78 (m, 2H, NHCH2 and H3); 2.67 (m, 1H, NHCH2); 0.88 (m, 63H, 
CH3C), 0.01 (m, 42H, CH3Si); 13C-NMR (126 MHz, CDCl3): 105.7, 103.0, 102.7, 
102.5, 102.1, 101.6, 82.2, 81.7, 81.5, 81.4, 80.9, 80.5, 78.4, 74.6, 74.3, 74.1, 74.0, 
73.9, 73.8, 73.7, 72.6, 72.5, 72.0, 71.5, 62.0, 61.8, 61.7, 61.6, 60.9, 60.6, 26.2, 26.1, 
26.0, 25.9, 18.5, 18.4, 18.1, -4.8, -4.9, -5.0, -5.1, -5.3; ESI-MS (MeOH): positive ion 
mode: 1978 (68, [M+H]+); 1988.5 (48, [2M+Na]+); 2000 (100, [M+Na]+); negative ion 
mode: 1946 (100, M-) 
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mono-3-deoxy-3-[N-2-hydroxyethyl]-3-amino-β-cyclodextrin (β-CD-AE-2F) (220) 
77 mg 219 (0.04 mmol, 1.0 eq.) and 51 mg ammonium fluoride (1.38 
mmol, 35 eq.) were refluxed in 2 ml MeOH for 2 h. After removal of the 
solvent, the crude product was purified by RP-18 chromatography 
(gradient: water only to 25% MeOH), yielding 34 mg 220 (yield 73%) as 
white crystals.  
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.21; 1H-NMR (500 MHz, 
D2O): 5.18 (d, J = 4.0, 1H, H1); 5.15 (d, J = 3.9, 1H, H1); 5.11 (d, J = 3.9, 1H, H1); 
5.01-5.07 (m, 4H, 4xH1); 4.34 (m, 1H, H4); 4.30 (m, 1H, H5); 3.50-4.02 (m, 42H, 7xH2, 
7xH3, 6xH4, 6xH5, 14xH6 and NHCH2CH2OH); 3.30-3.42 (m, 2H, NHCH2CH2OH); 
ESI-MS (MeOH): positive ion mode: 1178 (100, [M+H]+)  
mono-3-deoxy-3-[N-(2,2-(R)-methyl-hydroxyethyl)] heptakis(6-O-tert.-
butyldimethylsilyl)-3-amino-β-CD (270) 150 mg 70 
(0.08 mmol, 1.0 eq.) and 29 mg (R)-1-aminopropan-2-ol 
(0.40 mmol, 5 eq.) were refluxed for 3 h in 1.0 ml 
ethanol. The solvent was removed at reduced pressure, 
the residue dissolved in DCM and washed with water. 
The organic phase was dried over Na2SO4 and purified by column chromatography 
(SiO2, EtOAc/EtOH/H2O = 6:1:0.6), yielding 117 mg 270 (yield 75%) as white 
crystals.  
TLC (SiO2, EtOAc/EtOH/H2O = 50:7:4) Rf = 0.13; 1H-NMR (500 MHz, CDCl3): 4.85-
4.94 (m, 5H, 5xH1); 4.83 (d, J = 3.9, 1H, H1); 4.49 (d, J = 7.3, 1H, H1); 3.53-4.18 (m, 
39 H); 3.38-3.51 (m, 2 H); 2.85-2.92 (m, 1H); 2.45-2.65 (m, 3H, H3 and 2xNHCH2); 
1.12 (d, J = 6.2, 3H, CH3); 0.80-0.90 (m, 63H, CH3C), 0.00-0.10 (m, 42H, CH3Si); 
13C-NMR (126 MHz, CDCl3): 105.6, 103.1, 102.9, 102.6, 102.3, 101.8, 101.2, 83.2, 
81.9, 81.7, 81.5, 80.8, 80.6, 80.2, 74.4, 74.3, 74.0, 73.7, 73.4, 71.8, 71.5, 65.3, 62.2, 
62.0, 61.8, 61.7, 61.6, 59.8, 55.6, 25.9-26.2, 18.1-20.6, (-5.0)-(-4.8)  ESI-MS (MeOH): 
positive ion mode: 2014 (100, [M+Na]+); negative ion mode: 1990 (100, M-) 
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mono-3-deoxy-3-[N-(2,2-(R)-methyl-hydroxyethyl)]-3-amino-β-CD (224) 104 mg 
270 (0.05 mmol, 1.0 eq.) and 0.47 ml of 1M TBAF in THF (0.47 mmol, 
9.0 eq.) were refluxed in 2 ml THF for 4 h. After removal of the solvent, 
the crude product was dissolved in 2 ml water and extracted 5 times 
with chloroform. The aqueous phase was purified by CG-50 ion 
exchange chromatography (water), yielding 26 mg 224 (yield 56%) as white crystals.  
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.20; 1H-NMR (500 MHz, 
D2O): 5.19 (d, J = 4.1, 1H, H1); 5.16 (d, J = 3.8, 1H, H1); 5.12 (d, J = 3.9, 1H, H1); 
5.02-5.10 (m, 4H, 4xH1); 4.36 (m, 1H, H4); 4.30 (m, 1H, H5); 4.15 (m, 1H, 
CH(CH3)OH); 3.51-4.05 (m, 40H, 7xH2, 7xH3, 6xH4, 6xH5, 14xH6); 3.38-3.44 (m, 1H, 
NHCH2CH(CH3)OH); 3.06-3.16 (m, 1H, NHCH2CH(CH3)OH); ESI-MS (MeOH): 
positive ion mode: 1192 (100, [M+H]+) 
mono-3-deoxy-3-[N-(2,2-(S)-methyl-hydroxyethyl)] heptakis(6-O-tert.-
butyldimethylsilyl)-3-amino-β-CD (271) 175 mg 70  
(0.09 mmol, 1.0 eq.) and 69 mg (R)-1-aminopropan-2-ol 
(0.90 mmol, 10 eq.) were refluxed for 3 h in 1.0 ml 
ethanol. The solvent was removed at reduced pressure, 
the residue dissolved in DCM and washed with water. 
The organic phase was dried over Na2SO4 and purified by column chromatography 
(SiO2, EtOAc/EtOH/H2O = 6:1:0.6), yielding 140 mg 271 (yield 77%) as white 
crystals.  
TLC (SiO2, EtOAc/EtOH/H2O = 50:7:4) Rf = 0.12; 1H-NMR (500 MHz, CDCl3): 4.85-
4.95 (m, 5H, 5xH1); 4.84 (d, J = 3.8, 1H, H1); 4.50 (d, J = 7.2, 1H, H1); 3.54-4.18 (m, 
39 H); 3.38-3.51 (m, 2H); 2.86-2.94 (m, 1H); 2.47-2.66 (m, 3H, H3 and 2xNHCH2); 
1.12 (d, J = 6.3, 3H, CH3); 0.82-0.90 (m, 63H, CH3C), 0.01-0.11 (m, 42H, CH3Si); 
ESI-MS (MeOH): positive ion mode: 2014 (100, [M+Na]+); negative ion mode: 1990 
(100, M-) 
 
mono-3-deoxy-3-[N-(2,2-(S)-methyl-hydroxyethyl)]-3-amino-β-CD (223) 128 mg 
271 (0.06 mmol, 1.0 eq.) and 0.64 ml of 1M TBAF in THF (0.64 mmol, 
10 eq.) were refluxed in 2 ml THF for 4 h.  After removal of the solvent, 
the crude product was dissolved in 2 ml water and extracted 5 times 
with chloroform. The aqueous phase was purified by CG-50 ion 
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exchange chromatography (water), yielding 42 mg 223 (yield 55%) as white crystals.  
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.20; 1H-NMR (500 MHz, 
D2O): 5.20 (d, J = 4.1, 1H, H1); 5.17 (d, J = 3.8, 1H, H1); 5.13 (d, J = 3.9, 1H, H1); 
5.04-5.11 (m, 4H, 4xH1); 4.38 (m, 1H, H4); 4.33 (m, 1H, H5); 4.17 (m, 1H, 
CH(CH3)OH); 3.53-4.07 (m, 40H, 7xH2, 7xH3, 6xH4, 6xH5, 14xH6); 3.40-3.45 (m, 1H, 
NHCH2CH(CH3)OH); 3.08-3.17 (m, 1H, NHCH2CH(CH3)OH); ESI-MS (MeOH): 
positive ion mode: 1192 (100, [M+H]+); positive ion mode: 1190 (100, M-) 
 
mono-3-deoxy-3-[N-2-hydroxyethyl]-3-amino-β-cyclodextrin (all glucose) (225) 
100 mg 228 (0.09 mmol, 1.0 eq.) and 0.1 ml aminoethanol (1.80 mmol, 
20 eq.) were stirred in 1 ml DMF for 12 h at 85°C. After removal of the 
solvent, the crude product was precipitated in acetone, filtarted and 
finally purified by RP-18 chromatography (2%-gradient: water only to 
35% MeOH), yielding 34 mg 228 (yield 34%) as white crystals.  
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.17; ESI-MS (MeOH): 
positive ion mode: 1178 (100, [M+H]+); positive ion mode: 1176 (100, M-)   
mono-3-deoxy-3-[N-methyl] heptakis(6-O-tert.-butyldimethylsilyl)-3-amino-β-CD 
(272) 118 mg 70 (0.06 mmol, 1.0 eq.) and 0.23 ml of 8M 
methyl amine in EtOH (1.85 mmol, 30 eq.) were stirred in 
0.75 ml EtOH in the microwave for 6 h at 82 °C. After 
removal of solvent and excess methyl amine, the residue 
was dissolved in DCM and washed with water. The 
organic phase was dried over Na2SO4 and purified by column chromatography (SiO2, 
EtOAc/EtOH/H2O/Et3N = 50:7:4:0.6), yielding 77 mg 272 (yield 64%) as white 
crystals. 
TLC (SiO2, EtOAc/EtOH/H2O/Et3N = 50:7:4:0.6) Rf = 0.17; 1H-NMR (500 MHz, 
CDCl3): 4.85-4.94 (m, 5H, 5xH1); 4.81 (d, J = 3.6, 1H, H1); 4.48 (d, J = 7.3, 1H, H1); 
3.40-4.16 (m, 40 H); 3.01-3.09 (m, 1H); 2.60-2.67 (m, 1H) 2.38 (broad, 3H, CH3); 
0.84-0.90 (m, 63H, CH3C), 0.01-0.05 (m, 42H, CH3Si); ESI-MS (MeOH): positive ion 
mode: 1948 (100, [M+H]+) 
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mono-3-deoxy-3-[N-methyl]-3-amino-β-CD (232) 77 mg 272 (0.04 mmol, 1.0 eq.) 
and 51 mg ammonium fluoride (1.38 mmol, 35 eq.) were refluxed in 2 ml 
MeOH for 2 h. After removal of the solvent, the crude product was purified 
by RP-18 chromatography (gradient: water only to 25% MeOH in 30 ml 
fractions), yielding 34 mg 232 (yield 73%) as white crystals. 
 TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.15; 1H-NMR (500 MHz, 
D2O): 5.12-5.18 (m, 2H, 2xH1); 5.01-5.08 (m, 4H, 4xH1); 4.89 (d, J = 6.9, 1H, H1); 
4.36 (m, 1H, H5); 4.17 (m, 1H, H4); 3.52-4.02 (m, 39H, 7xH2, 6xH3, 6xH4, 6xH5, and 
14xH6); 3.02 (broad, 1H, H3); 2.51 (s, 3H, CH3); ESI-MS (MeOH): positive ion mode: 
585.5 (32, [M+H]2+); 1148 (100, [M+H]+); 1170 (48, [M+Na]+) 
mono-3-deoxy-3-amino-β-CD (235) 60 mg mono-3-deoxy heptakis(6-O-tert.-
butyldimethylsilyl)-3-amino-β-CD (0.03 mmol, 1.0 eq.) and 40 mg 
ammonium fluoride (1.01 mmol, 35 eq.) were refluxed in 2 ml MeOH for 2 
h. After removal of the solvent, the crude product was purified by RP-18 
chromatography (gradient: water only to 25% MeOH in 30 ml fractions), 
yielding 19 mg 235 (yield 54%) as white crystals. 
 TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.09; 1H-NMR (500 MHz, 
D2O): 5.15-5.18 (m, 2H, 2xH1); 5.01-5.09 (m, 4H, 4xH1); 4.87 (d, J = 6.7, 1H, H1); 
4.25 (m, 1H, H5); 3.51-4.01 (m, 40H, 7xH2, 6xH3, 7xH4, 6xH5, and 14xH6); 3.17 (m, 
1H, H3); ESI-MS (MeOH): 1134 (51, [M+H]+); 1156 (100, [M+Na]+) 
 
mono-3-deoxy-3-[N-ethyl)] heptakis(6-O-tert.-butyldimethylsilyl)-3-amino-β-CD 
(273) 62 mg 70 (0.04 mmol, 1.0 eq.) and 0.04 ml 
ethylamine (0.47 mmol, 15 eq.) were stirred in 1.0 ml 
EtOH for 12 h in microwave tube. After removal of 
solvent, the residue was dissolved in DCM and washed 
with water. The organic phase was dried over Na2SO4 and 
purified by column chromatography (SiO2, EtOAc/EtOH/H2O = 50:7:4), yielding 39 
mg 273 (yield 48%) as white crystals. 
TLC (SiO2, EtOAc/EtOH/H2O/Et3N = 50:7:4:0.6) Rf = 0.15; 1H-NMR (500 MHz, 
CDCl3): 4.84-4.95 (m, 6H, 6xH1); 4.58-4.63 (broad, 1H, H1); 3.40-4.18 (m, 42 H); 2.62 
(m, 1H); 2.46 (q, J = 7.3, 2H, NCH2CH3); 1.39 (t, J = 7.3, 3H, NCH2CH3); 0.84-0.90 
(m, 63H, CH3C), 0.01-0.09 (m, 42H, CH3Si); ESI-MS (MeOH): positive ion mode: 
1962 (100, [M+H]+); 1984 (16, [M+Na]+) 
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mono-3-deoxy-3-[N-ethyl)]-3-amino-β-CD (236) 39 mg 273 (0.02 mmol, 1.0 eq.) 
and 26 mg ammonium fluoride (0.700 mmol, 35 eq.) were refluxed in 2 ml 
MeOH for 2 h. After removal of the solvent, the crude product was purified 
by RP-18 chromatography (gradient: water only to 25% MeOH in 30 ml 
fractions), yielding 21 mg 236 (yield 90%) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.20; 1H-NMR (500 
MHz, D2O): 5.00-5.17 (m, 6H, 6xH1); 5.01 (d, J = 6.7, 1H, H1); 4.38 (m, 1H, H5); 3.56-
4.00 (m, 40H, 7xH2, 6xH3, 7xH4, 6xH5, 14xH6); 2.98 (m, 1H, H3); 2.81 (m, 1H, 
NHCH2CH3); 2.65 (m, 1H, NHCH2CH3); 0.98 (t, 3H, NHCH2CH3); ESI-MS (MeOH): 
positive ion mode: 593 (98, [M+Na]2+); 1162 (100, [M+H]+); 1184 (63, [M+Na]+) 
 
mono-3-deoxy-3-[N-(2-methylpropyl)] heptakis(6-O-tert.-butyldimethylsilyl)-3-
amino-β-CD (274) 60 mg 70 (0.03 mmol, 1.0 eq.) and 
0.05 ml isobutylamine (0.47 mmol, 15 eq.) were refluxed 
in 1.0 ml EtOH for 12 h. After removal of solvent, the 
residue was dissolved in DCM and washed with water. 
The organic phase was dried over Na2SO4 and purified by 
column chromatography (SiO2, EtOAc/EtOH/H2O = 50:7:4), yielding 53 mg 274 (yield 
86%) as white crystals. 
TLC (SiO2, EtOAc/EtOH/H2O = 50:7:4) Rf = 0.17; 1H-NMR (500 MHz, CDCl3): 4.85-
4.94 (m, 5H, 5xH1); 4.79 (d, J = 3.7, 1H, H1); 4.45 (d, J = 7.4, 1H, H1); 3.48-4.20 (m, 
42 H); 3.35-3.42 (m, 1H); 2.62 (m, 1H); 2.46 (d, J = 6.4, 2H, CH2CH(CH3)2); 1.67 
(broad, 1H, CH(CH3)2) 0.93 (d, J = 6.4, 6H, 2xCH3); 0.84-0.90 (m, 63H, CH3C), 0.01-
0.06 (m, 42H, CH3Si); 13C-NMR (126 MHz, CDCl3): 105.5, 103.4, 103.0, 102.6, 
102.4, 101.9, 101.4, 83.4, 81.9, 81.8, 81.7, 81.2, 80.9, 74.3, 74.1, 74.0, 73.9, 73.8, 
73.6, 73.5, 73.4, 72.6, 72.5, 71.8, 71.7, 62.3, 61.9, 61.8, 61.6, 61.4, 58.6, 55.0, 25.9-
26.8, 20.9, 20.4, 18.5, 18.4, 18.1, (-5.0)-(-4.8); ESI-MS (MeOH): positive ion mode: 
2012 (100, [M+Na]+) 
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mono-3-deoxy-3-[N-(2-methylpropyl)]-3-amino-β-CD (237) 53 mg 274 (0.03 mmol, 
1.0 eq.) and 0.21 ml of 1M TBAF in THF (0.21 mmol, 8 eq.) were refluxed 
in 2 ml THF for 4 h.  After removal of the solvent, the crude product was 
dissolved in 2 ml water and extracted 5 times with chloroform. The 
aqueous phase was purified by CG-50 ion exchange chromatography 
(water), yielding 16 mg 237 (yield 50%) as white crystals.  
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.22; 1H-NMR (500 MHz, 
D2O): 5.17 (d, J = 4.0, 1H, H1); 5.14 (d, J = 3.8, 1H, H1); 5.10 (d, J = 3.9, 1H, H1); 
5.04-5.07 (m, 2H, 2xH1); 5.03 (d, J = 3.4, 1H, H1); 5.00 (d, J = 6.7, 1H, H1); 4.35 (m, 
2H, H4 and H5); 3.53-4.01 (m, 40H, 7xH2, 7xH3, 6xH4, 6xH5, 14xH6); 3.01-3.12 (m, 
2H, NHCH2CH(CH3)2); 2.02-2.11 (m, 1H, NHCH2CH(CH3)2); 1.00 (d, J = 6.4, 6H, 
2xCH3); ESI-MS (MeOH): positive ion mode: 1190 (100, [M+H]+) 
 
mono-3-deoxy-3-[N-benzyl] heptakis(6-O-tert.-butyldimethylsilyl)-3-amino-β-CD 
(275) 60 mg 70 (0.03 mmol, 1.0 eq.) and 0.05 ml 
benzylamine (0.47 mmol, 15 eq.) were refluxed in 1.0 ml 
EtOH for 12 h. After removal of the solvent, the residue 
was dissolved in DCM and washed with water. The 
organic phase was dried over Na2SO4 and purified by 
column chromatography (SiO2, EtOAc/EtOH/H2O = 50:7:4), yielding 55 mg 275 (yield 
88%) as white crystals. 
TLC (SiO2, EtOAc/EtOH/H2O = 50:7:4) Rf = 0.54; 1H-NMR (500 MHz, CDCl3): 7.35-
7.38 (m, 2H, Har); 7.28-7.32 (m, 2H, Har); 7.21-7.25 (m, 1H, Har); 4.78-4.88 (m, 6H, 
6xH1); 4.40 (d, J = 7.4, 1H, H1); 3.38-4.15 (m, 43 H); 2.73 (dxd, J = 2.0, 10.8, 1H); 
0.84-0.89 (m, 63H, CH3C), 0.02-0.06 (m, 42H, CH3Si); 13C-NMR (126 MHz, CDCl3): 
139.2, 128.7, 128.6, 127.3, 105.5, 103.4, 103.0, 102.6, 102.4, 101.9, 101.4, 83.3, 
81.9, 81.8, 81.6, 81.2, 80.8, 78.1, 77.8, 74.4, 74.1, 73.9, 73.8, 73.6, 73.5, 73.4, 72.6, 
72.5, 71.8, 62.2, 62.0, 61.8, 61.6, 58.9, 51.4, 26.0-26.2, 18.4-18.5, (-5.1)-(-4.8); ESI-
MS (MeOH): positive ion mode: 2047 (100, [M+Na]+) 
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mono-3-deoxy-3-[N-benzyl]-3-amino-β-CD (238) 55 mg 275 (0.03 mmol, 1.0 eq.) 
and 0.22 ml of 1M TBAF in THF (0.22 mmol, 8 eq.) were refluxed in 2 
ml THF for 4 h.  After removal of the solvent, the crude product was 
dissolved in 2 ml water and extracted 5 times with chloroform. The 
aqueous phase was purified by CG-50 ion exchange chromatography 
(water), yielding 12 mg 238 (yield 36%) as white crystals.  
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.23; 1H-NMR (500 MHz, 
D2O): 7.48-7.54 (m, 5H, Har); 5.17 (d, J = 4.2, 1H, H1); 5.15 (d, J = 4.0, 1H, H1); 5.12 
(d, J = 3.7, 1H, H1); 5.05-5.07 (m, 2H, 2xH1); 5.03 (d, J = 3.6, 1H, H1); 4.97 (d, J = 
6.6, 1H, H1); 4.56 (d, J = 13.0, 1H, NHCH2Ph); 4.37 (d, J = 13.0, 1H, NHCH2Ph); 
4.30-4.36 (d, 2H, H4 and H5); 3.52-4.01 (m, 40H, 7xH2, 7xH3, 6xH4, 6xH5, 14xH6); 
ESI-MS (MeOH): positive ion mode: 1225 (100, [M+H]+) 
 
mono-3-deoxy-3-[N-2-tosylsulfonamidoethyl] heptakis(6-O-tert.-
butyldimethylsilyl)-3-amino-β-CD (276) 350 mg 70 
(0.18 mmol, 1.0 eq.) and 391 mg 154 (1.83 mmol, 10 
eq.) were refluxed in 3.0 ml EtOH for 12 h. After removal 
of the solvent, the residue was dissolved in DCM and 
washed with water. The organic phase was dried over 
Na2SO4 and purified by column chromatography (SiO2, 
EtOAc/EtOH/H2O = 50:7:4), yielding 350 mg 276 (yield 
95%) as white crystals. 
TLC (SiO2, EtOAc/EtOH/H2O = 50:8:5) Rf = 0.23; 1H-NMR (500 MHz, CDCl3): 7.73 
(d, J = 7.6, 2H, Har); 7.28 (d, J = 7.6, 2H, Har); 4.87-4.92 (m, 5H, 5xH1); 4.72 (broad, 
1H, H1); 4.48 (broad, 1H, H1); 3.48-4.12 (m,  41H); 3.42 (t, J = 9.2, 1H); 3.05 (broad, 
2H); 2.73 (broad, 2H); 2.50 (s, 3H, ArCH3); 0.84-0.89 (m, 63H, CH3C), 0.02-0.06 (m, 
42H, CH3Si); 13C-NMR (126 MHz, CDCl3): 129.9, 127.2, 105.3, 101.3-102.8, 80.4-
82.5, 71.9-73.8, 61.5-61.9, 47.4, 43.1, 42.6, 29.7, 26.0-26.2, 21.7, 18.3-18.4, (-5.1)-(-
4.8); ESI-MS (MeOH): positive ion mode:  2153 (100, [M+Na]+); negative ion mode: 
2129 (100, [M+Na]-); 
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mono-3-deoxy-3-[N-2-tosylsulfonamidoethyl]-3-amino-β-CD (230) 318 mg 276 
(0.15 mmol, 1.0 eq.) and 1.49 ml of 1M TBAF in THF (1.49 
mmol, 10 eq.) were refluxed in 2 ml THF for 4 h. After removal 
of the solvent, the crude product was dissolved in 2 ml water 
and extracted 5 times with chloroform. The aqueous phase 
was purified by CG-50 ion exchange chromatography (water), 
yielding 153 mg 230 (yield 77%) as white crystals. 
TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.21; 1H-NMR (500 MHz, 
D2O): 7.78 (d, J = 8.0, 2H, Har); 7.56 (d, J = 6.8, 2H, Har); 5.15 (d, J = 3.9, 1H, H1); 
5.11 (d, J = 3.6, 1H, H1); 5.08 (d, J = 3.6, 1H, H1); 5.05 (m, 1H, H1); 5.03 (d, J = 3.6, 
1H, H1); 5.00 (d, J = 3.8, 1H, H1); 4.94 (m,, 1H, H1); 4.35-4.45 (m, 2H, H4 and H5); 
3.35-4.13 (m, 42H, 7xH2, 7xH3, 6xH4, 6xH5, 14xH6 and CH2NHTs); 3.20-3.33 (m, 2H, 
CH2NH); 2.51 (s, 3H, CH3); ESI-MS (MeOH): positive ion mode: 676.5 (20, 
[M+Na]2+); 1331 (100, [M+H]+); 1353 (17, [M+Na]+); negative ion mode: 664 (18, M2-); 
1329 (100, M-); 1365 (29, [M+Na]-);   
 
mono-3-deoxy-3-[N-(N-2-pyridyl)-methyl] heptakis(6-O-tert.-butyldimethylsilyl)-
3-amino-β-CD (277) 200 mg 70 (0.10 mmol, 1.0 eq.) 
and 0.11 ml pyridin-2-ylmethanamine 197 (1.04 mmol, 
10 eq.) were refluxed in 2.5 ml EtOH for 12 h. After 
removal of the solvent, the residue was dissolved in 
DCM and washed with water. The organic phase was 
dried over Na2SO4 and purified by column chromatography (SiO2, EtOAc/EtOH/H2O = 
50:8:4), yielding 60 mg 277 (yield 29%) as white crystals. 
TLC (SiO2, EtOAc/EtOH/H2O = 50:8:4) Rf = 0.05; ESI-MS (MeOH): positive ion mode:  
2025 (31, [M+H]+); 2047 (100, [M+Na]+); negative ion mode: 2023 (100, M-); 
 
mono-3-deoxy-3-[N-(N-2-pyridyl)-methyl]-3-amino-β-CD (231) 43 mg 277 (0.02 
mmol, 1.0 eq.) and 28 mg ammonium fluoride (0.74 mmol, 35 eq.) were 
refluxed in 1 ml MeOH for 2 h. After removal of the solvent, the crude 
product was purified by RP-18 chromatography (gradient: water only to 
40% MeOH in 30 ml fractions), yielding 16 mg 231 (yield 62%) as white 
crystals. 
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TLC (SiO2, EtOAc/i-PrOH/NH4OH/H2O = 7:7:5:4): Rf = 0.18; 1H-NMR (500 MHz, 
D2O): 8.57 (d, J = 4.4, 1H, H6py); 7.92 (dxt, J = 1.5, 7.6, 1H, H4py); 7.53 (d, J = 3.9, 
1H, H3py); 7.92 (m, 1H, H5py); 5.12-5.17 (m, 2H, 2xH1); 5.10 (d, J = 3.8, 1H, H1); 
5.02-5.08 (m, 3H, 3xH1); 4.94 (d, J = 6.7, 1H, H1); 4.22-4.45 (m, 4H); 3.53-4.04 (m, 
38H); 3.40-3.51 (broad, 1H); ESI-MS (MeOH): positive ion mode: 1226 (100, [M+H]+); 
1248 (10, [M+Na]+) 
5.2.5 Catalysis: Conditions and Separation of Enantiomers 
 
5.2.5.1 Catalysis Conditions 
 
The ligand (0.0050 mmol) was dissolved in H2O or H2O/DMF (3:1, 0.25 mL), 
[RuCl2(C6H6)]2 (0.0025 mmol) was added, and the resulting mixture was stirred for 1 
h at room temperature. Sodium formate (0.500 mmol) was then added, and after 
further stirring for 10 minutes the ketone (0.050 mmol) was injected. The reaction 
was then stirred for 12-72 hours at room temperature or at 50°C. Then 1.0 ml water 
was added, the mixture extracted three times with hexane (2 mL), the combined 
hexane extracts were washed with water (6 mL) and dried over Na2SO4. The yields 
were analyzed by nonchiral GC on a Supelcowax column. The ee values of the 
products were determined by chiral HPLC, chiral GC or 1H-NMR/19F-NMR 
spectroscopic studies of the corresponding Mosher esters. The absolute 
configuration of the stereocentre was determined by optical rotation or mosher 
correlation model.  
For the synthesis of racemic alcohols: see 5.2.2.1 
5.2.5.2 Alcohols Separated by chiral HPLC: 
Following substrates were separated on the same Chiracel OD-H column from 
Daicel.  Conditions: 0.5 ml/min, 25°C, UV 220 nm. 
1-phenylethanol (278): HPLC (heptane/i-PrOH 95:5): 15.0 min (R-
isomer); 18.0 min (S-isomer) 
1-p-tolylethanol (279): HPLC (heptane/i-PrOH 97:3): 21.0 min (S-
isomer); 22.6 min (R-isomer) 
OH
OH
5 Experimental Part  139 
1-(4-chlorophenyl)ethanol (150): HPLC (heptane/i-PrOH 95:5): 14.6 
min (S-isomer); 16.0 min (R-isomer) 
 
1-(4-tert.-butylphenyl)ethanol (280): HPLC (heptane/i-PrOH 95:5): 
11.2 min (R-isomer); 12.1 min (S-isomer) 
1-phenylpropan-1-ol (281): HPLC (heptane/i-PrOH 95:5): 14.8 min (R-
isomer); 15.7 min (S-isomer) 
1-phenylpropan-2-ol (282): HPLC (heptane/i-PrOH 95:5): 13.2 min 
(S-isomer); 14.4 min (R-isomer) 
4-phenylbutan-2-ol (283): HPLC (heptane/i-PrOH 97:3): 15.8 min 
(R-isomer); 22.3 min (S-isomer) 
1-(naphthalen-2-yl)ethanol (284): HPLC (heptane/i-PrOH 97:3): 
27.8 min (S-isomer); 30.2 min (R-isomer) 
cyclohexyl(phenyl)methanol (285): HPLC (heptane/i-PrOH 97:3): 
27.8 min (S-isomer); 30.2 min (R-isomer) 
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5.2.5.3 Alcohols Separated by chiral GC: 
6-methylhept-5-en-2-ol (286): GC (Hydrodex 3-β-P, 25 m, 0.25 mm, 
from 100°C to 110°C, 0.2°C/min): 32 min (S-isomer), 35 min (R-
isomer)  
(E)-6,10-dimethylundeca-5,9-dien-2-ol (287): GC (Hydrodex 3-β-P, 
25 m, 0.25 mm, from 100°C to 119°C, 0.2°C/min): 75 min (S-isomer), 
77 min (R-isomer)  
(E)-4-(2,6,6-trimethylcyclohex-1-enyl)but-3-en-2-ol (288): GC 
(Hydrodex 3-β-P, 25 m, 0.25 mm, from 100°C to 120°C, 
0.2°C/min): 64.9 min (S-isomer); 65.7 min (R-isomer) 
6-methylheptan-2-ol (289): (Hydrodex 3-β-P, 25 m, 0.25 mm, 
from 100°C to 115°C, 0.2°C/min): 67.9 min (S-isomer); 69.9 
min (R-isomer) 
5.2.5.4 Alcohols Separated by Esterification with Moshersubstrate: 
general procedure: The catalysis was quenched with water (1 ml) and extracted with 
TBME (3x2 ml). The organic phase was dried over Na2SO4 and the alcohol separated 
from the rest of the ketone (kieselgel, hexane/TBME 3:1). The alcohol was stirred 
with (R)-(+)-α-methoxy-α-trifluoromethylphenylacetyl-chloride in 0.25 ml of pyridine 
for 30 min. After quenching with 1 ml of water the solution was extracted three times 
with 2 ml of TBME, the organic phase dried over Na2SO4 and purified over kieselgel 
(hexane/TBME 10:1) to get the pure mosher ester, which was analyzed by 1H-NMR 
(OCH3 of ester)/19F-NMR (CF3 of ester):  
hexan-2-ol (290): 19F-NMR (376 MHz, CDCl3): -72.57 (S-
isomer, -72.62 (R-isomer)  
6-methylheptan-2-ol (291): 19F-NMR (376 MHz, CDCl3):-
72.55 (S-isomer), -72.59 (R-isomer)  
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octan-3-ol (292): 19F-NMR (376 MHz, CDCl3): -72.41 (S-
isomer), -72.48 (R-isomer) 
octan-2-ol (293): 1H-NMR (400 MHz, CDCl3): 3.58 (S-
isomer), 3.60 (R-isomer); 19F-NMR (376 MHz, CDCl3): -72.57         
(S-isomer), -72.62 (R-isomer) 
nonan-2-ol (294): 19F-NMR (376 MHz, CDCl3): -72.56 (S-
isomer), -72.62 (R-isomer)  
nonan-3-ol (295): 19F-NMR (376 MHz, CDCl3): -72.41 (S-
isomer), -72.48 (R-isomer)  
decan-2-ol (296): 1H-NMR (400 MHz, CDCl3): 3.57 (R-
isomer), 3.55 (S-isomer); 19F-NMR (376 MHz, CDCl3): -72 56 
 (S-isomer), -72.62 (R-isomer) 
1-cyclohexylethanol (297): 1H-NMR (400 MHz, CDCl3): 3.60 (S-
isomer), 3.57 (R-isomer); 19F-NMR (376 MHz, CDCl3): -72.47 (S-
 isomer), -72.51 (R-isomer) 
1-cyclohexylpropan-2-ol (298): 1H-NMR (400 MHz, CDCl3): 3.58 
(R-isomer), 3.55 (S-isomer); 19F-NMR (376 MHz, CDCl3): -72 43 (S-
 isomer), -72.58 (R-isomer) 
 
The optical purity of 1-(1-adamyntyl)ethanol (299) was determined by comparison of 
the intensities of the methyl doublet in the 1H-NMR (1.08 ppm for the S-
isomer and 1.10 ppm for the R-isomer) by using the chiral solvent reagent 
(S)-(+)-2,2,2-trifluoro-1-(9-anthryl)ethanol (TFAE) (JACS, 112, 1990, 4441-
4447)  
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5.2.5.5 Separation of Keto Esters 
All keto esters were separated on the same Chiracel OD-H column as most of the 
aromatic ketones 
methyl 2-hydroxy-2-phenylacetate (300): HPLC (heptane/i-PrOH 
95:5): 14.6 min (S-isomer); 24.7 min (R-isomer) 
 
methyl 2-hydroxy-4-phenylbutanoate (301): HPLC (heptane/i-
PrOH 90:10): 12.1 min (R-isomer); 17.2 min (S-isomer) 
 
ethyl 3-hydroxy-3-phenylpropanoate (302): HPLC (heptane/i-
PrOH 90:10): 14.0 min (R-isomer); 17.2 min (S-isomer) 
 
ethyl 3-hydroxyhexanoate (303): HPLC (heptane/i-PrOH 75:25): 
7.0 min (R-isomer); 7.8 min (S-isomer) 
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